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<;admium ¥ an ubiquitous toxic metal to .w~ich everyone is ~~ .at
low levels. .It is toxic 10 almost every organ system of the body incl~dins
the ' immune system. In this study.. the ef£;ects of a rel~tiv.ety low dose of
_.cadmium o~ the immune systerh of .mice"~ the , ~ffects . 01 .~ . moderately.
large ~ose of 'zinc on(Cad~ium.induced immunOpalhO!~F~e *Idicd. 'SIx~
week old t:S7BU6 male .m~ were exposed ' -I~ SO.ppm ~~dmiumJn drinking
' water for 3 weeks, .and .killed 0, '3 ' an_d 6 we~ks ' a/lcr -. cessatlon. .
. edrnintstratlorr-v prevented -tbe " enhancement of antlbody-fcrml
~S'ponse. p~olir~iatiye · re~ponse , ' of SP1~en ~:E to 'the - T' CCI\ ltogens :
'phytohaemagglutinin _and concanavalin A tend : to be high' F cad iil~
• treated, mice' an~ ' zi~c ' administration after , sure to cad~ium tended to .(
lower it.' The number , of CJ;>g+ cells in t~e spleen was lower and the ratio
of CD4+ to ' CDS+ cells, "'refleciing' th~' ,baiance . of . lmmuncreguletory T
lymphocytes, was higher · in cadmium treated mice., Concurrent zinc
adrOi~istratiori' prevented, the.. alteration of ,'T 'cell subsets•. Suppressor cell
,aetivity - t~n~ _' to be~~o.w.~ in; cadmium tre~t~:...... .~ i~•.. -Natural.Id~ler _~II '
activity ' in .the spleen was low in 'cadmium 'treated mice . and ,concurrent
zinc treatment 'prevented the suppression. B: cell co~nt , In ' _the
antibody .'-prOduction" by splenic Iymphocyte~
,:,:
··i....' ."
iii" ~ p:-- ~
. timulatlon was not altered · by cadmium or zinc treatm ent . Cadmium and
'Il~DEXING KEY WORDS : cadmium, zinc, collularimmunity
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CHAPTER 1
1',',
INTRODUCfION
--..
1.1. TRACE ELEMENTS
The bulk of living matter consists· of five elements, namely, carbon,
. .
hYdrogen, nitrogen; oxygen, and ' sul~r. They ' are present in tissues -in
· concentrauons':of grams per kilogr~m and their aduU human require~en,ls
· are in the , range of , gr~ms per dlty. !he inacrominer~ls' s~iu~, potassium,
~lcium, magnesium, chlorine and ' phosphorus ;serve _as" ·structural
~~~!1e~~ __o~ ti~!J~ or ~ co~stituenls t.Pf -,Ihlt · body . ..,,....~"'"'._~.c...,..;
co'nc!ntration in living, tissue and adult hu~an requirements are somewhat
lower than the bulk elem~nts, · but still can be expressed as grams per .
kilogr~m ' and grams' or fractions of a ' gram. per .day. The bulk ' elements and
macromin~ra1s arc essential for the function o~ all. cells and the organism.;»
· 'as a ~hole. The remaining e1cme~ls of the: periodl~ table- that' ~u.~
naturally in th~ living· tlssues are ,-present in much lower cqnceniratlons.
Earlier analyt~cal .. methods were unable. . to determine their precise
concentration, hence they , were of~n . described as .~rr}ng ' in "traCCl;~
and .yg .tenn "trace .element" arose, to tknote them. Although present-dey
· techniques" can. virtuaity estimate all ' elements in biological rnatc;rial '. wl~
·~cat a~l1racy , the .term '. "tra~ ' element" is ~UII , retained ' In Ilte~ature
largely -because it, ~ hall~d by time and tradition. Nevertheless the tenn
docs provi~ a descriptive-:,classi~cation for a group of elemenb whOle
"\c
c.,~
' /:'. 1
.. ~" . '~': ', '
very ,maD and expressed in terms of milligrams
or microgr&mJ per~m (Mertz, 1981; Mcrtz. 1986).
hormones, cobalt ls. the essential metal. in '.vitamin B,J2~ chromium acts ' as a
cofactor Cor ' f~uliR. ' e ine . is, an essentia l roCactor.in many .metalloenzymes .
and copper b , a key regulator of Iysyl oxidaSe activity. , ~I'race elements ere
,:requJrcd ' in..' an ' opti~um level fo; their'. function. , Deficien~ will, result in ;
,pie, iron is . an .essential ' ' compo~ent . ~r the .oxygen ~ng ..protein
. ( haemoglobin, . i.odine is essential for , -CunctloI!aJ, activ,ity .of thyroid
T~ c1cments. which include all thc naturally ~g' elements
o:~pt th~ bu~ element and Duu;rominuals. can be classified into ~
CategOries : ,6n t. .~ '''':i? proven _ esscnt~ity; second, ~ose for which
' p~oof of - essentiality' .does·· net cxist_ (1'4ertz, J986). The ' essentiality of a
tr~ce e l~~nt ,. b-·. jUdg~d by-,. the cn,tenon 'that its def1ciet.t,.J~ntak~
-con!~tently . resulu : In' imPainn.ent of a function- which is ' prevented or ,
corrected. by IUPPle~en!-Btioh ~th , ph~iological. ~eve~~ of the- particular ,
element and not bi·ot hers., By .th is criterion chromium" ,cobalt. copper,
. ' ~ , : . . " . " " ' ., . " '"' ,
f1~orine, . iodin~•. •iron. man~anese, ~~Jybdfnum, selenium and zinc \ are
. . . accepted "as essential at present, even .thau~ all of these do not ' present a
r>. ,_ - practical ' -nutritional prob lem to hu~ans.~~- additi~n, 'arsenic, : niCk~~
. , ilioon, tin .~ vanadium are often included in the essenti~ trace el~meni .
group as ~~fid;;;q,Symptoms---.h8,!O ~rel1 bun reponed for. the m. but 'the \.
. .. , ite . , nd inode of eeticn of ti.':~';e~no;..ytt clearly defined .
•(Me~ ;981; Menz,I986~ . . .. -~' . \ '. '
. '.~
Most, ~f the eisen tial .tra ce 'elements" act ' pri~anly as s~ctural .\ . .-
components .or catalYsts in large molecules, hormones! ~'nd enzymes. 'Fo; \
\ .
~ " . .. . .
'· ·~:;".:~t. '"..~·~.v.~ ~i·~:~~:~,.~i>o i:~i;) '(;i~~:.,. ,I",,;,b. .i.'.: -~ -.:.." " ":":";,:;,.~""•., •,;" .~~'~...,,,.,...~,.; :;.i.•:....,.;;:
.. ~
c
suooPt~mal funct~isea~ \~d in extreme death" Similarly, 'excess
intak~ will cause toxicity and\ can have a ' fatal outcome. All essential trace
elements thus have a bell-Shaped dose response curve, the kurtosis of
which varies. For some, like\ selenium, difference between optimum tissue'
level !U'd ' toxic level is ver;. nerrcw; while for othert , 'like zinc. it 'is \_
. . I'relative~. r~' In tihe bio~ogical system\ ,"Optimum concen~~tio .ns of. trace
elements are ·'.,-.main~ained by\ ~.series '..p~ regulato~ .~echan lsms like
absorption, . distribution, metabolism and ' etcr~tlon. Some proteins are . also
involved 'm the . ·meta~U;in Ji trace elemeo~; " Uk~ transferrin forlroo,
ceruloplasmin for ~.p~i, .: .~nd.\ metall~~IOn~in ',"for- h~a~ ' tetalS. cadmium,
zinc,. copper and ~.thers~." . Althor~h t~e function of all th~se prot,elns ' are'.
. ~ot precisely ~own, most a~~\ as \carriers or b~ffers aglli(lsJ excess,
Among the ' second group lof trace elements, for which no css ntiel
function has~~n described i~" ran, some are of importance due ' t their
prm:~O' toxicities. Lead, . cadmiu1 ' and mercury are Important examples 'of
tl).is group, .A lthough all tr.ace '!e~ei~ts, .incl,uding jhe essential ,e l emen~, _
have inherent properties of toxiC,itt:ovhen..present in excess; lead, cadmium
and ,, ~erCury serve " n~ . eSsentia~ 1~IOgi~I ' f~nction, . they are ' ·eumula'tlve !"l
"poisons and ~re. , toxic ' ever .!It \ low · · do.~es. Their p.~ma~ . Importance to
biologists ' is due to Illeir toxicity. Ideally none of these. toxle metaIJ
should be present in the ~iSSUes. : but due tovindustrial activity a1id 'human
' I habits, ' all . ,orga.nisms are, C4?ns~ntly , exposed-,....,to these .elemeats , and
\ accumulate a .ccraidereble amount :0[ ' them in 't~e tissues, Toxic, heavY
\ metals arc brought up from the ,' e'ai1h's crust for i~d~strlal ';'Ie and uioolly\ . . •..
ve~ , little of I~em arc recycled. :l;hus t~eJr lev,eJ In,: the ~nvfroilJ~ent iJ
grad~ , In~ea.tng, also are the, levell In human ' and animal ; tiHue.
; 1' . _ •
(N a tional Academy or Sciences, 1978). This is particularly true for lead and I
~dmi~m. ··TIle . po tent ial toxiciti~ s> 1~1s of th ese ·. e nts to' which -
th e genera l populat ion , ia inadvert ,rltly espesed ~ thus of conside rable /
.. - - . ' !
PUbl ic...health Importance. ' . /
Among many functions of tra ce cleme nts, recent studies have also
dem~mst~ed their importa nce in .the ~egula tlon or immu~c Jun~,~ns i nd
host detens e mechanisms. Th.~ . irnpetu sto . the st~dY of trace element ! and
i,~m\lnity was generat ed from stud ies de monsiratlng ~~~stent . Impairmen t -
.·" :1"
" ,I
I
i I
:( . ;'~drl .an~ ,: Dayt~\:l.~),.~ -' H~r~_ .'. 1n . "m~i ,·.-or "i,' ';Immunol~ty, •~"I h:~' . "" 0' . he r rente,roJ,.m ode of :",mm~"'tI<>?
i:::, ,h : _~ >' ; " "" ;L..:\ ,:" .:",JL.",;.~,~.:,.,;,,•.",.. \ ,~ _ '~' ~>',I O." ,,,,,"i.: ' -" i ~
' J
df;t . ~i ' i~uQe functions ' in childre n ~uffering from gross ' undernu trn ion, like
fi proteln-energy malnutritIOn, in ~hiCh" not 6DIy-' supply . ofprotei~ . ;;;" ~ '
~ . :. tlll~ries are . defiden~ bilt a lsO, body stores -cr most vitamins and ~ntia l . .~~: ~ . trace elemene are leu than ' 'adequate (Chandra. 1972; ' -Otowdh~ry ~~ .
> , . Cband~ Ch.nd" 1988), . ' '-
~ '" The ...!,opK:\t... tra ce clements and imni~nity ~ been'" the subJect of
. . ."., '~~. . seve~1 workshops.' reviews _and m~~phs (Ol aoon. and Dayton, 1982; "
1 _ . Beise~ 1982i Olowdh uf)' Bnd _Chandra, 1986b, Chandra, 1987). !he esscntml
t~; trace . elements, p~CUlarJ). ZinC. ~n, ' coppCr an d _, sele~ium arc ' now
{~ . ei tablls hed critical {actors ' in the generation. maintena nce and arr(pliflC8.tion
~: . : or . Immune :~.po~ '. D'efic~eneles o~ .thC~ ..' elements _ r~duces _ the ~Ilular
.~~ Imm une function '. both In man and labo ratory ':a,nlmals and -Increases. the
v, suscept ibility ' 10 ' i nfe~tlon " and other" Im~unOI~g1callY:" mediated ' diseasC5. '
," Among .the non-e!.\en~I~I, trace ~et8ls",j ' 1C8~ ' Cadmlu~ " and mercury h~~e .
- ~ "'-'
been shown to be Immunotoxic in expe rimental animals (Kolle r, 1980;
has been used which is of rela tively little significance to possible huma n
toxiclty.,.yevenheless., these studies show that toxic metals also affect
...:".:0' I
immun~ponses that are of potential health significance. '
,~~
O ne important aspec t that has e merged from rece nt stuF!les on trace
. . .
el~men~ is the existence~ "Interactlons among them. · Trace elemen ts
interact , between themselves a\d a.lso with other d ietary elemen~s. The ",
topic hJ " bee n reviewed recen tly,' (The Ta.sk .Group on Meta l In te ractjo n,
19~8j Levander )~nd ' Che ng, 1980; .AbdUlla, . Nair ' 8n~ Cha~dra, 1985j ·.· "
Ch~dhUry~ .Cha~drs" 1981). However ' the effects ..s nd impli~ionll of~
this ph enome non on immune funct ions h as nct : been studied . On , the
. \
J
t;"'Jr,-~ ' premise that essential . trace eleme nts have importa nt immunoregulato ry
effe~~ ,and the known toxic ' elements are 'also toxic to the Immune
sjs tem. . del"oostmtion of such interaction ' among these two gr? ups of
elemen~/~ould7"be of basic an d applied signi~.
Cadmium and zinc .,are twoi~portant members of the
element groups . They both, be long. to group 118 of th e periodic ta ble and
, . -' . .
thus hav e many physical a~d ehem ical ~mi1arities . . They are ~sual1y found
togeth er in na ture and also -tn biological tiSll uCS:' where they com pete for
. binding sites , in ligands like meralloeneymes and the heavy, . meta l , binging
protein metallothlonein. Thus they form , an interesting _toxiC" . and. . essential
trace e~7~t psi;in the b'iOlogi~1 . sysi~m. In. the sUb5~quen; lection~ of
this cha pter, ' salient featu res of ~dmi~m end zinc will be discussed v.:i(~ , '
particular emphasis . on ' the immune ', system effects. 'Metallothionel n, which
is invo lved in the metabolism of both cadmium an~ zinc, will be '•.brJefly '.
..,
·:,; "., ' , "'. " '-: ~" '" ,:.'>-
discussed . and. the known inter aclions between cadmiu m and zinc wil l also
be discus sed.
1.%. CADMIUM • A TO XIC REA VY METAL
"
. , Ca d mium is an ubiquitous element to which ,~veryone is ' constantly
e spo eed 'at a low .jevel. At birth cadmium is virtually absen t from . tissues,
' . but it is gradua,lly acq uired from the: "e nvironment, so' .that in a lifet ime an
ecerege perso n l~ving , in . ll:J1 i'ndustrlal :,society , acCumulates "about 15 to 30
~g ~f cadmi~m in " his ' ,~y ·(~;iberg, piscaior, N~rd~i' and ~j:lIstrom. .;."..~ "
1.974). ~~~?~gh th~e .- acute l(;lldcity of cad~iu~ ' op, .the lung ' and
gastroi,:,te stinal tract has been. kn own for ~er e.' cen tury . (Whee ler. ' 1876) ,
it was o nly in 1950·~ . t~.t· 'th~' d~!1 8er ~f chronic expos~;e t~ cadm ium was
apprec iat ed, ! n 1942 Nicaud, ~Ii«e " a~d, ' G rcs ~in France ~~P?4ed"ilJ)
unusual numbe r of cases of os teo porosis associated with' an impairment of '
general . l;lealu\1:.i.n an alkali~~attery factory workers ~~d s~ggested
ca dmiu m t~ pe" lhC causative , age~t ' ,"<Fn1>erg et . ~I.. 1974): A few ~e~rs
later( In Sweden, Fnberg ' "(1948,' ' i9~0) conductecf' ~ '8 ~uJvey o~ worker~­
exposed to· ·.cadnii~~~de dust in' , a~ electri cal' b81~~ry Plant. " ~nd fOl!Jld .8 .
high ' . numbCr ' of' cases C!f lung ' 'and kidney "~a~ag~ ~~ar~ct~rized ' by<.
cm~hysem.~nd low molecul~~ ~t ' . prote incrie :rcsPc:~t~e ,y. , ~~hiCe, then,
mllny sir~:lllar !nvestig~~S)ns performed in "sever al ' cOuntri.es ha*} ~nfirtJ:l~
the ' danger , of , chroni c , . long.;term: cadmium "exposure, end cadm~m
rec ognized as a seriow occupational •health' hazard
..:~" , ' ,
t
The greatest conce rn ov~r cadmium polluti on ' wa s trigger~d by reports
from' Japan which showed" th~t . chronic ca dmium poisonin:g was - not
restricted , to .ind listrial workers 'only, but ';8n constitut e a ' hca lt~ hazard to
I th e gene ra l popu lation as' well. . A larg~ . po pulalion grou~ '- in Japa n "was ,
expose d to cadmium by contatni!,ation of food and water -thro ugh a mine.
Th e total daily intake of cadmi~m was abo ut ~en.fold greeter- than that in . _~ .:~'
most pa rts or the world. In 'so me areas the exposure was high ' ~nougb to
cause an epide mic of severe bon e disea se - th e /Iai·ita i diu Qse. (Fribe rg et :
. al., .1974) . ·Anoth t:r case of 'CBd~iU~ exposure amon;'th~ ' genCr~I' 'p6pulatlon '
occ~rred in ' a ,:i1lage i~ 'Englan~" TIil:: - source of cont~ination was food
gr own in an old zinc-mitlil}8 area. The level c t exposur:e was com parobl e"to,
- 'O' - .....th at of Japan, liver .cadmium . le~ls wer e high in th e exposed' populatlA,:,
and some eviden ce of kidney damage was ~oted, ~ut none de vejcpe d the
typical features of ltai·itai difeasl! ' (Carrothers anq Smith, 1979; Inskip,
11. 'Be ra l 'a nd McDow all, 19&2). ' ," . '
~\y ,~dmium has n~ dsentlal- biologica l fu~c~n. A1thO~gh . bne preliminary .
Com~unicatiQn has 'repo rted a gtowt~ supporting .effect of ~odmium i~ts
(SChwarz, 'and Spallholz, ) 976), there are )~o confirmatory repo rts
\ . . , .
subs tantia ting th is finding. So at , p resent all evidencc Indicate that
ca~;"ium is ' o!,1$>' a toxjc· element . and its , presen ce in t ells m'u~t be regarded
as somethi ng to be mir!.lmized.
".-.
environme nt: Industrial processes that use cad~lum include~ctroptatlng,
.
&.
a nd generalbpth in the indulitrlBI
\
. '
" . ,
fabrication of alloys and solders, manufactur e of paints where . cadmium
aalts are used as pigments .and plastics where it is used as a stabilizer,
and .in manufacture of cadmium-nickel batteries (Bernard and Lauwcrys,
1986). Certain' oth~r industrial.?processes, lik~ produc.tion ~f cadmium and
its com.pounds, smelting and refining ' of ~nc and lead ores, recovery of
scrap :netal, combustion of coal and oil, and disposal of sewage' and sludge
and of waste ' plastics produces ~dmium as a byproduct (Web b, 197.5).
Workers in both types of industries are at potential dllnger .of inhaling
large amounts of cadmium" as ~he ' processes involved emit cadmium
part icles and increase its level in the air.
, ' I
Fo.t the g~ner8.1 : POPulati~n, cadmium iFosure occurs mainly thr:ough
food. .However. . cigarcJte"ol smoke contains a ' significant amount of cadmium,
and thus in heavy smokers this is an importa nt additional source of .
,cadmium. Drinking. ' WDI~r . an~ ambient air usuapy contain very little
ca~mi\lm, and contri1;lUtl9,l] to total body burden of cadmium from these
sources 'are insignificant
Vol~nic activity and .e rostcn of land has cont,aminated the earth 's
environment, 'and pollut~d , its food supply with cacfmiu~ since thc beginning
of Iiic ; but it.is ,0~1y in the )a,st thr~' decades' that cadmium has bien.
" given a serious 'consideration i s a 'food contaminant. As "the industrial use
. ' " "
of cadr.nium increa sed over the , past thirty years" so did its level i? the
~ '~~nvironment ~nd .oonseque~tJy irr the food , chain (FOX: ~979; . Ryan, Pahren
. ~ Lucas, .1982). Several studies ,havc bee n conducted to ~timate the .
,"" avenae dally cadmfum intake from food., The values are extremely variable
depe~~~s ,,, on t)le geographical region, dieta ry habit and source 'Of
r.
contamination. Some foods like oysters. kidney and liver are known to
contain amounts of ,cadmium consi~erabiy higher thnn most other foods.
DietS rich in these foods may consi~er8bly _increase the cadmium intake
(Mahaffey, Cornellussen, Jelinek and Fiorino. 1975). The reported dally
inta~c of cadmium from various countries shows values of 10 • 51 ~g/day
for the United States. 10 • 20 p,Flday for the , United Kingdom, 11 • 18
wI/day. for Sweden, 15 p.g/day r lJelgium and 20 - 70 lJ.g/day for Japan
(Buchct, Lauwerys, Vandev rde and Pycke 1983; Page, :El·Amarny and
Chang, 1986). F~r Cans:a. t' average daily. intake ha; been reported to
be 67 p.~_ (Kb~atri~k and , Co.ffin, 19?4). 'It has been ,estimated that
cadmium intake of. ~39Q p.Yda~ far 50 years by' a healthy 70 .K~ 'man
would result dn kidney damage (FoX;1?83). Thus it can be derived . t~at the .
current d!etary· cadmium con~ent ~f normal people' provides a safety margin
of only 4 to 20 fold.
Various studies have documented the Importance of cigarette ' smoking
as a source of cadmium. An~lysis ~f necropsy material ' from smokers ,show . ';;
a higher body burden o.f'cadm:iu~ in smokers as compared I~ nOt1.smo~ers .
(Lewis, !usko, Coughlin and Herta, 1912j Hahn, Ewers, Jermann, fr~ier,
Brockhaus and Schlipkcter, 1987). The amount of tetained cadmium is also
, . " , " ' \ '. ~
directly proport,ional 10 the numbef of cigarettes ', s.h~ked. By In vivo
measurement,· the lot~1 body burden of cadmium was seen to be double i~
smoke'f. as , compared to non-smoke~ (Ellis, Vartsky, Zanzi, CohnBnd
Yasamura,-1979). in pregnant women who smoked, cadmium",levels were
- , elevated in their blood, as also' In the placenta and fetal: blood (Kuhnert,
KUh~~rt" .Botto~. and Erhard, 1~82). In a recent survey, bl~ cadmium
level was ' seen to. be increased in smokers with a 'dose-effect relatlonihlp
, '>
~ .'
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to the number of cigarettes smoked per day: Even ex-smokers had higher
blood cadmium levels (Moreau" Lellouch, Juguet, Festy, Orssaud and paude,
1983). .
1.2.2. Metabolism or cadmium"
The principal features of cadmium metabolism are its long biological
~alf-lif~ and interaction with other nutrients, particularly zinc. The long
half-life"'is due to the .Jack of any hom~ostatic control mechanis~s that
can .deal with the increasing intake of cadmium ~th age. The only
protection the mammalian ,system offers against cadmium is through the
synthesis of the.jntracetlular metal-binding protein metallotbionein. "
The main routes ~f cadmium entry into the body the
gastrointestinal tract and the lung. Virtually the total amount of cadmium
present in the body enters through these two organs.
Very little quantitative data are . available on th~ absorption of
cadmium in ~an. Most values are bas~d .on the analysis of human autopsy
m~lerials -end estimates of dietary intake. These Ii,ued" human 'data and
supportive animal experiments -indlcate th~t the gas~roiniestina! absorption
of cadmium is very low, l!l1d is geJler~l1y between 3 and 8 percent of the
·intake (Perry, -Thind and Perry, 1~6). Cadmium is absorbed by a process
of passive diffusion in . the duodenum, ;jejunum and il~um (Sahagian, '
Herdlng-Berlow and ,.Perry 1966; ~f1agian, Harding-Barlow and Perry 1967).
~~ ~._Intest ine, ; cad~ium con~~trates in '~ ' epitheliai , ~lls and much of
_~t is subsequently lost when", the cells are shed from . the villi. However, the
observation of enteropathy in '/ Iol-ilal dis~ase patients (Murata, ") Iirono,
· '; ~ '. \ ';
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Saeki and Nakagawa, 1969) and in experimen tal animals fed large doses of
cadmium ' (Richa~n.: Fox and .Fry, 1974) suggest that when cadmium
concenua tio." in the .Yll i crosses 8 critical level. j he cells
and a substantial amount of cadmium may enter the body.
damaged
Absorpt ion 9f cadmium . from the lung is ,much ~igher ,as compared to
the gastrointestinal tract. The rate of absorp tion depen ds on thr." size and
molecular, Iorm of the rt5pi~able particles of cad~ium. 'J?lc form~scnt l~
cigarette smoke is usually more. completely absorbed than those from
industrial sources. 'O ne modo! base'd 'on human aut opsy study estima tes that
50 percent of ' inhaled cadmium from cigarette smok!': is absorbed (Ellnder,
Kjellstrom.. Friberg, Und ~nd Llnnman, 1976). In non-smokers, inhalation
contnbu tes very .little . cadmium to the body. The 8~~orbcd fraction. is also
conside?a bly Ie$;' for other resj:>irabre sources. Ge nerally about 2S percent
of cadmium inhaled in ambient air is deposited in the lower re~pira~or/
tract. and about , 13 to 19 percent of the inhaled cadmium is absorbed
(FnOe'l! et el., 1974).
Nter absorptio n cadmium is transported in blood. The mode. of
cadmium transport in blood is unlmowri. but iI is 'thought that cadmium is
~nsported in 'pl~ma bound ~o ' ~ molecular , weight proteip(s) an'd ' in
erythrocytes bound to haemoglobin and other protein(s) (Nordberg, Piscator
and Nordberg," 1971). Animal studies indicate that freshly absorbed cadmium
is first taken up by the liver and incorporated into metallothioneln. This
cadmjum-melail~;hlonein ~mpIU' is then slowly. relea~d fnto blood ~nd
taken up by other tls.sues, particularly ' kidn~ (Kell ial. "1986). In tinue. ,
cadmium is , ~gain bound hito metallolhionein, Which. keep" the metal In a
"~.'" ," ; ,'"
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non-ionic fonn that is eon-tcdc, Kidneys. (or some unknown reason '
produce the highest 'amount of ~mctallothioncin and concentrate . the largest
amount of cadmium: Uvcr also concentrates a considerable amount of
cadm~m. but the amount is . generally much lower than kidneys. However.
due 'to its larger weight the liver contains a signif'icant fraction of the
to tal ' body burden. In kidneys. a cac mfum. gradient occurs with the
concentrat ion , in the outer ' Cortex being ' twice that in the medulla
. (Uvingst~n. 1m ).
Cadmi~m_ once stored in tissues. is r':,leased very slowly. Its biological
half·Ufe-has been calculefed to be . 5-10 years in the liver and 1~3.3 .yeers
- fn th'e -kidri~ ~jcJl5trom. 1971; F~~rg et aL, i974)~ V~ry ~ma11 a~ounts
, " A ' . '
o r eadmium are norma~ _ excreted fro m the" bqdy. Th e principal route ~f
cxcr~lIon is the urine and in normal man the urine cadmium -'concentration
'varies ~m <. Q.5 to 2 p.glliter. The ' I~cl is higher in smokers -than in
non.smo1r:~n. AIsO with inaessing age., as tissue' cadmium levels .increase,
. '
the urina ry out put of cadmium also lncreeses, Th us ' normally unn ary
cadmium leveb\e~t the tot~ body burden _of the metal (Kos.tial, · 1986),
. \ . . " ' . ~ -
However, ;hen re;w da~ge .occun due to .~ry hi~ kid~ey _~miu~ ..~d, _~,
the excretion' Increases..d~at ieally and may reach values over 100 Wp day
(Hallenbeck, 1986).
1.2.3. ToxIc efl'ectaor cadmium
" Cadmium ;, tOld. ' to , <inually every system' of the body. ·~.n;~e< I'
. . . . \ ,
information exists on the toxic effects or cadmium, however, for obvious :
. .- . . . . . . , . .
~easons - most or tbe data are from ' animal studies. Ta ble 1.1 summarizes the .
Ii
Toxic Effects of.Cadmium
Type ,Effet ts
Acute Gastroenteritis
Bronchitis and pulmonary edema
R~productiv~ystem effect •
> )
Chronic Renal' damage and proteinuria
11a~7i1ai disease
Chronic obstructive lung disease
Essential"hypertension •
Carcinoma of lung and prostate •
Teratogenesis •
Immunotoxicity•
"~sionally - Mild ane~ia,
Yellow coloration of teeth,
Nasal mua: sal ulceration,
Anosmia, Live'r .damage
• InconclusiVe eVidence of occurrence in man
Nordberg e l /:~.I.;' 1973
Friberg et 81.; ..1974
Parizek; 19S6.& 1983
Pis~tor1 1986
Friberg' et. aI., '1974"
Stanescu et el., 1977
.xcop er al., 1982
Thun et al., 1985
Machemer et aI., 1981
Koller, 1980 •
. Borgman et al., 1986
Bemerd .et aI., 1986
"" ~
man~estations of. aCylC and chronic cadmium toxicity. In this ~ction the
major featuret of Jdmium toxicity are discussed. while in the next section
(1.2.4) the present sta tc .of knowledge on the immune system effect.s of
cadmium is reviewed.
. ..:. Acute cadmium '~isoning is rare in. man. .Massive -oral Md respira tory
cadmium exposure hu bee~ . reported ' foD,owing ingest ion of f~
contaminated by cadnlium.pJated utensils . (Nordberg, Siorach and Stenstrom
1913) and rro~ , inh'BlatJon ,:'of ' ~dmium containing 'fumes' in jndustrl~s
'(Be~a'fd an~ LaUwc~~ 1986)." Symp~~~ of ' oral cadmium exposure v.:cre
. ~~stly ~' rerer~ble to ',th~ . -:~~~~ '~~~Oi~teS l~na l t~act; 'and i~~uded_nause"a:
vomiting. diarrhoe a," abdominal " cramps and rarely .shock due to dehydration.
Inhaladon of ' cadmium £Umes. which '-~n ~r ' in industries where cadmium
is heated to ii vel)' high" tem~rature .multing in the prod~~on of toxic
·cadmium..oxide fu~es. · ' cit~ .. b~nchial · · .and pUlmo~iuy' irritation and
sometimes fatal 'Putn~nlU)' ...edema (S~~ Veriter, Fra ns, - Goncettc,
R~1s, Lauwerys ' and Brasleur.: '1977). Labora tory .anima~ exposed to large
. . '" .
doses of cadmium by oral or inhal~tion route also show similar
manifestations, ~~I for': some _Unknown reasons rode nts tol~rate large
., dOSesof ora! _C8dmi~m Wihout gastrointestinal rea~tio~ (Kostia l, 1986).
-e, Fol1~ns · parenterai administration , of large doses of cadmium to
" . .. . • -. . , • i- •
animals, ' reproductive system effects are most .promine nt. In.' male rats, 8 .
" .,
single large dose of " cadmium by . injection characteristically causes
. . I •
heemo rthegic necrosa. of tho testis '(parizek and zahor, 195~. ',The necrosis
'is caused bY'interference 'with' :' testicul~u blOOd supply :by .~d~lum (Gunn,
GouM"and ~(ie~n, 1963a). 'Testicular necrosis can also be ind~d ·~
',' ,
-:
J .
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relatively low doses that do not damage other organs. In female reu,
cadmium injection causes hyperemia pi the ovary. ~tresia . ott the follicles_
'and features similat; to toxemia o~ pregnancy (Par~ek. 1983). The cause -of
this predominant involvement of the reproductive organs is not known. In
) h~S, no ~effects'" on reproduetive~r8ans have b~n reported, but it is
hypothesized th~tcadmiu.m . may playa ' role in th~ devetopmen.~ of
pr~gnancr induced hypertension (Chisolm .and Handorr, 1985).
. . . . . \
1.!nlike acute cad~i~.m toxi~ity. i hlonic ,cadmium, toxicity is relatively
more com~on. In cadmium e~~ur\ all tissue! . ·a~uire the metal, but
kidne~. c~~Centrate . the high~st ~~otin\ and renal damage is the maJor .
featu~e . of cadmium poISoning. Even !'lfte~reSPiratOry expcsjire, .k i~~ ar~
ultimately . involve~. al.though lung is th first or~ <affected. PrOximal,
tubular cells. are typically damaged In chro ic cadmium toxicity resulting 'in
a Fenconi ~ proteinuria charact~rized b~\ loss of Jow.~olecular 'weight
proteins like .ai-microglobulin, retinol-binding:" protein and I~zyme; and
amino aci~, glucose and phosphate [Plscator, \ 986). In cadmium exposed
. \ ~
.workers, increased urinary excretion of high molecular -weight , proteins like
albumin, g~mma.giob'lin. and 'tran!'err;na,e Ofte~~delected as an Isolated
findi~g . or in ass~iation with low molecular wei \t proteinuria ,(Bernard, .
Bucher, Roels, Masson and Lauwerys, 1979; Buchet, Roels. Bernard and '
Lauwerys, 1980). The loss ~f high' molecular we~t proteins probably'
results from an increased glomerular penneabilitY together with ,decreased
tubular reabsorption (Lauwerys, ' B'emard, Roels.v Bucbet and Viau;.1984). ' .
. , " . , ' -------... "
Renal dysfunction typ!~~1I1y OCCltrS when the average- cortical concentration
reaches 200 to -300 Mfg wei welgJtt, t~e '. amount ,varia depending on the
~ Of, ~mium compound and . rapidity of admlnlstrat.i~;~: _(EIIls, Mor~Ti,
. ., .
otherwise ~ptoma~t; is-'a topic. of, deb~te. However, tubular . dysfunction,
o~ce esta~hed, !s . irreve~ible and Usually progressive; thus it is usually
accepted ~ an , e'arly sign of cadmium toxicity (Lauwerys and Bernard,
1986). ' Recent stUdies in indUstrially exposed workers show that tubular
. . . . ' ' .
~~etion even appeArs at exposure levels that ar:, currently a~pted/as
( -
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ZBnzi, Yu.u"~~,._va_ruky and Cohn, 1981; Reels, Lauwe~ and Dardenne,
.J98 3;4'iiCator, 1986). The precise mechanism of cadmium nephrotoxicity is
not known. Nonn ally, cadmium-metallothloneln complex released from the
liver into the . blood is freely filtered - thro ugh the glomeruli 81;1d
Jubsequent ly taken up by the proximal tubular cells. by pinocytosis. Inside
the tubular cells cadmium is bound to newly formed metallothionein. It has t
been suggested -that kidney damage is prevented 85 long "as tubular cells .
""-prodU~ enOugh" 'mct~lothionei~ : ' beyond that th~ . 'cells ate damaged by 000- '
'mctallothlonein·bound ' ·cadmium ,ion, and law molecular weight prot eins that .
\ , , ~ -- . ' - ..
arc norma'lI~ reabsorbed _by p~mal tubular ' ~ Ils begln . 10 appe.ar in"urine
. (Fnocrg ; ,' i984). It hal also been proposed that the- .iubulai epithelial cell
membranes may be damaged during \ the process. of eadmium-meta llothionein
. , .. ./' . ..
complex . absorption from the tubular , lumen, and the cadmium-
metallothionein complex itself may damage the tubular cells in ·additil?n to
frec ionk: ' cil.d~ium {Kostial, ,1986; Suzuki and Cberian, 1987). The immune,
system. ~as also been imp.Heated in the pathogenesis _-of cadmium
nePhrot,ojl city. In . cadmi um treat ed. an imals Immune complex
, glOOl:erulrePhrjtis , (JoSh~ Dwivedi, p~n .· ~nd HOlscher, . 1981) ap.d ,
C. i~CU. Itt8 antl.g1~m~ru. lar .. bas.ement m. e.mbraneantibod. Ies _..(Be~ard.
Lauwc Gengoux, Mahteu, -Fcida rt, D~ct and Weening, 19841 .have beel;l
. detee,ed, The health ' impUeatio~ of low-molecular proteinuria, which is
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normal (verschcor, Herber, Hemmen, Wibowo and
Jakubowski, Troj~nowska, Kowalska, Gondek, Sta~ki,
Jajte, 1987).
Bone leslolU characterized by osteomalacia, osteoporosis , and
sponta neous fractures are usually late manifestations of severe cadmium
poisoning . Itaj-iJai disease was an extreme . manifestation of cadmium-
induced osteomali;cia. ·'Typ ical features were bone pain, ' difficulty inI . .
walking, and s~ntaneoUJ fr~ure. The disease . . ,typically affect~d -mlddle-
aged multiparous women (Fri~rg e( ~1.• . 1974). Since cO,Deenllation oJ
~dmium in the bone doc s not increase even ' at II. high body burden, and
cadmium is not known to ' haVe any direct effect on bon~ - the eff~ct of
cadmium . .on bone in /tai-iJai disease peuents was probably secondary 10'
~renal tubular, dysfhtipn with increased ufina'ry. loss of calcium BDd
phosphate . along With decreased dietary intake of protein ond ~Icium and
increased 10M due to prc8Jl.ancl~s.
Cadmium , has also been linked to other diseases . like . essential
hypertension and carcinoma of the lung and prostate. 'Th e hypothesis of a , , ~
link between cadmium. and hypertension was based _on the observati~n" that
.several anti-hypertensive drugs show increased ' binding 10 som~ transition
elements .like cadmium. ~pper and zinc. Of these , 'cadmium received most
attention due to its affinity - for the kidneys, the organ recognized -for _its
role ' in conlTqlling blood pressure (Perry, 1!r72). R~t studies ~Iearly Indicate
that cadmium at a dose range of 0.1 ' to 20 ppm in dj.!n~ng water can
produce elevation ' of systolic and , .d ias~Oli-c blood pre"~~ while dose.
above this r.a,oge de~eBsel the blood pr~"ure (Perry,': Erloo.er· and Perry ,
1977; Peny, Brlahger and l~rry, 1979; Koop~ Gtonek, Perry, Erlanger and
. Pe~ 1~)".,·~ spite of clear evidence ,in animal: there is no' direct proof
of an assdciation between cadmium and hypertension in .bumans. In ~n
~ endemic: area of high -ce dm lum exposure in Japan; examination of a very
large , sample 'of the' 'population did not reveal any relationship of blood
pressure ,with t.he degree of pollution (Shlgematsu, Mtnowa, Yoshida and
Miyamoto, 1979).
',The interest In cadmium possible 'qrcin~en generated by
some earl)' epidemlologicill Studies ' shoWing' an increased im:ide'nce- of
~ , " . '"pro~tatic : and. lung , cancer _ in occupationally ~d workers , C)Gpl~ng.
waterhouse, 1967; Le~en, lCe, Wagoner ,snd; Blejer• .1976). But in 'm,ost oC'
these studies the number of o~;n..ed cases were too small to permit 8
finn con~lu~I.On, .and oft~n the ,_possible ef!eets of cocarclnogens . like
tobacco and other Industrial chemical~ were not considered. However, 'in
rats and mice, cadmium siv7n by injection or at a large 0~1 dose for a
tong pedod vproduces lnte~titi al cell. tumour in the testes or sarcoma at
the site of injection (Haddow, Roe, D~kes and -Mitchley, ' 1964; . Bernhard,
Vogel and 'Loser,' 1987). Also prolonged inhalation of cadmium' Chloride/\,
/' fumes at ~tire '17veiS within 'the current' occupational limits has been
/' demonstrated to cause a- dose ~~_pcndent . increase in lung cancer in' rats
.. \ (Takeneke, -OI~ligeS, Konig, Hochr~iner and OberdC:~ter. :1983). In contrast .
'to dennr-we anim.al studic~ results fro~ human sJudles _~re Inco~c1usive. A'
. . , ...
recent report "of a s~udy in which a large cohort of , industrially exeosed
workers ~.e~ ,~ined, a d~finlte: ' incre~c in ' lung can~r wa~ o~served
(Thun, Schnorr, Sm.i~l,\ H81periti and Lemen, 1985). HOWever, in another
almilar study , nc ' association 'betwe:~n ' ~dmi~m and . found
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(Sorahan, 1~87). Thus the ~iation of cadmium Bnd.human mallgn~ncles
is not yet ~establishet'"'"but the evidence strongly suggests that c"admlum is
a carcinogen.
Other toxic effe.cts often aunbuted to cadmium, incJude teratogenicity
and embryotoxicity (Machemer and Lorke, .1981; . Machemer and Lorke, - -
1981). Cadmium has also bee n reported to' cause mild ,anemia, yellow
• I . - •
coloration of teeth, anosmia, ulceration of nasal' mucosa and signs o~ liver
damage (Bernard and Lauwerys,1986).
1.1.4. Effect or cadmium .~n Immune responses
Th~ effects of cadmium compounds on the Immune system bave been
studied eXtensiVely in dj~erent animal species in recent years and the
topic has been ",reviewed (Koller, 1980; Exon and Koller . 1986). rCadmium
has been shown to significantly affect the immune responses, however a
review of the literature- reveals mpny inconsistencies. The antibody
response and cell-mediated immunity have been .shown to be both enhanced
and suppressed following cadmium treatment, The ~ffect varies dependi,ng
' on the dose,·, duration and route of cadmium treatment, temporal
relationship between cadmium treatment and administration of antigen and
, the species of animal tested; ·This is not unexpected as cadmium absorption
from different sites is known' to v~rY·'and the effect of 'a ' toxic element on
an intricately controlled system like the immune s)'item would be expected
to be dose dependent.
Although the results ' of different studies ere ambiguous, cadmium
generally immunostippresive (Koller, 1980), Primary ond secondary Immune
.\
<, ' .
responses against heterologous antigens 'a~e suppressed in rats and mice
treated 'with large oral doses -of 300 ppm cadmium, in drlnldn.8 water for 10
weeks. (Kotler, Exoo and Roan. 1975) or by _cadmium i\njection [Bozelka,"
Burkholder and Chang, '1978; Shippee. Burgess, .Ctaverra, DiCapua ' and
. "" . ' .
Stake, 1983) or inhalation (Graham, Miller, Daniels, Payne and Gardner,
1978; Knystyniak, Fournier, Trottier, Nadeau and" Chevalier, 1987). In
contrast, low.oral d~s of '25 or 'So ppm ca~mium i~ 'drin~g 'water has'
been reported to have no effect ,.on.'primary antibody forming, cells (Muller , .
Oi1lert. Krause, Jautzke; Gross arid Diaman\slejn~ - i979; Wesc~nberg and
. Wesenberg, )983), 'or to" increase (Malave and DeRuffino, 1984) or to
de~.r~ase (Blakley, 1985; regman, Au and ~andra, 1986)' the~r 'numbe~:
Also parenteral administration of 0.15 .mg of cadmium in mice before
antigen challenge increases IgM and fgG antib~y . production (Koller, Exon
and Roan, 1976)." but at doses of " 1.8 mg/kg body w~ig~t suppresses
antibody response d~e to direct inacnvation of B ~lIs (t::ujimalO, 1985).'
Cadmium-Jnjection initiated 7 days. before antigen. administ~tion suppresses
anti~ synthe'sis., b~t it enhances the ' response when initiated 14 -days.,
earlier (Jones, Williams and Jones, 1971).
·Other data su~est that ~llular 'immu,ne functi~'ms . are ~also affected' by
cadmium; Delayed cutaneous hypersensitivity ! caction which is a classical
in vivo t~t for cell-mediated immunitY 'is impaired bY cadmium in mice \
. (Muller et at., 1979). However, the iii;vuro tests .of cell-mediated immunity
. .. . " . . " \ ..... -
.dc not show, ~nif~~ . effects f~l1owi~g cadmirm exposurec Lymphocyte
tra~f~rmation in ' viJro . tomit~gens , . like p~~tohaem!lgglutinin (l?HA);
concan~valin A. (Con A) - a_~~ po~eweed 'mjl,eri. (P~) is B eOm~o~ly .t:-~ emp10rcd \fS8Y,of' cell-mediated} mmunity: The plant lectlns PHA and , Con'
l :~ ..\
',;'. 1i!i':';':" .':'''.'';';:'i L,''> •.;'c':>.';:;';:;.. '.'..':;C':.:,kv, .,""".,..:, .: i • . ;,:".:..... ~ : '
r:
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A acnvate T cells; and PWM. activates both T and B c~ls. In some studies,
lymphOcytes from mice and rats exposed to cadmium have been shown to
have increased re~po'lise<lto ~ cellmrtogens (Muller -'C1 t ·al., 1979; 'M~lave. ;nd .·
DeRuffino 1984). whereas in ethers no change (Wesenberg ariC!. Wesenberg,
. 1~~,' ; Blakley, 1~8S,) or a, d~re~se (GaJJSki and S, harms, 1978) In .respo.nse.
has been . observed. ,B cell responses re general,ly increased In .cadmium
treated animals (Muller : et. al., : 1979; Koller, ' Roan and ' Kerlcvlie't, 1979;
Blakley, l?8s), These contlicti~,,8' repo inalcate that ~dmluin can' impair
" '
some parameters ofthe immune response while augmentjng others, ' ,
Oth~; i~~UO" . cell, ~~~' the ,J~~~,ge, and polymorphonuclear ..
leukocytes are ~ ~dve'~elY a~~cted f~ cadmium. Phagocytic capacity o£,
these cells is reduced (Leese , ~i1kwO~h and Warringto'n, 1978). ·
. :~acrOphageS from cadmi~m · ·tres ted ! animals pro~uce less macrophage~
, migration inhibitor " faeeor, 8 Iymphok ne (Kiremidjian&humacher, Stotzky, "
,. Likhite, Schwartz ~nd Dic~tein: 1~,ljll , ~re sl~ggisti in movement a~d less
responsive to macrophage migrat on . inhibitor factor (Kiremidjian.
Schumacher, "~totzky, ' Dickstein ,.an~ Schwartz, '1981):" 'AlSO~ cadmium
treatme nt .inhfbin "the ' ability o~ i~I- "". :acrophages to destroy "?"
~11s in vitro (Nelson, Kiremidjian humacher and Stotzky; 1982), In
• addition, .large doses ~f cadrniu.~ r a~icts, lh~ ma,tu~tion o£ lymph,oid cells
and results in an increase in large i~mature cell types (Ohsawa and KawaJ~
.\1981 ;, ~ B~;c~iel. , ~~dle~;. Cameron, pi,n er, Urn, E,Il~S. 'an~ stewa rt" 198;)"A>
a result of.. g~ner~lized immun~upp ssion, ca~~jum, treated ~~lmal. show
increased susceptibility jo bacterial, viral and protozoal infection (Cook,
' H.offmann :md D;~O' 19(5.; Gaine r~ 1~7; ~~n. Patton. 8.nd Koller, 1979;
, Bxcn, .~lIer and Kerkvliet, 1979~, Jr~~~en~ ~£, ~ncer ~. also Incrcaed In
\ , .,
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8 dose dependen t fashion (T akenaka < et al., 1983). Development I:!( cance r is
probably ·multifaCtorial, but ' cadmium i~duced . 'a lte ratio n of immun e function
• I - mey contnbutc to its pathogenesis.
Th e impli~tioris of cadmium immunotoxicity on buman hea lth are
prese ntly unknown : -Howeve r, ~nimal observations suggest that cadmium
m~y well be immunotoxie in man. In viJro studies with human blood
exposed . to cadmium' chloride show that lymphocytes accumulate - cadmium
r;r · i~ exce~ other cells: When blood b expos ed i.~ cUlIure 10 cad,miuml
at levels co~trab le to blood ' cadmium levels found in cases of
~ . , .
occupallonal hu~~n expolU~~. , the }Ymphocytes .~cc:um.u la t~ approximate ly
~(old more cadm ium than re~ cellY (HlIdebmndand Cram , 1979). The
. .
cause of such select ive uptak e of ' the metal is not known. however, this
observatio~ provide s on~ possible explanation for t!Ie finding of altered
immune response in experimenta l .animals exposed to cadmium, . as
lymphocytes ' ere the key cellular compo nents of the immune functi?n. A
;imilar litu~tion may' ajso e)dst 'in the \ uman population ~xposed 10 high
i'-els of cadmium in induStries or through heavy cigdrette smoking.
1.3, ZI~C • AN ESSENTIAL TRACE ELEMENT
Zinc~ ,has long been know.n. to be an essential trace element for the
growth and development C!f living organisms. The > fin t evidence - of its
. \
eSsentiality in . biology was the demorut ralion over a century ~. ago that zinc
is. required by the fungUs-Aipergillus nig~r, Aft'iJ' a I~pse of almost sixty
' years., the essenll ality o,f zinc for ' the higher forms or plant life was
established. Subsequ ently m~ny Investigations revea led the ' presence of .elne
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in plants and animals in concentrations often comparable with those' of
~on and usually mU~h greater thay those of - other trace elements (~'Dcll,
1984). ' However" the essentiality .~c for mammals was not established
until 1934, because of early diffiCUlli~ in, producing 8 zinc deficient diet
for laboratory animals and the apparent absence of natur zinc deficiency
sta tes. Todd" ,EJvchjem and Hart (1~34) first produCedfnequ~ denee
that zi~c is an essential dietary element for the rat. Subsequent ly other
wQ,rkers es tablishe d ,the esse ntiality of zinc in o ther
inclu~ing. rodents, poultry and rumin ants (Luecke, 1984).
anjmel species
, \
, "
Inter est in zinc in human- nutrition followed the work of Prasad and
, , '
cOworkers " .(Prasad~ . Miale ; Farld,. Sandstead and Schulcrt, . 1963; . Pra sad,
Mlale, Farid, Sam;fsieat;l. Schule rt and Darby. 1963) who In early 1960s
. I • -
provided the first evidence for the occurrence of nutrit ional zinc
. deficiency t he hu an, ubsequently acrodermatitis ente roperhtce Wi ll
described as ge tic defec of zinc absorption; end it was appreciated
that nutritional and conditional zinc deficiency may complicate many
disease states in man including steatorrhea and other melebscrpuoe
syndromes, p~atients on total parenter al nutrition, penicillamine ' therapy,
\ .
alcoholism, bums , sickle cell anemia, Qown's syndrome end chronic renal
dise'as,e (Prasad. 1984; Hambldge, Casey and Krebs, 1986). The importa nce
"\ ' -. . ' .
of zinc\in bumae- nutrition was further , highlighted by jhe o~servatlon thai
even in\ the Iree-Iiving population I~ " an Industrialized country, zinc
nutriture was marginal or deficient in some groups, like the elde!ly, some
Infants, pregnant . teenagers, institutionalized individuals and the ' poor.
(Sa~dslead, i9 73).
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In humans -zlne is essential for almost every organ system of the body.
The clinical manifestations , of zinc~ deficiency include bullous-pustular
dermatitis, alopecia. diarrhoea, mental .disturbances. male' hypogonadism,
poor ' appetite. decreased tes te acuity, abnormal dark adaptation. delayed
, wound healing and Intercurren t infections as a result of.. disordered cell-
mediated immunity (Hambidge, Casey and Krebs, 1986). '-Animal studies abo
substantiate these findings. Th e rolc "~r "zinc 0 .11 immune functions has been
studied cxt~nsively in recent years an~ reviewed (Chand~ 1983; Chandra
and Puri 1985; Fraker, GershWi\. Good and Prasad, t986; Fraker, Jardieu
and Coo~'1987; Chandra, 1987). I~ a subsequent section-'( 1.3.i ). the role of
iinc in immunity ii discussed - jn jgrcater dc!a il. T~ pla~e ~he information
into pe?pectiv e, the genera l biological a~d ' cellular functions of zinc are
briefly dlscussed in the ' next section.
1.3.1. Blologtca~OD' of zinc
Zinc has the ab ility to ~onn stable complexes with t~ side chain of
. proteins. a property that is relevant to its biological functions. The
involvement of :zinc in enzyme functions and structures is the best known
function of thfs metaL' V811~ (1983) conjectured that ' the biologi~1
abundance of zinc, its ability to interact with wide ly varied coordination
g~omelries and its resistance to odde tlcn-redcctlcn have generated '
. . . {
selecuve evolutionary pressure for it to serve as a biological catafyst.
rarbonlc . enbydrese ~s the fiDt ·zinc metalloenzyme to , be identified and
purified .(Kellin and Mann, 1940). Subsequently many other zinc enzymes
I
i have been Identified, ' and if related . enzymes from ' diffe'rent species are
.!Included. the~ ' over '200 zinc ' metall~nzymes arc now on record (Vallee,) ,
-s.>
.. .;":.. •<·i••: •••.•• ~ •.• _• •~ < .' I -~. .;
2S
../
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1983; Prasad, 1984). Zinc is postulated to have a catalytic, structural Bnd
regulatory role in ' these proteins. Among others, zinc is also needed for
enzymes involved in nucleic acid metabolism like DNA polymerase, RNA
polymerase, reverse transcriptase 'and nuc~eoside phosphorylase ~Uebcrman,
Abrams, Hunt and axe. 1963; Ballester . a~d Prasad, 1983). Involvement of
these enzymes in zinc deficiency would thus be expected 10- hove II
:r~found effect on rapidly proliferating cella like the C that take part
• In Immune responses. . . 1ItP
. .
Zinc also has an important structural role at other sites. It . is
speculated. that zinc may form mercaptides . with the Ihiol . grou p of
proteins, link the phosphate m~iety of phospholipids or - interact with
carboxyl groups of sialic acid or proteins on plasma membra."..Fs resulting in "
, a change in fluidity. and stabilization of plasma membranes (ChVapil, 1976).
SimjJ~r effects can also ' occur at oth~r biomemb}anes. Substantial quantities
of zi.(1c are present in RNA and DNA wh~ is thought to stabilize the
structure of jhe molecules (Ha~bidge, Casey and' Krebs, 1986). Some
regulatory proteins ,involved in gene expression also 'Contain the zinc atom
which stabilizes the three dimensional structure of the DNA binding
domain of thesl; p~teins (Kadcnaga, Camer.vMaslara and Tjlan, 1987; Klug.
, '.
and Rhodes, 1987). Thus in zinc deficiency, membrane functions arid nucleic
acid metabolism are altered, which partly explain the int'murtological . ·
alterations ~en in zinc deficiency.
1.3.2. Zinc and Immunity
The . effects of. zinc deficiencY . have been studied extefllive l~ . In
patients ~th acrodenna titis enteropathies (Chandra, 1980) and other Itatel
.:<
. , "i.',
J
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of acquired zinc deficiency (Golden. Jackson and Golden, 1977; Pekarek.
Sandstea l!. Jacob and Berccme, 1919; Olandra and Puri 1985; Tapazoglou,
Prasad. Hill, Brewer and Kaplan, 1985); and rodents fed zinc deficient diet .
(Fe mandes. ' Nair. Once. Tanaka. ~ and Good, 1979; Fraker. Zwick] and
Leueke, 1982). Zinc deficiency affects various immune responses. but cell-
mediated immunity is affected more' than others. Both in man and
laboratory animals, the lymphoid tissues panicularly the thymw, are
at~phicd. The effect is more prominent in the cortical area of the thymus
and thYmus~ependent ar~as ' of peripheral' Iymp'hoid tissues. In' . the
.peripheral ,"bl~, absolute number of ,i;;'phOeytcS, T ' cells and ' CD4'*
helper/indlJcer T cells are redu~ed in ' number. Furthermore, lymphocytes
(rom zinc deficient subjects or ' animals . show reduced blastogenic res~nse
10 T cell mitogens PHA and Con A" As. 8' rCSldt of altered ' cellular immune
profile and T cell function, pa tients with zinc defici~ncy arc usually
anergic to common reca ll ant igens. Sensitivity to che mical sensilizing '
agents is also subo ptimal Othe r cellular functions like the natural-killer
eeu adivity and antibody-dependent cell.m~iated eyto~ty are also
reduced- in zinc ~ellciency. but these findings" are nOI, consistent. 'The'
effects of zinc deficiency on ce llular immune , functions usually d~lop
rap idly following depletion, and replenishment with zinc the
erreeu; ... ·
Studies on the ' impac,t of zinc deficiency on antibody productio.p and
" ' ' .
other aspects of humoral I immunity show that Beell function is, also
affected by zi~. In zinc ' deficient animals, both primary . and secondary
a~~ibody responses 10 hete rologous antigCns ~re reduced ; and , proliferative
response of Iymph?"Y'es to 'the B eelt , specific mitogen., lipopo1ysaccharide
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is red uced. Z.inc deprivatio n during in utero development In micC? severely
affects the immune cells and cause a persistent stale of immunpdeficlcncy
in the offspring that can even be transferred to subsequent gcnc~8lionsl
-,
sUijcsting that rinc plays an important role'in--.. Immunologic ontogeny
(Beach, Gershwin and Hurley, 1982).
Zinc also affects the function of polymorphonuclear leukocytes
(Weston, - H~ff. Humbert, Hambidgc, Ncldner and w elrevens, 1977). In zi~c
deficiency, chemotactic respo nse of these cells -is reduced .whleh Is
corrected after reple.nis~me~t. However, ' following ex~essive nne intake In . .
hu\maii" subjects, polymorphonuclear "function .has . been reponed . to -be
reduced along with reduced blastoge'nic .response ,of I T cells to mitogens" . .
Altered lipid profile in blood' and leukocyte membranes has .been 5ugges~ed
as an expl~nation .for thCf observation of suppressed immune response in 11
zinc excess (Chandra; 1984a).
As a result of altered immune function, zinc defieie~l laboratory 'y
ani~als usually show increased susceptibility to common.. infectious agents.
./Zinc -deficiency induced immunosuppression also delays the onset and slows
the ' progression of spontaneous autoimmune disease in NZB mice resultlng
in enhanced ' rate of survival and increased li (~ span (Beach, Gershwin and / .
Hurley, 1981). Depressed immunity may alsobe largely responsible for th~
increased su~ptibility to infections ' and poor wound' healing seen / S::;ten
. . ./
in congenital and acquired zinc deficiency states in human. . »<
Various' hypotheses have been put forwa.rd to explain the . effect of
zinc on irilmunity and some of these ~ave . been proven experimentally.
Serum thymic honnone .activity Is usually 'reduced in zinc deficIency' and II
:.:.// .
" J;. ~. , . '
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promptJy corrected by dietary zinc supplements. Experiments suggest thnt
zinc is an esiential cofact9r for thymulin, one of the ~c hormones
(Dardenne. Pleau, Nabana, Lef:rancier. De rden, C\oay and Ba,11. 1982;
Derdenne, SavnJ.. Wa~e. Ka6e;1ian, Lemmonier ,and Bach. 1984). Reduced
ahymic hormone activiay e:tplains in part tbe immunological effects of zinc .,/
deficiency. E.xperimenlaJ eviden~ suggests that even in acquired '
, lmrnunoddici~ncy syndrome;' ~me 'of the immunological de~~ . ~' be ,
. partly " due . to decr~~d ,zinc saturation .and consequent !e duction.. in
thymulin level" (Farb i~• .:MocChegiani; ', Galli, Irate, . ' LaZzarin add Moroni,
1988). Zinc defic!ency' ,is also ,associated -~th ,on elevated ,'level of fre~
cortisol ecncentretlon in the blood, which may have a Iympholytic effect
(DeP8squale.Ja~de~ and Fraker, 1980).', Z.;nc being' ~n esSe~tia] ' ~faclor' of
a"variety of ,metalloenzymes is essential for ~lIular. multiplication. Thus in
. deficiency, cellular multiplication is decreased and the numbers of T and B
cells. produeed during abe norma l resting phase ~s well .as during antigen
stimulation are reduced,' .
p uc to Its :~ immu,!ological effects zinc has been tried i~ various
immunodeficiency ,conditions. Elemental zinc : supplementation at" a .dcse .of
50-100 mg daily for 4-6 weeks has been shown 10 bave-a beneficial effect
on depressed . immune, ;es~"nses' that are 'common in the aged (Du~aieau,
Delepe~, Vrijens and Coll~t. 1981;" Ch~ndra 1984b)." At a ' dOS~ ' oC 150
~gf~ay . Cor on~ month zinc even stimulates ~ph~C, res~nse" of n.oonal
healthy . ~dults (Duehateau, Delepesse and ver eecke, 1981). From these
, studies ,' it appeers that ' zinc, may ' also exert immunoregulatory
-. pharmacological effect.
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1.4. MFl'ALWTHIONEIN
Metallothionein was first discovered as a cadmium and zinc binding
protein in the kidneys of horses (Kagi and Vallee, 1960). Subsequent
studies have characterized the structure, function and distribution of the
protein to a gre~~ <extent, and the topic has been reviewed recently
(Hamer, 1986; DunnBlalock and Cousins, 1987):
Metaltothiorietns . are ' lew-molecular weight intracellular protiins that .
.~lect~IY bind hea,ry metal. ions such as _the ' nutritionally , 'es~ent lal trace
. ele ments zinc' and ' coppe r and _the potentially' toxic e lements cadmium and
: mercury. Metal ' free protc~n ' is called' "thionein" and that bound"'m 'one or
. . . .. .
more metals' is called metallothionein. Sometimes more specific terr~s like
(cadmium)-metallorhio nein, (zinc) -mctallothionein, (cadmium,'Zinc)·
metallcthloneln are used when the metm content i~ ,.knOwn. Vertebrate
tissues contain two fonns of metallothloneln, .metallothienein-I . aO,d
me ta Jloth ionein- II. Met attotht oneln-I has further subfo rms. like
metellcth ioneln-Ig, "metallothlonetn-Ig etc. Metallothic nein-Il is usually the
predominant fonn of the protein.
• 1.4.1. PbysiolOlYand ,blocbemllhy of.metanotblonel~
. '
Metallotbioneins 'are present in a broad range of eukaryotic species' in
many differ7nt '.ti~ues and ~II types, with highest concentrations in ',the
liver, ~~neys, and .i~C protc in . _h~ also been , ~cpo.rtcd to OCCU, r
( in .invertebrates an . icr _. ganlsrra. Within celiS" metellcthlonetns are
located mainly in the . cytoplasm', but the protein ha' been found ,'within,
J • • •
hcpatic and renal nuclei as well, SynthesiS of metallothloncin Is Induced by
30
various agents like metal ions, hormones, and' other factors. The.
synthesized metallothioncln binds to heavy metals and degrades with a
half_life of 12 to 84 hours. The rete of degradation vanes, depending on
the metal content. Thionein is most rapidly degraded. followed by zinc-
metallothionein, cadmium-meta llothionein and ccppe r-metallothicnein .in that
order. Af ler degradation, the. bound metal is released and ·'the amino acids
enter t~e cellular amino acid -poct It .is "thought _that the " degradation
. process occurs mainly. in the - lysosome. Metallothionein can also release the
metal without being degraded _a nd can ' readily' exchang~ - m~tals with either
frccmetal ions.in the cytoplasm or' ions bound 1,9 oth~r . li~~ds.
~.'
.~.
~etal1othlonein is a low -molecular weight (less than.. 10,000 D) protein
with a high content of cysteine; and no aromatic amino , acids, histidine, or
disulfide bonds. Each molecule contains 4-12 metal atoms. A typical
thi~nein is a 61 amino-acid peptide ' conlaining20 cysteines, 7-10 serines,
and 6-8 ' lysines. The !fajority ' of cysteine residues are present in eys-X. .q
Cys and Cys-Cys sequ~ces, where X is an amino acid other than cysteine.
Isoforms of inrJ~llolhione.ins g~nera~iy . have amino' acid replacements
outside these, sequences. Metals .are associated ,with thionein exclusively
ihroug!\ thiolete bonds to a,1l_20 cysteine ·residues. The tertiary 'st~cture
of metallctluoneins .is charl1lcterizcd by two domains, an a-~omain within
the ,car'boxyl-tenn inal end eXtending from ' amino acid 31 to 61, and an . .':.
j. ' - ' ., . " ---,- - :- - - -- _ .., . ';
amino-term inal p-domain extending from residue 1 to . 30. Both dom~ns . are, -; .';
globular t~ ' give. the wh"ole molecule an ellipsol~ shape. In both 'domains;
the polypeptide chain makes three' 'rer..erse turns to' splral vercund _metal
ions (FUrey, Rob~ins" a lfney, Winge, Wang and Stout, 1986). The 'a-d~main
contains '11 ~teine re:ddues. and 'binds 4 at?~ of zinc or cadmium or 6
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atoms of copper. The p-domain contains 9 'cysteine and binds 3 atoms of
zinc or cadmium or 6 atoms of copper . Zinc an.d cadmium preferentially fill
the a-domain first and then the ~-domajn; whereas copper saturates the
protein in reverse" order. The affinities of metals for binding to
metallothioneins difr~r; ,-that of copper is , tOO-fold 8re8~er than cadmium, I
. which i9~' turn is abou t ' lOoo-fold greater than zinc. Th7 rt,letal composlrtcn
of native metallotbtoneira ' are heterogen eous, even metal Induced
metaUothioneins do 001_ COntain ~xclus ively th e metal usedis an .inducer;
but it 'is not ·known whether more than o~e metal type can bind to one
domain.
1.4.2. Role or metallothlonein In metal- metabolism r
The function of metallothionein has been debated ever since ~
discovery. Meialloihionelns appear to function .05 detoxtt lers, regulators
and to some e:rt~nt as carriers Of, heavy metals. In yitro studies show thai
cen lines that do not synthesize metalloihioneins are more susceptible , to
toxic effects of · hea~ .metals, whereas cells that show' resistance produ c.e
higher than _ nonnal levels . o f metal1ot~ioneins (Crawtord, Enger, Griffith,
Griffith, < , Hann ers, Longmire, . Munk, Stallings, Tesmer, Walters and
. .
Hildebrand , 1985)'. ,In intact animals pretreatment with cad~ium which II
known to ' Induce metallothion ein synthesis also reduces the toxic effects of
cadmium (Min, Harte , Onoseke, _ Ohio, Okada a~d· Tanaka, 1981). '
Metalloth ionein . seems to be wen suited for . detoxifying cadmium. It (is
Induced readily :'by cadmium, bi~ds cadmium -wlth high affinity. becomes
, mote -stable after binding, and degrad ative release of the metal r~uJlJ In
~ts reassociation with other metallothion~jns. This cycle apparently keeps
' .-i '
-.
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cadmium in a relatively toxic form ' within cells. Other potential
.\
detoxifiealion functions not directly related to metal include free radical
JC8venging and protection against ultra-violet and X·ray 'da~gc.
Metall?thfone~ can also act as a storage site for nutritionally essential
metals llke copper and rinc and regulate lhe~ metabolis~ by modulating
their movement within cells either. ·directly through: donation of these ions .
to . meta' · requiring a~~es or metabolic compartments like
bicmembrenes, .or Indirectly by regulating. .thelr ; free or ,available
concentrations. The level of ~etallothionein varies - in res~nse . to -(~lie~ary .
~~d physiological changes. ' ~e · ' inverse reletlonsbip berween in t~S:tina~
metallothionein and absorptiqn of CQPpcr '. and arne suggests that _ the
pruteln may also regulate intestinal absorption of these metals" .A carrier
function of metallothionein is not clearly de~onstrated. but the .presence
·of low concentration of the p~tein in 'ptssme, urine. .and bile suggests
that the protein may a~ transport~1s in' the body (Danielso~ Obi and
Huang, 1982).
I
Th e . best known regulators of metallodtionein . synthesis are bury
metals like cadmium, copper. zinc · and ·mercury. · TheY induce
. . .
metallothi onein lyntheSis / cprima rily by . increasing ..the . ~ate of
• metallo thionein gene transcription. Since the ' metal ion itself .lnitiates the
t.ranscriptional event, the SyntheSis 0"£ metal1o~hiondn is regulated by a
feedback mechanism. Metal1othloneln , synthesis Is"0150 induced by, hormones
l.ncl~ding ~ucocortldo:~ds, g1u~n, a~d ' epinephrine and ~ ' B number of
other faeton , like Cyclic.AMP, interf~ro~ and · Interleukin-I . They' also
pro~bly act at the mCl!llothionein gene level. Any acute stress also
.' . /
· .;
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induces metalJothionein synthesis pe r haps through the ab ove hum oral
agents (DuM, Blalock and Cousi ns, 1987 ).
1.5. INTERAcnONS BE'lWEENcAnMIUM AND ZINC
Cad mium and zin~ have rna.oy physica l and chemica l simila rities as they
bo th belo ng to group lIB . of the Periodic . T able. ~cy are usually found
together in the ores and also in mamm alian tissues, and compete wtth each
other for va'nolll ligands, Thus intera ct ion between these two ei~enls I n .
the biological system is likely.' Hill an d Marrone . (197~) ~ypothesized that
eleme nts whose physical and chemical pro perties are sim ilitr ' will act .
antago nist ically ~o eaeh other - biologically. E lements of similar pro pe rties
probably compete for the same trahsport a~d storage shes in the cell s, and -
displace each ot her fr om reactive en zymatic ' and recept or prote in s.
Parizek (1957) first demonstrated that a large dose of . zInc .....could
prevent cadmium Induced testicular necrosis In rats when give~ together
with cadmi um, Webb (1972) showed th at pre treatment with zinc was also
prot ective against test icular cffects of cadmium. Subsequent stu~ies have
confirmed these findings and ..extended the interac tion to other toxic
effccts of cadmium like mortality (Shippee et el, 1983), growth sup pression
(Powell, Miller, Morton and a ijton,. 1964,; Aho kas, D ilts and LaHaye", 1980),
nephro toxicity (Watanabe, Non~mura~ Ta~tanl en d. YBmad~,
1985), car emogen lcity (Gunr{, Gould and Anderson , 1963b), hypertension
(p erry•. Er iangcr and Pert)', · 1977), te ra togenes is (Warner, Sadler, Tu JJ. and
Smith, 1984; ·Mar~ and Free man. 1987) and Inhibitio n of DNA repnceucn
and rep air , (N9CCntini. 'i 987). ,.Th e biochemi cal meehan lsm(. ) of cadmlum-alnc
..-.
,. :. j
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inte raction is unknown, bUl, various cellular a~d subc;ellular processes like
the reuc of cadmium to zinc., induction and Synthesis of rnclallothioncin,
. .
binding ch ar acteristics of metallothlonetn , allcr~tioll of abs.orp tion. kin e tic
parameters, < and ti.S!ue displacement of onc i metal by. anoth~r and .
competition 8t the level of zinc con tainin g met alloenzym es may be invo lved
in the intcracti~ns. . \ .
• ~ II
In an imals, cad mium treatm ent causes an Increase in hepati c and ren al
\ ..
zlnc concentr~tion !It the expense '. of othe r organ'f (Pe tering, Johnson and
Stemmer, 1971; R Oberts, . Miller, Stake, G e ntry, and \Neathcry, 1973) . Mar cu;
(198Z? demonst rated ·. th~t zinc treatment affects the kinetic paramct~rs, of
cadmium a nd alters movement of cadmium from-one body compa rtme nt to
another. Alierations of cecmrum an d zin c dj~tribu tiO?S in the bod y, whi ch
are prob abl y medi ated by metallo thionei ns, -may be a mechanism for the
inte raction between cadmium and zinc.
In in-vilro -stud ies, cadmium ha s been shown to {edu ce the act ivity of
several zin c depend ent enzymes (Vallee a nd Uimer; !1912). It is poss ib le
, .
.. tha t the -t oxicity of .cad mium is, er ' lea st panly, dic to- a compctiti?n
. between cadmium and zinc at cofactor sites in enzym es rcquiring :pnc.
Tubular ' prot~lnuria that~ in chroni c ~dmiuJ poisoning may be
explained by .. d ecr eased aOli~ty of certain zin c 'iqUirin. e nzym" like
alkaline phosphatase ' and leucine emlnopepudese, whi
l
h .arc l~ted in the
brush border of .. proximal tubular e~ithelial cel ls .~nd specula ted te. be
involved in tubular rea bsorpt ion :of proteins (Wachsmuth a1J.d Torhorst,
19?~). In cadmi um trcatec:t. rati and pigs reduced activity , of thesc enzymes
hai been observed (Elindc! a~d Piscator. ·1978).
3S
Studies in fats show tha t ..." low level of cadmiu m prbd ucea seve re
manifestations of zinc defi ciency when ,the diet " is defi cient in zinc, . but .
, not when thcdiet is adeq ua te (Petering et el., 1971). The ra tio of cad mium
and zmc in the d iet alld 1\150 }n th e t issue s is prohably also . a de termining
factor -of cad mium toxicity and the interacti~m.
~
The hnplicatto ns o~ these interactions between ~dmium and zinc
unknown, ~ut their occ urrence under . cont ro lled ' Ieboraj ory conditions
sugges ts ' t hat similar eve nts may also occu r in . free -living humans n nd ...
an imals, an d thus is 'of po t,entiai health significance .
\
.t .
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CHWER 2
RATIONALE AND OBJECfIVES
U RATIONALE
Cadmium is an ublquilOla toxic ~~tal to which everyone" is exposed at
low levels, II iJ toxic to every~ organ system of the body. Nephro toxicity is
the charaCleri;s tic' fea ture . of. cadmium· toxicity and .has been studied
extensively both in man and laboratory "animals.. Animal studies show that
cadmium b also t~e 10 the immune system.I"However, · in most .of the
studies on cadmium immunOI~ty. ~rcn,~rai ,m01.cs of cad~i~m or large
oral doses had been used which bea r lillie resemblll~: to ~ible human
cad mium ~ur~ the ru ults. were incons isten t ~ntl varie d dc~nding
on the . dose, duration . 811d route of ' cadmium treatment. The prinCipal
Ob~ctive . Of . the .present st~ ~ to characterize ~\Cf!e~lSor: a .
relatively ~ dose ' of oral cadmium treatment e n the. Immune system of .
mice., Mice were . chosen u the esperimeatet model as their immune system '" ,
is .well characlerims :nd ~cvelopmen18IIy. ~ructuraJly . apd". functionally the '- •
murine immune ¥Iem is~ remar~bly sh~Thfr to tli~t ·of"m~n. Si~Ce cadmium
is known 10 ~ve a Jong biological half·life, the study .pe?~ wes cxten~~
aRer cessation of cadmium.treatment to look for any pe~istint - 15i'.~de layed
effe~ of cadmium toxicity.
. .
\
)\ r,
37
Zinc and cadmium have many physical and chemical similarities and
they arc usually .found together in nature and also in mammalian tissues
whe re they compete for binding sites. in ligands like enzyme end other
structural pro teins. Both also bind to the heavy metal hinding protein
meta llothionein. Studies have previously shown that mnny manifestations of
acu~e and chronic cadmium toxicity in animals can be prevented by '
increasing the zinc status of the host. Thus it is possible that the
immunological effects of cadmium may also be re lated to zinc stalds, arJd
administration of a pharmacologic dose of aine. may prevent or correct . the
~ffects.\. The other principal obj~ctive of the study' was to char,aclerize the
effect of a modera~ely large dose of zinc on cadmium-induced
. immunopathology: Demonstmtion of such an inte!8ction at the cellular.
level would be of basic 'end .applied significance.
2.2. OBIECrivEs
The objectives of th~ present study are summarized as follows •
··1.1.... PrlmllJ'Y obJK:tlvrs
1. To t'udy the effects of a relatively iow dO,se of .oral cadmium
treatment on the immune system o.~ mice. \
:z.. To study t~e effect ~f a moderately. large dose~f zinc on cadmlum-
Induced immunopathology. ,..... )
1.2.1. Se~Ddary obJedlve. .
l. ' T~ lOOk. ror an Immunological mechanism of ren~1 to~ iCi ty of cadmium.
,..-."
.»,
..
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2. To study . the < effect of cadmium "on renal morphology'" and
ultrastructure.
3. To study the tissue cadmium level and distribution after treatment.
4. To . study the interaction between cadmium and zinc on renal
mo~hology and tissue cadmium level.
/
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CHAPTER 3
DESIGN OF THE STUDY
A series of four experiments were performed IQ study Ih~
immunological effects of a relatively low dose of cadmlurr r, and the
interaction -beiween cadmium and zinc on the immune system of mice. In
the four experimen~1 the basic study design was identical, however, - the.
~arameters examined "varied. In" edt:nce , one experiment led, to questions
which were. addressed in the next experiment. In the folloWing sections the
design of the study and . the ' four experiments are outlined. Experimentai
procedures are..described in chapter 4.
3.1. EXPERIMENTAL GROUPS AND TREATMENT SCHEDULES
Male six week old C57BI..J6 mire were used in the study. They were
divided into six experimental groups, some of which received 50 ppm
cadmium and/or SOO ppm zinc in ' drinking water. Other variables such as
diet and ho~sing, _.w~re identical for all groups. The design of the
experiment is shown in Fig~ 3.1. Group ' I received n o treatment ; ' group II
received 50 ppm cadmium (cadmium chloride, No. B 10064-34, ,BOH
, Chemicals, -Toronto) in de io~ized ,distilled water for 3 ~eelu a~tJ · no
'treatment for the next 3 or 6 weeks; . group III received _50 ppm cadmium
together with 500 ppm zinc (zinc chloride, No. z-DISO, Sigma .Chemlcal
Company, St. Louis; Missouri) for 3 weeks and 500 ppm zine for next 3 or
40
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FIG. 3.1
J?eSign of the~riment.
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6 weeks; group IV received SO ppm cadmium for 3 weeks and 500 ppm zinc
for the next 3 or 6 weeks; groups V and VI received zinc in amounts
equivalent to that given to groups III and IV bu; no addltio~al ~ium.
The treated waters were analyzed' for cadmium-{nd zinc content to ensure
that the desired amount of cadmium and zinc was present . The water
consumption of the animals was monitor~d and was com parable for all the
groups• •
Animals were killed for examination immediately after 3:' -'weeks of
cadmium treat ment and at 3 and 6 weeks after cessation of trea tment. The '
~xamination periods 8TC termed 0, 3 and 6 week.
I~ each eJ(aminat ior\.pe~od there were 8 to 10 mice from each of the
six groups. ' However, for a week there were four ' experimental .groups as
groups II and IV, and groups I and VI were identical at this point.
Thls design allowed ' study of the effect~ . of a relatively low dose of
cadmium immediately after cessation of tre.atment and at two time 'periods
~sequently (group if), and . also the erfec.ts of a large dose or zinc given
, . to~the; with and~Ol1owing or only following cadmium treatmen t (group III
and IV). The two groups (group V and VI), w~ich received 'equiva)em
amount of zinc as groups ttl and IV but no additiemll cadmium were
included which allowed 'study of zinc per ! e on the immune system, Th~ ho ~ .
trea tment group (group I) gave the baseline values in Ihis experimental
setting.
Low d~ of cadmium and the oral route of exposure were chosen as
they are more relevant .from the standpoint of ('9ssible human cadmlu~
/
)
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~ 42t ctty. mce cadmium IS known to have a long bKllogical half lire, thes Udy period was extended after ~tion of cadmium trea tmen t. Cadmium
WllJ used at a(~ of 50 rpm as previous studies have shown that at this
dose the immune system of mice is aff~ed. but the animals do ~t , how
'"any clinical manifestations of toxicity (Borgman, Au 'l and 'Oumd~ 19s6). A
large dose of zinc was used as zinc iJ knoWn 10 ~ relativery non-toxic
.' ' .
and it was WUJated.' that ~ large amount of ~ne, .~uld be . required to
,counteract cadmiu~ . immunotoxicity. Beth cad.m.ium anp.-zinc were gr.:en i~
drin~ng water . BJ it Is an easy and controllable mode of treatment in
e~rimen~a~_anlmals. , I
)
3.2. SERIES. OF.EXPERIMENTS
/>:«: ,
~ A series of four expe~me.nu wcr~ ~rformcd•. I~ ~he first experiment.
animals ~om all groups and observa~riods wert stud ied, but in
subsequent experiments, groups p nd observation periods were red~ced ~th
r~ Ia~ .O/'_~e groups and
expected. tion waS
~~cnts.
ti~e periods in which abnormali ties were
based . on the findings from .the prcvil\.
. . " . J.1.1~ Expcy.. ' " . .
\
In -this experiment mice Crom~ and .examinaeion pe riods -were
studied. Weight of the mice and their Cood consumption was monitored on
a weeldy baslJ throughout th~ esperiment . The liver, kidneys, spleen and
... '\. ~hym~ were weighed. LymffCS were CQunted In the blood, spleen and
'\~ Direct plaque·lonnln ~u response, which ....1' IgM anlihody
" ' ~ ~
f;". '~-J. ."-~ • • , ;,~ ., . J~ " ~:;...;.-;j. ~.:~"; ~ • • , •• • ...: ~ {'i:. ....,' .:J""~ '.! r_(>·~ ""....;; ~J...., ' .... ~ ~ :~:,,' ~.~ ..--;:....( N ,1, ..1' ".~ . i;:~ '
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production against heterologous antigens. was measured in the 1spleen.
Proliferative response of spleen cells to T cell mitogens was also suayed
at 0 "and 3 week. The kidneys were examined for rgG and complement C3
deposition by immunofluorescence staining. At 0 and 6 week, transmission
electron microscopic. examination _of kidney sections was performed. and the
~r and jidneys were exami~cd for cadmium content.. ~
)
) I
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3.2.2. Experiment 2
In this e;ant the obsoh-ation period of 6 week- and treatment
grouP.s _IV.. . and _.:I. were .omitted. "n~~? delay.ed or pc.rSISlins .effect _~f
cadmium on the Immune System was ob erved in experiment-!: Weight qf
mice and food consumption were recorded , a the spleen was ' weighed and
IymPhocyt~s ~unt~d. InJect Pla~.e.for . " cell re~ponse, which assays
IgG antibody pro~ orr antigen challenge, was measured in spleen
J .-icells. . ' . 'to'
- . ,
3.1:.3. Experiment 3
In experiment '3, the groups s~u.~ere 'similar to experirenl 2,'b~l
the observation period was limited to 0 week, 8S In the previous
G,experiiiien~ immunnlngieai ch~.nges 'r re seen .only 10 occur immed.ialely
. ener ~ssation of cadmiu~ tre,a.line;;tlWeighl of . mice and ' food
consumption. - was rccofded•.. The spleen . was wefghed and -lymphocytee
counted. ~e nU~ber or helper . and suppressor, T ,.,cellS in\..he spleen ',was
countedSbr imm.unofluQrescence technique , usi n~ approp~iate n.'0noclonal
\J .
, "'----- ,
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antibodies. Concanavalin A induced ,suppressor cell activity in sp leen was
also aasayed.
3 .204. Experimeol 4
!
-.•.~. . ..
.... j
. In this experiment.~ .,:groups st.Ficd were similar to expert nl 3.
A5 " in previous experiments. we ight of animals and food consumpf n was
measured , spleens 'weighed and the ' Iymphocyt~s , ~unlcd. Th ' rnber of B
cells ' jnthc~ splee n was. coun ted by immunofl uorescenc . :technique • wing
polyclon~1 . puri fied' ~ntibody. Lymphocytes from , ~~e sp leen were isolated
tur~l.k.llI er cell activity .measured by . chromium. release .' assay, , and
an 'body production on pokeweed mitogen stimulation measured by enzyme-
link unosor ben t assay. The I~ was analyzed for trace element
levels.
3.3. TIM E FRAME
. ',fhe four -e~riment5 were perform~d ..sequ entially one _aftcr anothc.r.
Since a large nurobe,f, of animals, ranging from 40 to 160, were involved in
each serie~ each expe~ment was sprea d 'out oyer 2 t~ 4 months. On' two
or ~ree . days 8 week,' 4 to - 6- animals werC"""ilhrted -on-- the expe rimental
protocol. Also on the day of killing, the same number ' of animals were
h~ndled s im.ullane~usly_ , At I~ast one pnimar from eaCh,group was included
on eeeh day, , '-
/
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C!1APTER !:
METHODS
4.1. HOUSING AND FEEDING OF MI CE
Male C5181../6 mice (Cha rles . ~iyer Co~.ada. Mont real," Qu ebec) were
usd i in the experi !pcnts. . They were mainta ined in the anima l care ' facility
'o f the" Faculty of Medicine, Memorial Unjv~rsity . of ~eWfoundl,nnd . - The
mice were ~OJ.lsed singly in wire meshed hll ~ging ~ges ( o~ i~ _plastic cages
with beddin g. In expe riment 1~ 2 and 3 the fpJme r type of hO.llsing was
used , a nd in experiment 4 n1e tatter type was used. T he change was forced
d ue to availability of cages, howe ver , this would be of no significance as
in e~ch experimen·t ·only one type of housing was used: Th e envirqnment of
the animal r~ms was controlled at 22-24·C temperature, 45-55 % relative /
humidity , and 0800 10 2000 lighting hours . Standard g~delines for the ,care
and use of expe riment al animals were followed throughout (Ca nadian
Council on Animal Care, 1984), and the prot ocol was approved by the
University Animal Care Committe e.
Mi~ were purchased at ages of either 4 or 5 weeks . They were
acclimatized- for 1 or -2 weeks in the ~nimal· ca re facility .durins')w}lich . lhey
had free acce'ss to ordinary drink ing water and food, and the n put In one .
of th~ experiment~l groups a t nu(dom. All mice were 6 wee"" old at the
beginning of the experiment . The mice were fed 8 n~>n.p~rmed diet
I
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(Rodent Chow No. 5012,. Ralston Purina. St. Louis, Missouri). The food
peltcts were analyzed for trace element contents and found to contain 0.09 .
p.g cadmium/g a nd 43.3 ""8 zinc/g. Other constituents as indicated~
label are shown in Table 4.1. The mice also had free access ft drinking
. -
water ; water . provided to some animals contained additional cadmium or
,
zinc. The treatment schedules arc shown in Fig.3.t (page 40). Throughout
the experiment. the weight and general health of animals and fQOCl
. disappearance ', was closely ~onil?red and recorded. In experiment 1 tbe:: .,'"
measurement 'was done at weekly intervals, but,.. in "the subsequent
experrnients,~ food isappearance was. measured for - 8
immediately prece g the killing.
~.c_
-4,2. KILLING OF MICE AND COLLECTION OF TISSUES
day period
Mice were anesthet ized wi~h , ether, killed by cervical dislocation and
the abdominal skin was wetted and the cavity opened. Anatomical
~ttachm~'i\ts of the spleen, thymus, liver and kidneys were severed a~d the
organs. rc.moved and tmnsfe:red to , preweighedcontainers which were
weighed again to obtain , the organ weights. "The thymus was ,suspended in
normal saline, fatty tissue removed and the organ drie.d with tissue paper
before weighing. A single electronic balance (Mettler PC 180. Greinfensee,
Zu.rich, Switzerland) was used throughout the studies. "J \\
In experiments where spleen eo' were used for culture work,'pleen . ~~ was collected with f~lI ase·ptid. preca?tion s. 'The abdomina,1 skin and fur was
J cleaned with 70% ethanol, ~d afte r fI:aching the , peritoneal membran e.. a
second set of instruments sterilized "' with 70%' ethanol 'was used. The
...
. I •
i:....:,~",,~~-;":;\... : ,;:;.,~,. ;c; t.'; :i: ;' ,..:;' , .i.' ...,; !.~ ; " ;':'!'~ ~'_ ,r".: _;· \,.;~: ,','. , ' .: -. ',;,: t: : J ~._:~i '; " l'~ : '
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TABLE 4.1
Co nstituents of Diet
Anl!Ix>i>
eTude protein not less than
Crude fat nor less than
Crude. fiber not more than
Ash not more than
22-2% -
4·0%
5-0%
3-0%
~
Ground ~xtruded yellow com, soybean meal, fish ~lli l cane
molasses, wheat midd!inp," dehydrated alfalfa mea~~_
oats. brewers' dried yeast, wheat germ meal, d~ied beet pulp, ..
soybean oil, dicalciurn phosphate, calcium carbonate, sail, '
vita min . B-12 supplement, calcium pantothenate, choline
chloride, nbofla~n supplement, thiamin, niacin supplement, ,DL
methionine, vitamin A supplem ent, D ' activated animal sterol
(so urce of vitam in 0 ·3). vilamin B supplement , calcium Ioda te,
manganous oxide, ferrou s carbonate, cobalt carbonate, copper
sulfate, zinc sulfate.
'"
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spleen immediately removed and transferred 10 a tube . containing
stcrile culture medium, Subsequent ,handling of the organ was done I in a
Level A lAminar flow hood (Envir,* Bio-dynamics Inc., Albuquerqu e, New
Mexico). ' --/
In experiments where kidney sections were prepa red for electron
microscopic examination. the 'kidney was the first organ' removed. This was
done to maintain ultrastructural inlC~ty of 'the 'organ. . . ' •
i
I
4.3. LYMPHOCYrE COUNTS IN B~OD, THYMUS AND ~PLEEN
I '
4.3.1. Lymphocyte count 'l n blood
Immediately , a~ kill ing the morse. the right atrium of .t~e heart- was
opened and 10~ blood coneetfd .and diluted . in ' 190 ~I , of Tl\rk 's
SOlution (0.1 g gentian violet, 1.0 rot :95% ethanol and 0.5 ml acetic acid in
98.S rot distilled water). A sm~lI \ aliquot of the diluted blood ' was
transferred to a Neubauer co~ting, t~amber: and the lymphocytes c~dnted
.with a light · microscope. Lymp~peytes were identified by ~ their .
. morphological criteria end diffe ntis teJ from other leukocyte types. .'.
'--._., " ,", ' . . ,
4.3.2. Isolation aad (Oval or Ihymlc' ~phocytts
. . 'i "
. Thymus cells were ' obtained by , entlY homcgeni alng th~ , .organ .~th , .a
tissue pestle on . &<?: Cellector l)SSUi ..Siev~ (Mandel Sci.entiti~ R~kwood,
Ontario) with a mesh size SO and 0rning ,ize 0.28 mm. The contents 0/
the gland passed A through leaving t~e capsule behmd. · The product was
\;~. ~- '" · - ~- ·1~· " · ·-~.~~ . ,
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were broken down by gentle agita tion with a Paste ur pipe tte nnd a singlr
cell suspe nsion was obta ined by passi ng the material through graded
~dlcs (21'd and 260). Ten microliter aliquot of ce ll , suspension was .
diluted in 190 ~J Turk's solution and the number of lymphocytes counted in '
Neubauer, .chamber. Lymphocytes were idc~fied by the ir mOLPhological
criteri a a~d differentiated from olherleukocytc' types: Th e results were
expr essed as !otal ~phocytc cou~t in .the. thymus .
4,3,3, Isola tion a od ~UDt or sple nic lrmphocytc lI
\ .
In .eJ(pe~i,men~ where the ce lls were used for culture 'work, the entlr~
!~ . obtain . splcen -cells, . the organ was genlly ieusr .! with two curved
needles on a petri-dish co ntaining RPMI 1640 wit~ L-glulsml ne without
sodium bicartio~ate (N o. 1060120, Flow Labo rato ries, Mclean, Virgi~ln)
{term ed RPMI 16411 hence forth}, With th is maneuver it was possible to
' squecze; ,ollt the conte nts. from the cap su le. Larg e cellular clump s were '
bro ken down by gentle, agita tion with Pa$te~ pipett e and debris removed
by sedimentatio n for 10 minut es. Th e supernatant was collected and a
sirigl~ ' cell s~pension obta ined by passing the ma terial throu gh gra de d
needlee-~21G and 260). The procedure was carrie d out in a known volume'
of cUlt~re medi um. The lymphocytes wer e coun ted in Ne ubaue r chamber
and the result expressed es .tota-I co~nt in sp leen. Lympliocyte.
identified by. their morpho logical criteria a nd differe ntiated from other
leukocyte type s. This ce ll suspension was late r used for other
immuno logica l assays :
.'~ ......., .
c
.\ . "
so
procedure was carried out in a laminar flow hood with totel aseptic
preeeutlons .
4A . DIRECT AND INDlRECf SPLEN.IC PLAQUE-FORMING CELL RESPONSE
Pleque-Icrmlng cell (PFq response in spleen was assayed by a
microwcll liquid matrix mod ification (Kapple~. 1974) of the Jem e pleque-,
assay (Jeme, Henry, Nordin, ruji , Koros and Lefkoviu , 1974).
4.4.1. Immunlza(lon ~or mice
Sheep red blood cells stored in Alsever solution (Woodlyn' Labor atories,
.~ Guelph, Ontario) ~re washed three times in ~ormal saline at 450 x g, 10
mlnut,:, each; removif1g the buffy coat after each wash, and resuspended 10
20% (vol/vol) ' in normal saline. Mice were restrained'and injected
Inu aperi,loneally with ' 0.2, mJ of the {red blood cell suspension. ,Immunization
;ms done 4 or , 8 . da~ before killing for estimation of direct (ISM) or
indirect (I~) plsque-forming cells respe"ciiveli.
4.4.1. PrtparatJ(lD or spleen ails
Spleen cells obtained' as described a~ (Section 4.3.3.) were washed
' three umes in Hank's balanced salt solution (No. 18'104, Flow Laborat ories.
• McLean: .Virginia) (BSS): For washing, the cell suspension was centrifuge~
at 200 x g fQr 10 minuteS. I~pemataril aspirated and cells resuspended in
the remaining media by gentle tapping. Then BSS was ·added to bring up
th~ volum~ and the process repeated ; After the final wash, cells were
resuspended in-~ containing S% (vo~l) heal inactivated, (S7"C 'for 30
· ..
SI
minutes) fetal calf serum, counted and adjusted 10 2 x 106 IymphOC)'tes/ml.
This stock W8J used for the plaque assay.
4.4.3. Preparation or sbt'tp red -blood cell IOlulion
Sheep red blood cells were washed three times in norma l saline at '450
x g, 10 minutes each. The buffy toot was removed after each wash. A l5%
(Vollvol) solution of sheep red blood cells was made in SSS ond checked
by haematocrit. Forty microliter of the solution was added to t ml ass to
make a 0,57% (vol/Yol) solution. At this dilution, red cells were found to
. .
form a monolayer on the wells of microculture plates in the plaque assay.
This stOCk was u.~~ as' the target f~r lysis in the plaque assay.
4.4.4. Absorp tion of (ulnea-plg complement and antl.mouse.lcG
I '
Guinea-pig complement - (Glbco Laboratories, Grand Island, New York)
and rabbit anti·mouse.lgG . (MileS Scientific, Rexcefe, Ontario) were
absorbed over sheep :ed blood cells to prevent non-speculc binding: The
sheep red cells were .washed ", ~hree limes at '50 x So 10 minutes each,
removing t~e buffy coal each time. Ten milliliters gUinea-pig complemem
or .anti·mouse-JgG was then added to 2 ml packed sheep red cells and
incubated . for 30 minutes "at 4"C with continuous rotation 8t 10
cycleslminule. Nter incubatl8n the cells were packed "by centrifugatlonal
450 x 8 for 10" minutes, supernatants removed a'1d incllba~d with the
sheep red bl&x1 cells again. ~e process "NBS repeated three tlmel . After "
lhe absorption, 500 " I volume of the guinea-pig complement or anti-mouse-
IgG wa. allquoted anE stored at ~70"C. For the plaque anay, J/I0 dllutlcn
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(voVvol in BSS) of guinea-pig complement and 1/40 dilution (voVvol in
BSS) of anti.mouse.IgG WBJ used.
4.4.5. A....' TOr JaManUbody rarmlnl cell.
The assay was performed in flat-bottom microculture plates (Flow
Labora tories, McLean, Virginia) . In each well of the plate, 20, 10 or S ILl
of 8 suspension of 4, 2 or 1 :II: 106 lymphocytes along with 50 Jotl of 0.57%
(vol/vo1 in ~) sheep red blood cells and SO ,...1 of 1/10 dilution (~VvOl
in BSS) guinea pig complement were delivered. The final volume in each
well was brought up to 190, }.'1 by a~ding app ropriate amount of BSS.
Constituents of each -well are shown. in Table 4.2. The assay ~s set up in
. . \
tripll~te for each sample and cell dilution, 'J'lle plates were centri fuged at
SS x 8 for 3 minutes to obtain 8 \,monolayer and incuba ted for 2 hours et
37'C with 5% CO2 in air. Then the number of plaques was determined with
1 •
an inverted microscope. Wells for all three dilutions of lymphocytes were
scann~ and the triplicate samples containing the opt irJt.um number
(between IS and 25) of plaques were counted.. A clear zone of red cell,
lysis with a lymphocyte in the centre was count ed as positJve (Fig. 4.1).
Results are expressed as plaquesll 06 spleen cells lind plaques/spleen.
4.4.6. AIMY for laG antibody tormh ll e'ells
For Ih~ Indirect Plaq~e assay a similar 'rOICCOI was followed, but an
additional 50 fLl of 1/40 rabbit emf-mouse rad added to each well (Table
4.2). •Direct PFC n~mber was. also C81~ulaled land subtracted from indirect
PFC number to give IgO ,producin~ cell count.
, ...
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TABLE 4.2
Constituents of Culture-wells in Plaque Assn}
Lymphocytes/well .,.. , ,LymphoCytes/well
4<106 21106 ,,106 4<106 21106 1,106
J.l.l/well
Direct (IgM) Plaque Indirect.(lgG) Plaque
, srJ~nlg&}~I)suspenSlon 20. \0 5, 20 ' 10
sr~~~~ed BlOod Cells SO SO SO SO SO SO
Guinea-pig complement SO SO SO SO SO SO
(1110)
Mouse anti-lgO SO SO SO
(1/40)
Culture medium 70 80 8S 20 30 35
\ , '
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HAEMOL YfIC PLAQUES WITH ANTIBODY PRODUCING CELLS
FIG. 4.1
Two antibody producing cells. A clear area of red cell lysis surrounding
each lymphocyte is counted as a plaque. (x 3(0).
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4.5. IN VITRO STIMUlATION OF SPLEEN CELLS wrra MITOGENS
4.5.1. PrtparaUoQ or spleea cella
Spleen cell suspension was prepared llS described before (Section 4.3.3.)
and washed three times in RPMI 1640 (Flow laboratories , Mclean,
Virginia) at ,200 x g for 10 minutes each. After the final wash, cells were
counted and resuspended (0 1 x 106 Iymphocytes/rol in RPMi 1640
supplemented with sodium bicarbonate, 100 U/ml of penicillln, tOO ,uglml of
strepto mycin, 250 ,ug/mt of fungizone (a ll from Gibeo Loborat ories, Chagrin
.
Fa lls, Oh io) and 5% (yol/vol) heat inactivated (57°C for 30 min.utes) fetal
calf serum (Bocknek Org8~lc Material, Rex)lale. Ontario) (complete culture
m~um). Preparat ion' of sple~n cells and subsequent cUltur~ was carried
out with full aseptic precautions.
4.5.2. Mltoeen sUmulation
/'
For setting up the stimulation t ulture, 200 p-I o~ a. suspension of 2 x
loS lymphocytes and al) optimum amount of mitogen [18 p.g of
phytohaemagglutinin (PHA) (wellccme Diagnostics, Dan ford, England) or I
P,8 concanavalin A (Con A) (Sigma Chemical Company, St, Louis, Missouri))
diluted in 20 p.1 of nonn al sali~e was delivered Into each well of a flat-
v boucm microculture ' plate (Flow laboratories, .Mel.ean, Virginia). The ,
,. , .
oPtimum amount of mitogen was established in 'a preliminary. dose-response
titration and the same ' tock was used throughout the experiment, In
. control cultures; 20 p:-I of saline wu added in place of mitogen. Culture.
were set up in triplicate for each mitogen and ~mple. The culture plata
were ' then Incubated for 72 hours at 37·C ,In a humldJr,datmotphere _
Mean counts permlrune of
""'?" corol culture
Stimu lation index
/I'~ ) ,. J)")
-oontainln.ll 5% C02 ~" air . To, assets DNA eynthCSi. 0.5 ,,0 of
[3H)thymldine with B specific activity of 2 CilmM" . England NUcle:;"80510~. MllU8Chussets) was added to each well for ~ hours of
inCUb8t·on. Celli ~were then harvested on glass fiber fil~ers (MS,OdeScient Rockwood, Ontario) with a ~~1tiple' automated ~II harvester...... (Tilert Ie, Flow. laboratories, Roc . e, Maryland). The filter pa pers .were
dried "a pd discs put in scintillal n . vials wit~' 8 ml of liquid scintillati on
~lon (DOH Ch~miC8ls. To ronto , Ontario) \00 COUIJ1C:d for radlcactivity
~liqUid scintillation spe ctropho tometry (Beckm~/ Instruments LS~330.Uquid Scintillation , System, .Fulterton, California). ./ 'The results wert;ex ned 85 stimulation Index 85 follows : ;.
mean counts per minute oi\.
triplicate stimulalC:~ culture ~
.....-' (J
U: . ASSAY OF SUPp,RESSO R CELL ACTIVI1Y
Suppressor cell activity was assayed by coculturlng concanava lin A
(Con A) s~iinu.Jated splcen cells~ressor ·ce!I).....with autologoussplee~ ·
cells (responde r cell) a nd . measuring t~enlc re~ponsc of the
responder cell to phytoha em agglutinin (PHA)- (Catalana. Rat!iff a nd ,McCoo l
1980; O rzelak. Olszcwsld and Engeset. 1983). Asepsi s was maintained In ' all
stages of the assay.
j
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4.6.1. A~iva·tlo~uppressor . cells
)
) Splee n cells were prepared as described before (Section ~.S.l . ) and
resuspended to 2 x 106 lyrnphccytea/ ml i~ comPle~. culture medi um. Thr ee
milliliters of the suspension (6 x l06~phocyt.) ' was incubated with 60
",I of 0.5 mglml (10 IoI-gIlnl fina l dilution) 'Con A (Sigma Chemical Company,
51, Louis, Missciu;i) Cdt ' 18 hours at 37' C in an at mosphere co ntaining 5%
CO2 iii. atr., After incubatio~ls were waS~d J twice li t 250 ~r IS
m inu tes each and treat/ with 100 .uUrnl mitomycin C (S igmo Che~col •
<, Compa~y. 51. ~uis. . Misso uri) for 1 hour at )7'C tn stop further
multiplicat ion. Th e cells were ~hen washed ,. ice with 0.3 , M , methyl-a-
l!1anno~anoside (Sigma Che mical eom'pany, • LOuis, 'MissOuri) and th rice
with RPM I 1640 ' at 250 x S for 15 minu t each and resusp end ed to -I "
106 ..lymphocytc:~ml in cO~lete culture medium. , Ce lls thus activated were
use d as suppressor cells (SC) in the assay.
'- .Another batch~1fl were trea ted identically except thot the)' were
no t st.imulatedwi~ However , Con AW.as added 10 I~ unstimulated
ce lls afte r the 18 hou r incub ation to control for the effccts of the Co n A
itse lf be ing carried ove r with the cells in thc subsequent ste p'. These - cells
we re .uscd as contrOlS and arc called natur a l suppressor. cells ( NSC).
4.6.2. Relponder~ . { . <!.-- / \ ..,:;
Autologous ~pleen cells (p re pa rcd as des~~ ') In . section 4.5.1.)
suspe nded to 1 :It 106 Iymphocyt~s1ml in tomplct c"::ulture mcdium we re .J
• useOa: responder cell. (RC) In,the)"u~e. . ) c.- ~.
\
J
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4.6.3. Supprellor cell actlrlty
In each well of a flat-bottom microculture plate (Flow Laboratories,
McLean, Virginia) 100 ~J (containing) x 119 lymphocytes) of RC~
J£I (containing 1 x loS lymphocytes) at SC or NSC was added and cultured
• with or ~thout 18 p.g/well PHA (Wellcome Diagnosti~ Danford, England)
for 72 hours at 37"C in a humidified atmosphere containing 5% CO2 in air.
Triplicate culture wee sct up for each of the four combinations (Re + Sc
+ PHA, RC + SC ~ PHA,.R~ + NSC + PHA and. RC + Npt . Ma) and
samples, To S'SSCS5 DNA synthesis, O.~ f'Ci of (3H]thymidine' ~th a specific
activity . of 2 CilmM (New England Nuclear, Boston, Massachussets) was
added to each well for t~e final 4 ,hO~ {nell,balian. ~lIS we're then.
harvested. on gl8;ss fiber _filters ' (Mandel, Scientific, Rockwood, Ontario) with
~ multiple automated cell harvester (Tltertek, Flow Laboratories, Rockvillc,
Maryland). The . fllter papers were dried and discs put in scintillation vials
with ~ ml of I.iqui~ scintillation solution (DOH Chemicals, Toronto, Ontario)
and counted for radioactivity by liquid scintillation spectrophotometry
(Bec~an Instruments LS-330 liquid scintillation system, •Fullerton,
Califbrnia). Suppressor cell activity ~cA) was Flated using the mean
counts per ' minute of the triplicate ultures and xpressed as a percentage
as follows: . #' V"" ,
, '. . ,
(RC + SC + PHA) • (RC + SC • PHA) I
x 100 "
(RC + NSC + PHA) . (RC + NS<\. PHA)
/
/\ .
.,", ,-..,
(S9
4.7. ENUMERATION OF B LYMPHOCYTES AND T LYMPHOCYTE SUBSETS
IN SPLEEN
Enumeration of B lymphocytes and T !Ymphocytc subsets. in the spleen
was done by immunofluorescence staining uling appro;islc specifi,c
, .
polyclonal or monoclonal antibodies. The antibodies used were - fluorescein
isothiocyanate (FlTC)..col)jugated affinity purified goal anti-mouse .IS for '
staining B cells, and purified monoclonal Bntj·UT4 and FITC:canjugatcd
monoclonal " anti-Lyt-2 for the T cell subsets (all from Becton Dickinson
Irnmunocyt?metzy S~temsl ~ountitn View;"California). Antl·L3T4 · and anti.-
Lyt-2 identify' the murine differentiation glycoproteins . CD4 and CD8 which
are markers of helper/induce! and suppressor/cytotoxic T cetls re!tpectlvcly
(Adkins. Mueller, Okada, Reichert, "leissman' B,nd Spangrude•.1987).
B cells and Lyt-2+ cells we~e sta ined by -direct·' immunonuorescen~e
technique and,~T4+ cells by indirect technique. (Mishell a'nd 'Shiigi, J98O).
4.7.1. Dirtd Immunonuortsctnce staining
' Spleen cell suspension was prepared a~ described before (Section
4.3.3.), washed thrice at 200 x g for JO minutes each and adjusted to 2 It
107 cells/ml in RPMI 1640. Fifty microliters (J x Jo6 cellS)' of th-; stock .
was incubated with J ~g of F1TC conjugated anli·Lyt·2 or goat ant i-mouse
IS for 30 min~s'at room temperature in dark. AfIC:r~cubation, the cell~
were ~ . twice with Dulbecco-phosphete-buffered saline (PBS) (No.
4S()'~, Gibco. Laboratories, Grand Island, New York) containing 0.1%
(vo1/vo1) sodium azide at 290 x g for S minutes each and resuspended In a
' . I ""' (drop or 'moundn::; edi~m (10% glycerol In PBS). A drop of ~e cell
l
.. .. "..,..
suspensio n was placed
fluoreICCnt and lotal
a glass sl~ coded and the number of
celb were 'co~lcd with ' a Leitz fluorescent
l
mlcrosc:ope (Erns t Leitz Wc1Zlar, West Germany). Monocytes were excluded
by morp hological criteria with phase conma:; ' microscopy. O ne hundred
fluorescent cells were counted- and the results expressed as a percen tage
.er total celis.
4.7~....ect Imm uDOnuorelCence l talning
( The sple~n cel1~ . ~ere first tagged with purified ant i~1.3T4 and washed
as for ' dire ct stai ning method. Th en the 'ce lls were ' incubated ~th 1 .us of )
p hycoerythrin-conjugatge.d rat anti-mouse .Kappa ~ght-ehain . antibody
(Becton Dickinso n Immunocytometry Systems, M~unt.ll in View,. California)
for .30 minutes ' cat room tempe rature. After incubation. the cells were
washed, res uspended in mounting medium and eoumed ' 85 for the di rect
staining- method.
~~~ CELL ACI1VfIY .
Natural kille r •cell activity of splenic lymphocytes were performe d ~by a
.microwell ri'lOdification of the chromium release assay describe d by
Kiessling, Kleln a nd WlgzeJl (1975), and Kiessling, Klein, p! OSS and Wigzell
(1975).
4.&1. PrepantJon of .plenlc: lymphocyte.
Spl~n -cells were ob\lllnc:d as descnbed ' above (Sect ion 4.3.3.) and the
lymphocytes Isola tc:d by dc:nsi~ gradient cent?fugation. Th e suspension of
p
; . .
'.,.,.:" ';..:,,., ..•.•:.•""., .,>;c., :<'" ;, :'." __ i.i·,s. ,_,<.~", ,,' , ~, .,.,;.,.,.: ".:" "i'·'·M"C' ·....
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spleen cells was layered over Ficcll-Hypaque (Sigma Chemical Company, St.
Louis, Missouri) with a specific gravity of 1.09 and centrifuged at 400 x g
for 30 minutes at room temperature. The lymphocytes which formed a
visible interface were collected, wash1\! three times in RPMI·I640 at 200 x
g for 10 minutes each, counted and adjusted to 8 concen tration of 20 x
106 cells/ml in RPMI·l640 supplemented With sodium bicarbonate, 100 U/ml
of penicillin, 100 ~glml of streptomycin. 250. ",glrol of (ungizane ,(all from
Gibco Laboratori es, Chagrin-Falls, Ohio) and 10% (voINal) heat . inactivate?
(57·C for 30 minutes) fetal ca!! sc'rum (llockn ek Org~nic Material. Rexdale• •
Ontario) (complete culture medium). This stock was used 85 the effector
cells in the natural killer cell assay.
4.8.2. Labelling or target cells
Moloney virus induced mouse lymphoma cell line ' YAC·l (American
Type Tissue Culture, "Rockville, Maryland)' ma'"tai~ed in continuous cult?re
in complete Culture medium was used as ,target cell. for.\ labelling, 200 .uCi
S1er as sodium chromate was adde~ to S x 106~ tum~ur' cells in O.S ~l of
culture medium and incubated for 60 minutes at 31'C with continuous
rot~t ion at 10 cycles/minute.. The cells were then washed twice at 200 x g
for 10 minutes each at room temperature, counted, and resuspended to the
final concentration of 0.8 .x}06 cells/mt.
4.8.3. Chromium release. assay
For setting up the assay, SO j!1 labelled target cell suspension (4 x 104 "
cells) and 100 Ji\ effector cell suspension (2 x 106 cells) was delivered into
~ / .(./
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each well of a V-bottom microcullure plate (Flow Laboratories, Mclean,
Virginia). This corresponded to an effector target ratio of 50:1.
Spontaneous 51er release from target cells was measured in . the absence of
effector cells, and the total release was dete rmined by treating the target
cells with 100 IJ.Vwell of 1% (weightlvolume) Nonidet P40 (Sigma Chemical
Company, St.' Louis, Missouri). The volume in each well was~ maintained at
200 IJ.I bY adding ' appropriate amount of cultu~ medium. Fi~al constituents
t , , •
of the culture wells are shown , in Table 4.3. ' The plates were then
incubated at 37:C in '5% CO2 in air for 4 aJTt1 12 hours. Two sets of
~ulture, .each in . quadruplicate, were set up for .Ihe two time periods. After
. .incubation, the plat~ were .centrifuged at 400 x g for 5 minu,tes and '100
~I of supernatant was Collected Irom . each well and counted for
radioactivitY in a Beckman 310 system gamma count~r . (Beckman-
. Instruments, Fullerton. . California). -The results were expressed ~s
percentage lysis 85 follows :
---..
mea n counts per minute _ mean counts per minute
of experimental release- of spontaneous release
% lysis ~ ------ - - - -.- -.-- - ••••-,-.- - - .- - x 100
mean counts per ~inute
. of total release :'
_ mean counts per minute
of ~pontaneous r~lease •
r ·
Spontaneous release was less than 10 per cent of total release . in 4
hour culture and varied between 20 and 30 percent in 12 hour culture.
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TABLE 4.3
Constituents of Culture, Wells in Natural-killer Cell Assay
50:1 target/effector Total Spontaneous
. rat io ' release release,
\ ~lIwe ll p.l/well IJ.I/well
E(~~c~orl~J~I; 100
T('Xie~ C;:~/ml) 50 50 • 50
Culture medium 50 50 150
1·0% Nonidet P40 lOO ~
-. OJ,
I
J
• °
"-
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'4.9. POKEWEED M'ITOGEN SllMtlLATED J,G PRODUCTI ON
4.U. Po~ mltoaea .t1mula tlon or lymphocyte.
Lymphocytes were se parated by density gradient centrifugation 8S
described before' (sectio n ,4.8.1.) and resuspended 10 I x 106 cells/ml in
complete 'culture .med ium. Two mllliliten of the stock (2 x 106 cells) was
ln~ubalcd ' with' 200: 'Ill' of 1120 dilution of pokeweed mitogen (Gibcc
Laboratories, Chagrin Faits, Ohio) for 7 days at 31· C in 8 humidified
atmosphere containing S% CO2 in air. The cells' were then packed 'by
centrifugation at 4$0 x g for 10 minute. and !hc supernatan ts collected
. ,
and alated 81 -20- C. The samples were later tested for IgO level by
enzyme linked lmmunoscrben t assay. None of the samples were stored for
longer than.3 months when tested for JgO.level.
\
4.9.1. Enz;yme-linked Immunosorbent •• sa,
ThcJ! enzyme-linked immunosorbcnl assay (ELI~) was based on the
method described by Voller and Bidwell (1986),. For rending, calculation and
expreu lon of ELISA data a ~odi~cation of tfie computer assisted method
described by Ritchie, Nickerson end Fuller (198q was used .
Optimum concentrations of reagents and nnalyles were lint determined
by ltandard Utrat lonl .,. Then the . amples were assayed In one batch. The
snalytea 'were measured over the "Concentration ronge In which the ELISA
had steep doee-reeponse characteristla.
I
Indlvldual wells of a 96-well polys,tyrone EolA. mlcrotltratlon plates
(No. 7638104, ' flow Laboratorl~ Mclea n. Vlraln1a) were flnt Icnsltlu:d by
"-\~•.~ ,,•• '. ",.' , ,:".,..,). ", .e-
,I
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passive absorpt ion with anti -mouse . IgO. For the conting,- 200 1£1 of affinity
purified goet anti-mouse IgO (Jeckscn Immunoresearch Laboratories, WCJI
Grove, Pennsylvania) diluted 1/500 (vollvol in bicarbon ate burre.t• .pH 9.6)
was added to each well of the plate and incubated overnight (16 hours) at
4-C, The plates were then washed once with 200 p.\ ph o'sphnte-buffcrcd
salin~ contalnin~ 0.05% (Y0'!v0J) Tween-20 (PBS-ll (Sigma Chemical
Company, St. Louis, Missouri). For washing. the contents of the wells were
flicked off and the plale:; dried on a tissue paper, then PBS·T was ndd: d to
the wells and the comenu flicked . off and the plate s dr ied agnin. 'Tween• .
20 (polyoxyclhylenc sorbitan mcnotecretej .is 8 wetting agcnt nnd prevents
non-specific binding of 'immunoglobulin , to the plast ic surf ace, The
uncoated surface of the wells was further blocked by adding 200 ~I of
blocking buffer (0.1 mVml heat inactivated goat serum, 0..01 gm/ml bovine
serum albumin and 0.003 gmlml gelaun in PBS) to ta ch well for -I hour at
room temperature. The plates were then washed once with PBS·T. The first
well in each nOt coated to get the background reading of the
plate.
~
Chromatographically purl£ied mouse IgG (No. 7176, JockJon
lmmunoreseareh Laboratories, West Grove, Pennsylvanla} wns used os the
standard. Serial dilutions of the Itandard were mnde In POS·T to give
concentrations or 400, 2,00, 100, so, 12.5, 6.25 an d 3.125 nB IgO/ml. . In
different , wells of the coated E.I.A plntel, 200 ~I nf the Itondardl or
aupematant samples were added and Incubated overnight ( 16 houri) at 4·C. '
Each Itapdard and sample wal run In quedrupllcate. The plntei w~rCl then
wa..1hed- four time. with PBS-T 10 remove unreacred lmmunoglobullns.
Su~quently 200 "lor 11100,000 dilutIon (voVvol ' In J'Bs~ containing ,%
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goat lerum ) I;'ffinity. purified goat anti-mouse 19O conjugated with the
enzyme horseradish peroxidase (Jackson Immunoresearch Laboratories, West.
Grove, PennJ)'lvania) was added 10 each well and incubated at room
temperature Ior 2 hours. This conjugate reacts with the antibody captured
~ the sernltiaed plate. Afler incubation, the ~Iates were washed six times
with PBS-T to remove unreactive conjugate . Then 200 ILl freshly prepared
on hophenylencdiamine .[0.4 mglml in phosphate citrate buffer (pH 5)
.r containing 0.4 pI. 30% H20z/mH was added 10 each well and the plate
incuba l~ at . room temperature in ' the dark. The sUbstr~ le reacts ~th the
c:nzyme to produce 8 yellow coloured product. ~e colour reaction was
Slopped at 20 minutes by adding 50 1-'1 or 2.5 N H2S04 10 ~C\ well. Acid
treatment furthc~ changed the colour to ;. stable orange-.br+ prodiicl
which was then read photoelectrically by a Titertek ~ultiscan ELISA
reader (Eflab Oy, Helsinki, Finla~d) with wa~e le~gth set - at"492 nm. Th~
reading was given as loptlcal density.
The concentrations of sampl~ s were calculated from the standard curve
(Fig.' 4.2) using a com~uter program-run In lh) Memorial " U~ lversity
mainframe VAXlYMS . computer. The program subtracts the bockgrou'l,d
readings from test readlnp and uses this corrected optical densitY in
,
calcuJ8tJon~. Absorbances that : fan within 5 to 95 percent of the maximum
observed absorbance arc anI)' Included . In the :analyses. The results were
~rcuc:d as nslml.
•
s.:
I
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4.10. AUTOIMMUNE RESPONSE IN KIDNEY
4.10.1. I'ftpllratloa or k1d~ey HCt.IOD'
KldnC)'l were placed on blocks and covered with ocr embedding
compound (Miles Scientific,' Naperville. Illinois). The, block was placed "in .
petroleum ether for 5 minutes which was cooled with C02 in acetone. The
frozen tissue" were sectioned to a thickness 'of 5 J.l.rn in a cryostat and
mounted on a glass~Kidney section~ were prepared .on the 'day of
killing. The st'ttions were then stored at -20·C and examined later on the
same week.
4.10.2. Stalnln, and tumlnallon of tbe 1eC110D~.
.The scctlons were incubated- at room tempere tcre with 1/20 dilution
(vol/vol) of fluorescein lsothiocyanate (FITC)·conjugsted anti-mouse IgO .or
complemc~t C3 (Cappel, Division of ~per Diagnostic, Cochranville,.
P~nnsytvanla) f~30minutes. rinsed in' a ' PBS bath' for 3 hours, changing
. ,
,thc" PBS ~el)' Inutes, dried and examined with fluorescent' tight
' . microscope lor deposili~n of antibodies and complement.
4.11. ELECl'RON-~ICROsCOPY OF KIDNEY
Kidney' seciions were examined by tra'~smiS5ion eiectron microscopy 'at
'0 and 6 ~eb of observation. 'At 'least four animals from each -group were
examined. The procedure . was perfonned by the : Electron MlcrotrJkw
. . . ~~
Department, Faculty of Medicine, ~emorial UnIVersity of Newfou".dIQ~d.
In 1% sodium
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Kidneys_ were collected immediately ener killing the animal and
. processed. for electron microscopic examination. The tissue Was· diced "into
small pieces (1 cubic mm approx) and . immersed for 20 minutes in a
mixture pr paraformaldehyde and glutaraldehyde in' ~.2M sodium cacodyl81.e
buffer (pH . 7.4) for Iixatlon (Kamovsky, . 1965). After fixation the tissues
. were washed tho~ughly with a.1M sodium cacodylate buffer and postflxed
for 10 minutes in 1% (voVvoI) osmium tetroxide in a.2M sodium cacodylate
buffer : Then they ' were Washed with ' a.1M sodium .cecodylute buffer and
dehydrated by passing through serial concentrations (70%, 95% and 100%)
of ethencl. , The expQsurc was for . 3 minutes in each concentration with two
changes, and 10 minutes for absolute ethanol with two changes. After
dehydration, the tissues were immersed in absolute acetone for 1~ minutes
with two changes, and then transfene~o' a 50:50 .('0'01:'0'01) mixture of
absolute acetone and Epon BJ2 embedding resin for 10 minutes, nnd finally _.
to "1Q()% resin for 10 minutes with two changes. All these steps were
carried out in a fume hood at room temper ature and the tissues were
placed on a rotator. Then the tilSues were embedded with resin in cnpsule.
and polym~riud at JO'C for 16 hours in a Re chert KT·lOO oven.
,
Subsequently 0.5, J.£m sections were fu t with ' 8 LKB Huxley ultra-
mlcrotoJe and ultra-thin Iilv'~r sect ions ~ere .prepared with ' a R~lchert
. . \
OMU3 ultratome, ~ \ectlons were postsrelned with lend clteate and
uranyl acetate and" obsblved. under 8 Phlillps 300 uemmnslon electron
microscope . , .
, , ()
Sectlons, O'~thICk, I~alned with\ i%" tol~ld lnc blue
, : ' ., bora,l't"re~ obrrv,d . undcr , light.mlcroICoPC.
',,,' l~~..f . .~/ ',",:t:."
" 'f( . ~
· .1 . • · • ·.• '.· .' H"' , ~·
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4.11. TIlACE ELEMENT ANALYSIS
Ponlons o~ liver and kidney were: weighed, freeze. dried for 24 hours
and .tored at 4·C for cadmium analyse.s. The analyses were done tn the.
laboratory of Dr. James ~ Frie~ Department of Biochemistry, Memorial
University of Newfoundlarid. The tissues were ashed at SIXtC foc'16 hours
in porcelain crucibles. The ash was dissolved for -30 minutes in 0.5 mt pure
HN03 and ,.5 .mt 1 N HQ and t~e res~ljng solulloit was made up to 10 mt
.~ deionized distilled water. Acid wished .containers were used i~1
s~es of the procedure. The samples were a~ by ~t~mic absorption
. •pectroscopy (Perkin Elmer, Norwalk, Connecticut) (Beaty, ;'l,978). Cadmium
in the control mice tissues were analyzed with ; _HGA-300 graphite;.
atomizer with deuterium ere background corr ection, and the rem aining
') . .
samples were analyzed by, flame with a single. slot 4·inch burner head.
Standards' (BovI~e Uver,. No' 1577a, Nalional Bureau of Stenderds,
Galthereburg, Maryland) were 'also analyzed simultaneously Ao assure
a~acy ?f the assay•• All ' results are reported 8S ' p.8(s wet weight of
?rgan analyzed.
A second batch of Ii~ samples" (Experil!lent 4) were analyzed for
multiple trace elements through the cour:tesy of Dr. Viclo~ - COnti, tifeline
Clnical Laboratory, BALCo, San .Maceo, Californib. The analysis was done
by 'Inductively Coupled Plasma S~ccroPholometry" ln "this procedure, the
. '. ' .
samples were prepared by ashing In' perchloric acid:nltrlc .acid and the
~tumc made up In deionlze~ dlstilled water. The, samples were Injected
Into an argon stream..Of, plasma, heated to 10,000 K by Induct16n coils, and
11
the elements quantiteted "simultaneriusiy on the basis of indu~d atcmlc
I .
e~ion. Rc.suhs are expressed·as 'p.g/g of wet weight of tissue.
4.13. DATA RANnUNG AND STATISTICAL ANALYSIS
Data were stqied on BQT file in the VAX/VMS mainframe computer
system fi the Mem~l University of Newfoundland (EDT Editor Manual,
• 1980) and analyied by ~he statistical packages INITAB (Ryan, Joiner Bod.
Ryan, 19858; Ryan, Joiner "and Ryan, l~ nd--:SAS- (Cody 'Bod Smith,
198s). Data were _stored In Ii :~;;'dj nsional matrix suitable for handling
by .the statistical pa.ckagcs. 1-cne.~y analysis .o£oo Yarin;~~ was performed
to compare the gr~ps. When dif;ercncc was found to be present at P<O.OS,
trea tment•. effect~ai inf~rred 'Iand D,uneao's muutpte-runge test was
'performed to makemultlple comparison between the .means. Significance
levels · us~d .were 0.05 or less.- When a~.alys is of variance did not reveal any
significant ' difference, no further analysis was done. All results
~pone;d as me,an "± SI?
{
CHAPTER 5
RESULTS'
\
L
5.1. EXPERIMENT 1
5.1.1. general beaUb _or mtee
I'
_co"
Mice wt-re examined at least once a week for . obvious manif~tations
of . toxicity, fallur\ to gain weight, alte red feed Int~ke and death. No
outward ma~ifest8ti~ns of . any toxic e ffect was · sqen in any animal and
nonc o f the ani mals died on th e trea tment sched ules . Also on dissect ion
afte r IriIling no gross pattloJogjcal lesions were seen in any organs. The
anlmalJ thy ' appear ed IO ~lokrate the trea tment well
Weights of the animals measured ,; cckly arc shown for four time
PC~~ in Table S.l . There were no statistically significant differences
bctwebl the treatment groups. also the weight gain was similar in all
. groups.
Food disappearance do.l~ ar e shown in Table 5.2. Food pellets
welshed wec~1y 81 , I~C 'same tlm~ as the anlmab and the results were
8vcr8'~d (or the preced ing 3 weeks. The father J~r8e 8m~unt of food
pcllcta dlsappcartng was due to ' the na~ure 'af.. hauslng. In wire.me~hed
hangi ng , cages, • cop'!ldcl1Iblc amount of food b .wasted by the animals,
itnee ~l1ctl . of Im; ler •IIzc tend 'to d;op ~rr. So the m~urem~n~
: .J ' . '
,' ".'" ,:-:,.;;, .; .
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TABLE 5.1
-'
Weight of Mice
Tre atm ent Group Before o week 3 wee k 6 week
trea tment
gm
None 18·6::1: 1'4 20-6::1: 1-4 22-8 ::1: .1-3 2).9 ::1: 1·8
Cd for 3 wk lJ 18·7 ± 1-4 21-0 ± 1-4- 23·3 :I: 1·7 25·0 :I: 1·6
and none for )next 30r 6wk
Cd with Zn {or III 18·8 ± 1·8 21-6 ::1:1-6 23·9 ;t: 1·7 25'4 ::I: ), 7
3'1vk Cnd Z.
,fo.r 110t 3 or 6 wk
Cd [or 3 wk IV 18·2 ::t 1·4 20·8 ± 1·9 23·6 ;t 1-8 2~501 ± ] ,7
and Zn for
next a oe e wk
zn for 3, 6 r V 18'6 ::I: 103 UO± H~ 23·7 ± 1'3 24'7 :t 1-2
or 9 wk \
No ne for 3 wk VI 18'1 ± l-3 20-9 :t I" 23·2 ::I: 1-3 24-7 ± I'S
and Zn for ,
next a cr e wk '
.Resull s arc expressed as mean ± SO. Before . trc~lmcnl and 01 0 wee k,
there were 30 animals in Groups t, II. III and V, IIn~ 20 In Gro ups IV .
a nd VI. At 3 and 6 week, there were 20 and 10 animal. In each group.
, \ ' . '
There arc no statistically' .lgniflcont · difference. (P>O'OS,> between tb,c
treatment group. by one-way ana l)'lu or varlence. "
7.
TABLE 5.i
FoOd Disappearance
/
\
Treatm ent Group o week 3 week 6 week
gmjday
None 6·5 ± 1·2 6-9 ± 1-1 6-1 ± 1·5
Cd for 3 wk II 6·1 ± 0:8 6·8 ± 1·3 6·3 ± 1'2
and none (or '
next a or ri wk
Cd with Zn fcr III 6·3 ± 1·0 6·4 ± 1·0 6·5 ± 0·9
3 wk and Zn
for .next 3 or 6 wk
Cd for 3 wk IV 6'4 ± 0-9 6·6 :!:: 0·8 6-4 ± 1·4
" 0 and Zn for
nen a or ri wk
Zn for 3, 6 V 6·0 ± 1-3 6-7 :t 102 6·2 :!:: 1'2
or 9 wk
None for 3 wk VI 6·6", 1·5 6·4 ± 0·8 6·3 .:!: 1-1
and Zn for
next30r6wk
'; r ,
There ere no ita~sl lcally slgnlfieant differences (P>O"'QS) between the
. '-
treatment groups.by one-wayanalysisof variance.
Food disappearance of ,indlvidually.caged. mice were measured weekly.
. Results ' are expressed as mean ± SO food d jsappel1t~nce for the
preceding 3 weeks. At 0 week, there were 30 animals in ~roups I, II,
III and V. ~nd ,20 .In Groups IV end VI. ,At 3, and eweek, there were
20 and 10 animals in each group.
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prc;ented in Table 5.2 reflect the efforts of mice on food procurement ,
rather .than tru e (0:00 consumption. The results did .not differ between the
# six tr~a~mcn~ groups and three observations periods.
5.1.2. Weight or dllTerent orgaus
c
Liver, ?dnefl' thymus and spleen from all . animals were weighed
immediately after killing. Results are shown in Tables 5.3, 5.4, 5.5 and 5.6.
There Were no significant differences between the treatment groups et any
observation times, although the liver and kidneys tended to be heavier at
the 6 week observation ped~d (Le. 6 weeks after cessation of cadmium
treatment) in animals receiving cadmium alone or with zinc IlS compared to
animals receiving no treatment 01 zinc (Tables 5.3 and 5.4). However, the
difference did not reach the ievcl of st8IiStf0i'significance. The thymus
,_.tended to decrease in weight with incr~asing age of mice (Table 5.5).
5.1.3. Lymphocyte.countll I~ bl~, !bymus and SPleen'. .
Lymphocytes were counted in blood collected fro~- ' the rlght atrium of
,. the heart and in cell suspension prepared from homogenized thymus and
spleen. The results are shown !n Table~ 5.7, 5.8 and 5:9. The counls'"'dj~
not 'differ between the treatment groups 'at any 6bservotlon limo. However, '
the lyrnp~ocyte content of' thymus tended to decrease wlt~ increasing age
of ml~,~nd_ t,ha~ of spleen tended to fncrease. Thu,s cadmium und zfnc, at
the doses u~ed . in this experiment' dl~ not alter the Mol lymphocyte
content ill these organs.
.,
.'
'..".:':
;/
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TABLE S.3
Treatment o week 3 week 6 week
mg
None 1333·6 ::!: 160·8 1396-0 ± 149·3 1385·5 ± l OB·1
Cd for 3 wk 1416·8 ± 163'1 1283' 1 ± 231·7 1497·2 ± 160·7
and none for
next ) ,or 6 wk
Cd with ,Zn for 1383·6 ± 117·8 1380·7 ± 19O1i 1573·6 ::l:: 160·5
3 wk and Zn for
ncxt30r6wk
Cd for 3 wk and 1341·7 ± 187·9 1551-0 ± 192·7
Zn for next
3 or 6 wk
Zn for 3, 6 1403'8 :t 132·4 1487·3 ± 97·6 1404·4 ± 15&7
or 9 wk
None for 3 wk
I 1430·0 ± 125·8 1432i~ ± 174·7 /and Zn fornext30r6wk
Values arc:: expressed as mean ± SO of ,10 obse~alions .
<oj'
There arc .no statistiCally . ~ sJgnlfleant differences ~t?,,(}~5) between the
treatment group' 'by one-way analysis of variance.
. ,.
\ " ~ ' - ~" ,', .
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TABLe 5.4
Weight of Kid,!cys
Treatment .0 w..eek . 3 week . 6 week
None
Cd for 3 wk
and -none for
next3 0r6wk
Cd with Zn for
3 wk and Zn for
next30r6wk
Cd for 3 wk and
Zn for next
30r 6 wk
Zn.for 3, 6
or 9 wk
None for 3'wk
and Zn (or
next 3 or 6 .wk
-mg
286·3 :t 36'0 339'9 :t 2(}O 354·2' :t 22'0 ,
312·9:t 37-2 326·8 :t: 35·6 396·9 ~ 68·6
- 291'1 :t 25'8 6 34),6 ± 28·8 389.7 ± l 5'5
'31 "' 44-5 ' 38.7-6.,% i l;O
305·4 :t 3(}S 356'~ ± 34:8 374'1 :t 44'Q
335·5 :t 29-4 367·5 :t 42·6
V81~es are expressed e s mean ± SO of~ 10 obscrvlltions.
. . ,:\
There are no statistically significant differences . (P>O'05) belwce~the
treatment groups 1?Y one-wayaDolys}, of variance.
(/,'
' .'
,I • •, . .' .~
,"
..
. ~ : ,.\.
;"'., .«, :\ ::,'
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TABLE s.s
."
weight at Thymus
!
Treatmen t o week
~
3.week 6 week ,
mg
None 48·5 :t 4·8 .. 43'5 :t 12'3 3~'.1 e 9'6
Cd for 3 wk SZ,4 :t11·! 39-3 ± 13·2 3~iS ± 7·2
and none for >next aor ri wk
Cd with Zn (at' 45·5 :t "g·S 39'7 ± 5-6 397 ±. 4·2
3 wk and Zn for
next ~ or 6 wk ,.
Cd for 3 wk and 46·4 ~ 11'~ 35'S" ~'2 . ]
Zn for next
. -~'
3 or-6 wk
Zn for 3, 6 ~ 8.'3 42'8; ± 5·4 39·2 ± 4-6 . "or 9 wk
None for 3 wk ", 45·3 ± 4·7 36-3 ± 2·7
and Zn.for .
nexr a or ji wk
Valll.cs ar~expressed as mean .~'\SD of 10'observations.
.......... . ' ',
There are no statistically. ~ignifi cant differences (P>().05) between the
treatment groups by one-way a~alysis of V8riJ nce:
TABLE 5.6
Weight of Spleen
Treatment , . __ -..!!,eek 3 week 6 week
'---.
mg
None 106-2 ± 200Z 99·2 ± 12·4 9.'·~ ± 9·0
",
-,
Cd for 3 wk 112'6:!:: 42-8 103·0 :!:: 21·8 107·2 ± g'7
and"none l or
next 3 or 6wk
:-..Cd with Zn for 97·0:l:: 9·6 / :1:: 8'6 107·8 ~± 14·4 G3 'w~ and .Zn for
next 3· Or 6 wk
OJ-r~r 3 ~~ 'so'd i 03·6 ± 16-3 106·6 ~ 12·7
Zn for next
3 or 6 wk
Zn for 3. 6 92:5 ± 11·0 108·1 ± 17~3 109·8 ± 17·2
or 9 wk
None for 3 wk 100'1 ± 103 108·8 ± 22·2
and Zn for
next 3 or 6 wk
..
Values are expressed as mean :1::' SO of "10 ·observations.
There are no statfsti,cally significant, differen ces (P>O'OS) between the -..,
treatment groups by one-way analysis of variance.
~- , o' ~o
80
, " '-4
" l
TABLE 5.7
Lymphocyte Counts in Blood
..
There 0 are no statistically signi~~nl differences (P>0'05) , between the
treatment groups by one-way a~alYSis of variance.
-..... - Values are expressed as mean ± SO of 10 observauons.
2.85 0 :1:: 0·19
2·45 ::t'l}-18
2-93 ± ~66
2·43 :I:: 0·90
2·83 ± 1-11
2·32 ::t 1'042·52 ± 1·06
o week 3 week 6 week". ~
x 106/ml
2·25 ± (}91 2·99 ± 0·16 2-45 ± (}70
(.§i(± 1-2I 3-91 ± 0·83 2'5"9 ± (}51
"
\
3·02 ± 1·17 2·81 ± (}82 3'22 ± 0,77
Cdfor3 'wk
and 0 none for
next 3 or 6 wk
'Cd with Zn fo~ o . 0
o 3 wk. and Zn' for
°next 3 0r 6 wk
Cd for 3 ,wk and
Zn for next
3 or 6 wk -
Zn for 3, 6
or 9 wk
None for 3 wk
and Zn for
nexr a ot e wk
Treatment
None
.- ..
.Values arc e'fPressed as mean ,± SD of 10 observanon s.
# .# ..
The re ai-e-:-no ; ~Iatistically significant:" diff~ences (P >0 ·05) . be twee n the
treatnient groups by one-way analysis· ~f variance.
/ ~1
TABLE/"
Lymjhocyte Counts in ' Thymus
o week 3 week 6 week
x 106
96·6 :t; 43-4 110-7 ±' 35:3 81-0 ± 32-1
104·3 .± '63:8 ~ . 82'6 ± '\51-8 92 ·S ±.·17· 9
l "
.87·4 ± 46·7 83-2 :!: 26·9 80-0 ± 12·8
: \
104:8 :!: 46'0 77·5 ± 17-3
118·6 ± 53-2 99·0 :!: 33:7, 75·8 ± 18-7
\
% ·1 :!: 30-3 ' 79-7 ~ 13·6
• .Treatment
Non~
Cd for.3 wk
and none for
riext 3 .cr 6 wk
Cd with Zn for .
- -3 wk and Zn for
next 3 or 6 wk-
Cd for 3 wk and '
· 'Z n for nest
3 .or6wk
Zn for 3,--6
or 9 wk .
1" ' -
None for 3 ,wk
and Zn for
nen a cr e wk
I
I
,V - ,
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. TABLE S.9
Lymphocyte Counts in Spleen
Treatment o week - 6 week
None
x 106
i'~~± 53·2 · 205·3 ± -31-7 . 21601- ± 16-6
Values ~re expressed as mea,n ± SO of 10 observations.
. ,-
222·7 ± 35-1
224'3 ± 24-6 .
. ' .~
_.: .. . .: :/7
' 22N_i~~4 '". . ·.·.i
. " )
219'8± 29·7 .' ,1 , :;212'5 ± 36·4
. _ I
2()(}S ± 31·7
192-9 ± 96:1 21601 ± 4fH
174·7± 48·0· . ~1S04 ± 28·S
Cd for 3 wk
and none (or
next 3 Of 6wk
Cd with Zn for
3 wk and Zn ' for
next 3 or 6wJC
Thcre are no . statistiCally . significant differef'l.ce& (P > O'05) beiwccn' the
. treatment groups by':one-way analysis_Of variance.
Cd for 3 wk and
"Zn for next
3 or 6 wk
Znfor 3, 6 "
; or 9 wk --~
None for 3 wk
arid Zn for
next 3 or 6 wk
" 'J ',.
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',5.1.4. Direct plaque-ronnlDC'cell ~IPODse
~.
~ direct ' p laque-forming cell responses of aU mice were assayed by '
lIl,t«tlng sheep red bkxxl cells (SRBC) 4 days poor to killing and counting
the -"number of -·splenlc." 'lymphocytes prod~g j~ a;bbodY -aiai~t- -the
SRBC antigen in a plaque-essay, Results expressed as plaquesll06 spleer). .- .
: . . ' '. ' ,)
' . Iymp~es and plaques,fspleen arc shown in Fig. 5.1 'and T~ble 5.10 i.
respect ively.
Mice treated with cadmiu~ , for 3 weeks (week 0 qJ>seMtion) haq :
sl~jfiC8ntJy increased .',number of _5ple~ic IgM pi~q~e~r?nning cell (pF~ as
~mp8red . to th~5e receiving cadmium with .zinC, zinc or no :treatment. . Thm
. co~curreRt admini'S'trallon : of zin~ ' preven~cd 'th~' ~dmium~induc~d ':.increase
. . . ~ ' . .' .
. in I~. .PFC _~ponsc. .Th~e weeks .after .:cessa~lon of cadmium treatmen t.
(week ·-3 '. observati~~). . th? " number ' . of IgM ' antibody-forming ' cells s~
tend~ . to be high In, cad~um-treated c.animals, an~ the antagonis~ -effect . :
;,.-------"or-- um7'was sliD mamtamedt althOugh the-differences were
- \
' j
v . .
. statistically not signiflC8nL E~n ; -ziiIc given after cessation of cadmium
treat ment .. tended ,to lower~he ~dmium-induced increase in IgM · Pf ,C
number (Fig. s.i a¥ Table""S}O). After 6 weeks of -~tion of cadmium
treatment. '(week 6 ~rvatio~). · no -significant 'd ifference: in l,gM antit?OO;'~
iormi~g cell;' between the 'groups".were 'o~e~ed (fable 5.10).
. .', 5.1.5-, ProI!r.enUve· rtl.~Dse of Ipleen ~1I1
Spleen ~l1 cu1tures wC~ " stimulaled with the T 'cell mitogens PHA arid · _ ~"..\.:,k.'j:.'.
":' ~ : -, , Con 'A for 72 , h-o~n _ and r~djriactive' thymidine -inco~ratio ri duri~; · the last ,-F. 4 ' -houn of the ' culture measured, The ra tio between the thYJ:ll~di~ fl
k \ " ,;~
~~ ~\~i ·;i~ !;: <~~i·· ·- :;.:~t:i,~.i.:M:;::'::;'i. " . , '- '~-~;: '/ ;;:~ \: ~~~_ '.1 :~i;~:;.t~~~_' ·.:~:A': :~;;t:.J.~.;:" j- :::1 ~:.;:./'
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II III V
o week
II III IV .v
3 week
( FIG. 5.1
biecet plaque-forming (lgM) cells response in mice treated with cadmium
with or without zinc, Group, J received no treatment; group -n,-cadmium.cor
3 ~wel"rks 'and no treatment for .next 3 weeks; ,gro~p nt, clldmiulil ' wfl~zlnc'
for 3 weeks and: zinc (or next 3. weeD: .group~cadmium for 3 '-weeks
and zinc for next ·~ 'w~k.s; . and.'group V, _'zinc (Dr 6-~--:--Bars represent.
.'-. mean and SO of '10 observations. At 0 week. Cadmium treated aninl'als .bad
bight; ' ~uinber of plaque-forming cells.. th~; . the other. ' three .groups
(~P<O.OS) . SimuttaIlaQw treatment of cadmium and,zinc -d,id ,not result ~ a
greater " number or. plaque-forming .eeus. ' At 3 . week', ' there" were 'no
signiflcant di~eren~ s" between the gr~upi.
8S
TABLE S.lO
",
" Dir~l " PlaqUe-r ing Cell Response
Treatment o week ,3 week 6 week
I
{' None
t
. IgM, Plaques/spleen
63364 ± 11235 67125 ± 14262 . 75432 ± 10494
Val~es are expressed a,s mean ± SD of 10 observations.
·Signifi~tly different at . P<D-OS from other values "in the - same ~olumn ' by
Duncan's'm'ultiple-rangc test.
-e , "
68380 ± 12122 76137 ± 10424
67315 ± 13803 77728 ± 11980
57276 ~ 12161 , 68483 ± 9206 79912 ± 12498
56683 ± 11147 71958 ,± 10026 77450 ± 11428"
89466 ± 13104- 81793' ± 10331 81432 ± 1~923Cd for 3 wk
and .n cne for .
neXt_3 or 6 wk
Cdwith 'Zn for
3 wk and Zn for
ncxt 3 or6 w~ -
Cd for 3-wk and
"Znfcr next
3 or 6 ..vk
Zn ro~ 3, 6
or ~ wk •
None for·3 wk
. and Zn for
next 3 or 6"wk
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uptake of stimulated~and non-stimulated cells was expressed as stimulation
index. Results are shown in Table 'S.Il . There was a large spread of values
obtained from :the different groups. Differences between the groups were
not statisticallyIsignificant, however, the mean sthnularkm index tended to
- be highe r in , ~njmals receiving cadmium as compared to the non-treated
'"\ "
alterations . .by
,
for ultrastructuralwere examined
microscopy. Foul' animals from each group ' ~ere
and 6 we~k of obse~ation. Whol~phr.on and interstitial
controls, both r 0 and 3 week of observation. ' Anima,ls.recelv lng cadmium , ' ,'\
and zinc toget~er ~ad velues similar to those receiving cadrrqum alone, but
·zinc tended .ld\ reduce the response when given after .cessation of cadmium
treatment.". N~~e , of th~se d ifferenc~ reached the" level of .Slalisti'cal
· sign~cance: "I \ .. . .
, i \ /
. I.,
5.1.6. Autoimm une response In"k1dD~S
I ' ~ \. i.'J
Whole ki~ney sections were examined .for IgO and 0 deposulon ' by
fluorescence 1icrosco~ , using fluorescein tagg ed anti-mouse IgG and. 0.
Six to eight mice from each 'group were examined at , the, th:ee observ'atio n
·periods. No !evidence of autoimmune reaction involving' IgO ' and 0
i , • - , ~
deposition was seen ' in flY animal. Fluorescence was ' noted aro und the
glomerulus a~~ th~ cOiiVo1uted tubules, but th e amount of fixed antibodies
followed the I\same pattern and appeared to be equal ~n all treatment
~oo~. . .
5.1.7. Electron ~Icrosoopy of kidney
( \
,..
TABLE s.n
)rOliferative R~S~f1.!ie of Spleen ceils
<f-
aweek 3 week
Tre atment PRA Con 'A PHA Con A
I
g'7 ± "6'2None 7·7·± 2·9 15,.9. ± '6'6 15·8 ± 13,7
i
Cd for 3 wk 12·2 ± ;4'4 26.6± ,I 15.4 . 17-6 ± 24·9 27·6 ± 4(}oZ
and none for
neXt 3 wk
Gq,with Zn for 11.'1 ::t: g' l 25-9 ± 26-9 12·0 ± 9·6 27'4 ± 27·8
, 3 wk and Zn for
next' 3 wk
Cd for 3 wk and 7·2 ± 3·7 21-1 ± 21-8
Zn for next
3 w~
Zn for 3 or 9·6 ± 4, ) 17·7 ~ 12·4 9·6 ± 6·9 18·8 ± 19'4
6 wk
? w'-h,'chp~lirerallon response . is expressed as . st~~tion infiex repr esents
the ratio _between mean 'counts per minute of triplicate. cultures
stimulated with mitogen ~i~ded 'bY the mean counts per minute of
triplicate control cultures. The results arc expressed as means ± SO of
10 observatT~n$.
There are~o stat!stit:ally ' - signifi~nt differences EP>(}-OS) "between the
.treatm,ent ~ups by :-on~~y analys~s Of~riance.
"\ .
\ .
; ''..;
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tiss'ues were" examined. Abnonnalities w~rc pbs~rved in the prox~mal tubl:\inr
ep ithelial .cells in animals treated with cadmium for 3 weeks. As compared
- to the non-treated animal s, .the - mitcchcndrie wer e increased in number,
swollen _and the cisterna di;t orted. Inside several cells, electron dense
bodies were observed. (Fig. 5.2). Similar changes were ' also. seen 6 weeks
after cessati,;m of cadmium trcaun e.nt, and in -.animals receiving cadmium
together with zinc. Other areas of. kidney,- including the glomerulus
.appeared normal, in all groups. Thus cadmium altered the str~.cturc of
~roximal tubular cells whi~h pers~ted after ' cessation . of treatment and
'zinc had no e~/et on this as~ct of cad~ium toxicity.
;'
5.1.8. TIssue' cadm ium concentration
/ . ,
Kidney and liver sampl es from mice killed at 0 and 6 week observation
were ,' eeze dri~d ' a nd lat er ana lyzed for cadmium cont ent by atomicI . . .
abs orption spectroscopy. Re sults are shown in Ta bles 5.12 and 5.13. Kidney
an i liver ' cadm ium concentration was significantlY bigher in cadmium .
i t; eated mice at 0 and 6 week th an untre ated . mice. Int cadmium treated
Iimice, kidney cadmium con cehtrat ion also . increased significantly between 0
/ ..
'
,
. .' and 6 weeks, while a trend for decre~ in liver ' cadmium concentration
was observed' at the same time peri~. M ice rec~iYing cadmium and -zinc
together had significantly lower kidney and liver cadm ium conce~tration
than a nimals "rece iving '~dmiu~ alone. Zinc ' 8i~en aft~er cessatio n of
cadm i·u!!!.-treatment allP tend ed to decrease cadmium' concentrat ion in both
\:-"-..,.,
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ELECTRON MICROSCOPY OF KIDNEY SECfIONS
FIG. 5.2
Elect ron microscopic appearance of proximal tubular cell from a control
mouse (left) and cadmium treated (50 ppm cadmium in drinking water for 3
weeks) mouse (right). In the treated anima l, mitochondria are increased in
number , swollen and the cisternae are distorted. Electron dense materials
are present inside the cell. (x 12,000).
" ,
, : ' ,
.'
CadmiumConcentratlon hi the Kidneys·
" ,
---- - - - - - - - ---- --:-- -
Treatment
None ' .
Cd for. 3 wk
and none for
next 6 wk
Cd with Zn for
3 wk and Zn for
next 6 wk '
"Cd for 3 wk and '
Zn for next 6 .wk
o week .6 week
~g/g ', , '
" '1'1\1 ~ O'40'!
,
9,96 ± . 2·tt bc
..
'.
Values are expressed as mean ± SO of eight observations.
I , . ' . .'
In vertical columns values not · sharing a comrri.~ri s,uperf:rip~ letter are
significantly different at P<o-O~ by. Duncan's multiple-range test;
I
In horizontal rows values not "sharing a ' common supe~rjpt letter
sign~~cantly diff~rent at P<O:05 6y ~uncan" ,muH iple':ran~e test. . :t
-;
~ : "
.. ; ,
' ..
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TABLE 5.13
Cadmium Concentration in the Liver.
Treatmen t '
None
Cd. for 3 wk"
and, none for
'next 6 wk
- C,j,'witb 'Zn for
'3 wk and Zn for
next 6 wk .
Cd for 3 wk and
Zn r9f nc\t" 6 wk
o week "
7·30 ± o-l1 b
4·57 ± Q.99C
6 'week
0'41 ::!: Q'14a
4'35 :t l '9C,
Values are expressed es .mean ± SD of ei~t observations.
. In vertical colu~ns and horizontal rows values not sharing a common
~uPerscript letter ate significa~tl~ . different at P<D-05 ' by Duncan's
m~ltiple-range ~est.
.....
equally.
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5.z. EXPERIMENT 1
5.2.1. Gen(:raI health or m!ct
"G in experiment 1 .(Section 5.1.1.), mice were examined,at least once
a week for external signs .of toxicity, weight gain, food disappearunce nnd
death. No sign of toxicity was seen in any mice and none died while on
treatment. AfJ:. ' on dissecti~m after killln; all organs appeared hea lthy on <,
gross examination.
W eight of m.i(::C was monitored weekly. Results for three time periods
-are shown in Table 5.14. There were no statistically significant differences
between the groups' a nd also mice from all four groups gained weight
"
• Food disapp.eara~e was' checked for one week immediately prior 10
'kilhng. Results are shown in 'Table 5.15. As In the prevlqus experiment
(Section 5.1.1. and -Table 5.2. 'page 74), large amounts of rood disappeared
from' the cagh and the amount or food pe llets disappeari~g was , equal in
. "811 groups .
5.2;1. Weight and lymphocyte counts 10 spleen
Sp leen was collected at 0, and 3 weeks, weighed and ly.mphoC)'tea ....
counted ' on sta~dard 'NeJbauer chamber. Res~lts~ .are · ahOf" in Table .5.16. :
There '!"ere :~o •statisti~llY Slgni,cant diff~ren~ ~elween the kroupa.
Thus .weight and. Jymph~e content of spleen.. was 'not altered by' 'f e .
cadmiu m .and zinc treatment at the dosage .used in 'this experiment.
'\
, I
, ' , '.-. ~ '
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TABLE 5.14
Weight of Mice
Treatment Grou;rT Before
treatment
o week . 3 week
-~- gm
None 18·7 :t 1·3 20·4 ± [ '2 22·4 ::t 1·7
Cd for 3 'wk II 1&·6 ± 1·5 2O'3-±--!-3 22·4 ± i -i
and none for
next 3 wk .
Cd with Z~ , for . III 18·9 ± 1·0 20·8 ± 1·2 2~'4 ± i-a
3 wk and Zn for
next 3 wk
Zn for·-3 . V 19·Q,F± 1·3 2QoS ± 1-3 22,8 ± i -i
or 6 wk
Results.' are expressed as mean ± SD of 20 observations before treatment
and ai 0 week, end 10 at 3 .week:
There arc no .... stBtistically significant differences (P>~'OS) between the
treatment groups by one-way analysisorvariance.
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TABU; U S
Food Disa~peaCce
Treatment Group o week 3 week
6-5 ± 101
gm/day
6·8:l: 1'3
6-4 % 1·3 \ -
------------------J
None 6'4 s 1-0
_ Cd Cor 3 wk 11 &3 ± 0·8
and none for
next 3 wk
~, Cd with Zn for 111 6·0::l: 1-23 wk and Zn fornext 3 wk
"
Zn for 3 V &3::l: 1-1
• d'r6 wk
Food d~ppearance of ' individually-caged _mice: was measured for one week
prior. t?Jci~Hng. Results arc expressed 85 mean .± SO of 20 observaucne
at 0 week, and 10 at 3 week.
Ther e . are no statistically significa~1 differences (P>O-OS) between the -
treatment .groups by ?ne-way analysisof variance.
"'-:
.-..i
.... ..'~ ',..:.. " ...: ..:.~, ;;:,.;. .-.. '".;"',"
-------~-------~...
3 week
Lymphocyt e: count
o week
95
Weight
'3 weeko wee kTreatment
. :, Weight and Lymphocyte Counts in Splcen
TAB~5.16
There are no .statistically · significant diff~rences (P >O·OS) betwee n the
. treatment 'BroUPS byl:me.~y -a~~lysis .or variance. .
Va!uc<1 are expressed ,as "lean ± SO of 10 observati ons.
.- None . 73·6 ~ 5·0 78'4 :t:: 9·5 151'·6 ± 4(}Z
.\ ~\
· Cd for 3 wk 76·0 ± 14·5 75·1 ± 8·7 ' 162~8- ± 37·3
·-r-end -none fer. l ..
next' 3 wk
c:~t~~f~ r 72'4 '~ 7-8 7.7'6"£ 1306 53:4 ± 43'2:
· -fcr next 3 wk
lSO·4 .::!: 38·8 '
,
lA9-5' ::t: 42·3
1~9'4 ::!:: 46·1
163 -8 ± 37·9
mg
73-6 i:. 5·0 71' I '::t: 8~8Zn for 3 or
6 wk
- 0;"-
.
_statistically not
5.3. EXPERIMENT 3
/
~.3.1.. General health.or mice .
96_
5.1.3 ., Indirect plsque-fonnlDI cell response
As In previcusitwo experiments "",,'''nn.s.1.11
. examined' at least ·once a week for external mo.n;f,"" 'Uone
. . Indirect pJaque.fo~ing cell (PFq respon se essayed lmrnedlately
afte r cessation of cadmi um , treatment (0 week) ' -a nd 3 weeks 'l atc,r (3 week).
Mice ' were inject ed with sheep red".blood cells "(SR BO) 8 days prior to
killing arid the numbe r of spleen cells prod,Lcin~ IgO antibo dy against the
SRBC antigen was counted in a plaque-assay, Results expressed os tgO
plaques/ l 06 s~lee.n ~phocytc:s and plaques/spleen·"a re shown In Fig", 5,3
and I Tabl e ' 5:17 'respectively. The findin~_ f~1I0wed th e same: ~attern . as for
IgM plaque -assay (Fig 5.1, page 84; .Table 5,.10, page 85). At 0 week of .
Observation, _ cadmium. . . tie at;d . mlce had significantly 'higher IgO _ PF C
number than the other three groups, including that receiving cadmium , end
. zinc . 'to~ethet. The ' nUjnbe~ . of .PF C ln. the i.i ntfeat~d 8ro~'p 'and t~ose
t~eated .with - cadmium j and zinc, together ·,or '. only zinc ,w as not d ifferent
from: eac h - othe r: Thus' zinc prevented th~ cildmiu~duced increase in IgO •
PF C : rtePonse when given \ ~Iong with ~dmlum, Three we~ks a fter ceuation
of ' ~dmium, trea tment (3 week observat ion), -cadmium treated anlmals~~i11
tended to have high IiJG PFC number than >· other three groups and zinc
maintained the antagonism; but the
. significant ,
' .... ', 'V' :' . . . .;.'
'T1
IgO PLAQUES
2400
,..
; i_ I~direct plaque.~ormlng (lgG) cells eesporae In ~ce treated with , or
without zlnc..Gf9up 1 recebed no treatment; group II, . cadmium _for 3
week! and no t~tment for next '3 ~~ks; ', group ~III. cadmium With zi~c
f~r 3 weeks "and zinc ' for next 3 ' weeks; and ,group V, zinc for .6 we~ks.
Bari , represent - mean ..end . sner 10 ' observations. At , 0 , week ; C8drid~'m
treated ~Is ' had ' higher number of plaque-forming "cells than the other
three , groups E-·P<O.05). ·Slmulreneous . treatment of cadm\um and zinc .did
nol ~uI~ in," great~r n,'umber of. p,tiltlue-forming cells. At 3 . wee~ -' the;e
. 'were !lO . slSn~cant" differeo.ccs -betWe n the' groups. ' .." .'
3 week
II III VO. ~II , III V
o week
FIG. 5.3
. 1
1200
,';' ,' ' I
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TABLE 5.17
:. :
Treat ment o week 3 week
IgG. Plaqueslspleen
; :'.
None 242378 ':t: 41632 269728 e 66672
Cd for 3 wk 353412 ± 66444- 293382 ± 54312'
and none for
next 3. wk
,
Cd with Zn for 279664 ± 51852 279091 :t: 67875
3 wk and Zn tor .
. next 3 0r 6 wk
' Zn ror 3 ~r 281798 ± 56483 259596 '::t 75414
6 wk ':
•
Values BfC expressed .as mean :t'SO of 10 observations.
·Significantly different at P< D-OS from other values in the: same column by
Dun~n's mUltipl~~rangc test.
'. - ~' ,~'
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weight gain, food disappearance and death. No -aim of toxicity, both
· during the treatment and on dissection after killing were seen in any mice.
Weight of the mice at two time periods and food disappearance data
for a 7 day period Immediately p~or to killing are shown in Ta~le . ~. 1 8. ~
in"previous two experiments" (Table 5.1 page 73, Table 5.2 page 74, Table .
5.14 page 93 and Table 5.15 page 94) no statistically' significant differences
betW~en ihe groups were observed~
. colleC!ed, weighCd and .the. JymPh~es ~o~nted. Weight ' ot.vspleen and
IYmph.ocyte' "content for. the .Icur groups ,re _shown in Table 5~19. No
· diffe~ence between the treatment ~oups weretbS~ed. ;--
Although in .the ' previous two experiments no ·'_d.lfferences in spleen
weight and' lymphocYte conten~ were 'observed, the p~ocedure . was r~peated
and ,the data : presented as a background, since the other immunotoglcal
e: . J
5.3.1. Weight and -lymphocYte counts ' In spleen
: . ~ " ""," '
Immediately afte~' 3 'w~~k trea~~ent period,
--- (
mice were killed, spleens
. . ' .
assays wer.e performed on spleen cells.
(
.Splenic T ' lymphocyte ~U~IS counted by immunofluorescen.ce
" staining , wing ' .monoclonal . anti-L3T4. ,and' an·ti-Lyt.2 antibod.ies.'- These
· antibodies Id~ntify the murin~ lymphocyte .· differentiat~qn antigens CD4 arid
· CDB, w~icli are markers of helper/inducer and suppressor/cytotoxic T ' cells -. "
._respectively (&allay, '-Bartlett and Shortman, 1984; Lewis . and Cahalan
/'
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TABLE 5,18
'------ , ,Weight of Mice and Food Disappearance(, ,
Treatment ~:_oup , Weig1lt Food
Before o week. ~jsapp~arance
treatment
,
gm gm/day
None I 19-6:t 1'4 "23'0 ± 1-4 6·4 ± 1·2
'i" ,
Cd for 3 wk
\::1
1~'4 ± H 23,] ± 1·5 6·2 ± 1·0
Cd with Zn i9'6 ± 1-2 22'9 ± 1'4 6·5 ± 101
for.3 wk
Zn for 3 wk V 19·7 ± 1·2 22·9 ~ 1'4 6,3 ± .i-o
...
Weight of mice results expressed as mean .±. SO of e ight observations
before treatme nt and at 0 week.
Food disap pearan ce o~ individually-caged mice was measure d for one week
pr!0r - to killing. ,R~ults are expressed "as mean " ± SO of -elght
observations:
There arc no statistically significant differences (P>(}05) between Ih, ;
treatment groups by one-way analysis of variance.
IOJ
TABLE S.19
····7>
/
I
/
t
Treatment Weight LYmPhocyte
( count
IDg / x 106 •
None ~7 :!: '19-4 141-3 :!: 25-5
Cd for 3 wk 82·3 ± 2(}-3 139·8 %. 22·S
Cd with Zn . '88·6 ± 12·5 '; .m8:3± 22·S
for 3 \\til:
:
Zn for 3 wlr: 7S'9:!: 14-1 13i~ :!: 31·i .
Values arc expressed as mean ±'SO of ( ight observations.....
There are no statistically sj~ificant differences (P >(H)S) between the
treatme nt groups by 'o ne-way analysis of variance. .
... /
~ . .
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1988). Results arc shown in Table 5.20. Percentage of CD4+ « Ils was
similar in all' groups of ; mice, but thai of CD~"" cells was significantly
/ lower in the cadmium tre ated group than in the o ther three groups.,
:;>°1ncluding that trea ted with cadmium and zinc: toget her. Concurrent
~~ministra tion of zinc thu s prevented the cad~ium in~uced . selective
red uction of CD8+ cell num~r in the spleen. The ratio of CD4+ and CD8+
cells, which reflects the ba lance of immunorcgulalory T-Iymphocytc~; was
higher in cadmium treated animals than in all other group s. Zinc prev~ntcd
this increase.
S~.4. Suppressor cell ac:lJ~ty
The capacity- of Cod J\ i~duced spleen ' cells 10 inhibit the mitogenic . .
response Qf ~utologous splee n cells 10 PHA in eocunure was m~asured and
the percentage of suppression expressed as the suppressor cell "BetM!)'.
Results are shown in Fig. 5.4. There was a large spread of results and also .
some values were in the ne~ange. making interp retation of essay
resul~. complex. However;- mean suppressor cell activity tend ed to ~ klwct
in. • mice treated " with cadmium than in untreated contr ols, but Ihe
difference was statisdcaJIy not significant
5.4. EXPERIMENT 4
5.4.1. General health of mice
As in the previous three experiments (Section 5.1.1.. 5.2.11 and 5.3.1)
mice were examined at least . once a ~ek for external . signs of .toxlcity.
wei~t Bain,. food disappearance and deeth. All jnl~alS healthy
J
.;;;: : .........,...._r.· .:" ,•.'~ . " ••.•.. ....,."...•
,
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TABLE S.20
-i'-Jymphocytc SUbset5 in the Spleen at 0 week
CD4+ ",I' CD8.+ celts
Treatment (L3T4+ he.lper) (Lyt.2+ suppressor) helper/supp'ressorj"
%
i~, None 34·90 ± 6·63 . 2 4'96 e 3·SS 1'40 ± 0-21
~, { Cd for 3 wk 32·35 ± 5·98 17·24 :t 2-74 ' , 1·89 :t&32' ' .
to,
Cd with Zn 31-99 ::t 6·00 22· 19 ± 2-79 1-44 e ().19
ro~3"" wk
Zn for 3 wk 33-40 e 6-28 23-31 • 2·04 HO ± ()'21
!',
Values arc .C:XP~ as mean :t SO of eight OOselVlltions. .
'SignifK:antly different B.t P <(H)1 from o:hcr Values in the sa~ column !'Y
o.uncan's multiple·ra ngc lest,
\
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\
SUPPRESSOR CELL ACfIVITY
Suppressor cell . BctivitY (%suppression) o f ' Con A stimulated-'sple en celli.
Each· point represents one animal and lh,~ bars represent the mean value in
each group. There 'were no ~ significant dirCerol}cc:s ' (P>O.OS) between the
groups. . ~-> -. .:
..'
.,
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lOS
Ihrougho~t the ' nPerimcntal period and also on d tssecucn after killing no
~grou "pathological .lesions were seen in a ny organs . Wci8ht of mice. at twa
time periods and food disappeara nce for a 7 day period immediat~1y poo r
"to killing is shown in ' Table '5.21. As in prevk>us eXperiments (fable 5.1
page 73, Table 5.2 page 74, Table 5.14 page 93, Table 5.15 page Pot and
Table . 5.18 .page 100) no sta~isticaltY l ignifica nl diff~rcnccs be tween the
groups were observed. Ha....cvolo the food d isap pearanCe:~ . conside rably
~er than befo~e., as mice in this experiment we re hous ed in plas~ ic cages
· with bedding and 81 s~ch I~ss food pellets were wasted by the animals.
5.4.2. Weight, lym phocyte and B .ceu cou nt In spleen
s{
I v
Afler · three. we~~ treeunem periods, mice. ' kill~d, spleens
colleelc~. wel~hed' and Iymp~.s counlc~. . •B 'cells from .spteen "cell
s\ij~rision we,re stained with FITC-conjugated purified anti~mouse IgG and
counted using : a ~~oresccnce mi~pc. Spleen ";ei~t, Jym"p~ocy1e , co~~ t
· arid B ~n count 'resuld are shown in Table S;.n, Ther e were no
· . ' . . . .
statiitically signi!k&nt di£ferences between the groups. however, total . B
, . ~ " /
cell count in t~ spleen tended to be h,ighcr I" cadmium trea ted animals '
than in th7 other ,~ree groups.
..'
5.0. Natural~kJ lle~ eeu actJ-ri.,.
Natural·k,lller Cell activity was measured. in a ..... and 12 hour chromium
releasc "auay using the"Molorie; vi~ i~duce~ ' lymphoma. cell Ii~c YACI
" , labelled : with Sl~ 'as targ~IJI, R~;ults are '~~ in F;g s,;, The .netcrel-"
kille; cell activity was loWe~in cadmium treated animals as compared to
....
~ . . .
,-. ; ....... .: .. ...:. ;;-.' .:.
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TABLE 5.21
Weight of Mice and Food Disappearance
Treatment Group Weight
. Before . 0 week
treatment
Food
.disappearance
gm
No ne 20-3 :!:: 1 '~ 23·4 :!: I,'
Cd for 3 wk • II 21·2 ± 1·3 24,( ± ,..
Cd with Zn ' 111 ~O'.6 :.t "2 24·3 :!: 1·7
ror .3 wk
Zn for 3 wk V 20-4 ± t .• 24·3 ± .101
8m/day
3·9 ;t. 0·6
3·g :t: os
Weight of mice results expressed .as mean ± SO of ~O observations be fore
treatment and at 0 week.
"
Food disappearance of ind,vidualJy-ca'ged ' mice were measured for one wee~
prior to killing. Resu lts expressed . mean ± SO of dght
observations.
The re arc ' no st::-tistieally sigI:lificant differen~es (P>().OS) betw een the
treatinent groups by one -way analysis of .variance.
' - /
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TABLE 5.22
Weight, Lymphocyte and B Cell Count in Spleen
Treatment Weight Lymphocyte B cell B cell
count ..
mg Xl06 % xl06
None 67·4 :t 6-8 119·5 :± 46·9 37·7 ± 3·5 44'2 :!: 15·2
CdIor 3wk 72·9 :t 9-1 137'1 :t 49-3 36'8 :t 3·8 SG-6 :t 19.3
Cd with Zn 67-4 ± 9-2 121'7:t 3(}2 37·4 ± 3-3 45'5 :t 11'9
for 3 wk
Zoior3 wk 1.72~2 ± 4·8 123'3 :::t: 36'7 35-3 ± 4;4 43'4 ::t-12·7
Tho results are expressed as means ± of 10 observations.
, J
There are no statistically sighificant differences (P>l}OS) between the
treatment groups by one-way ana lysis of variance..
. ,~ " . ;,,: ,., : .
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NATlJRAL.K1LLER CELL ACTIV ITY
4 hour assay 12 hour nssny
50
0 0
00 0
00
40 0
,
,00
-lL
0 0 0
0 0
"
30 0 0
-lL
0 0
-lL dr. '
'.
0 0 00 00
0
-lL 00 0 0b 20 00 0 00 0
-lL 0
... 00
-""---
00
0 00 , 0 0
-.
0 0 0
10 0 0
00 0
0 ,
\
Control Cd Cd+Zn Zn Contro)t Cd' Cd+Zn Znt
FIG,5,5
Natural-killer (NK) cell activity (% lysis) in different treatment groups
after 4 and 12 hours of incubation of effector lymphocytes with labelled
r: target cells in a ratio_of 50:1. Each poimrepresents one animal and the
b~ • represent the mean value in qach group. 'jn the J2 hour assay,
cadmium treated animals had , lower , NK cen activity then other three
groups tp<o-OS}. NK cell activity of . groups receiving cadmium with zinc
or zinc. was not differentfrorn control. In 4 hour" assay, a similar tre nd
. was observed (P>OoOS). Between the . 4 and 12 hour Bnay, the mean
Perce ntage of ,- titrgei cell' lySis increased in the ,control "and .zinc - treated
groups (tp<~OS); but not in those l_eceivinlf cedmlusn alone o~ with zinc.
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untreated controls' a1 . both thne~ ' periods; however it' was statistically
significant at the 12 hour assay. The activity in groups receiving cadmium
- (
with zinc or zinc alone was no.! 'different from controls in either time
period. Zinc thus prevented the cadmium induced reduction in NK ,cell
activity.
In . the ' culture examined at 12 hours, the mean target cell lysis
• increased significantly over the 4 hour value in. control and Zinc treated
groups. Cadmium thus prevented the time dependent increase in target cell
lysis. Concunent . admlnutratlon..<!f- zinc tended to offsetv.the cadmium
induced suppression.
5.4.4. Pokeweed mitogen ItimulllltedlgG producu en
·\~purc . prepara 't,ions. _ftr I~Phc;qteJ were stimulated "with . the B. ceD
mitogc~ ,pokeweed mitogen for 7 days and the Jevc') of IS? in.jhe etJ.lture ,
supernatant measured by ELISA. Results are shown in Tobie 5.13. There
were no s tatisti~11y signific,antdifferences betwee:n.the treatment groups. .
5.4.5." Lhu trace element levels
Liver samples .were frozen at .20oe and li.ter analyzed for multiple'
! - ' .
trace elements' by , inductively coupled plasma spectrophotometry: Results
. , ' .
are shown 'in Table 5.24. ,Uver. cadmium concentration was ' - ~ignificantly
. higher in cadmium treated mice as .compar~d to non tr~~t~d controls, ·MiCe·
receiving ca,dmi~m and " zinc ",tog~t~ei iuid ' . lower liver .cadmium
concentrations' as compared to those receiving C8dmi~m alo~c. " 2inc level
was stightlybut significantly elevated in mice .treated with C8dmi~m andy
'.
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TABLE 5.23
Antibody Production by Pokewee d-mitogen Stimulated, Lymphpcytes
. .
Values a~e e~ressed as mean ± s5of ·10 observations.
Ther e are no statistically significant differences (P>(}OS) between the
treatment groups by one -way a nalysis of varia nce .
Tre atment ISG ;;0-
"glml
None 7S'7 ':t 14-4
.,
Cd for) wk 76·2 ± 16·4
, Cd with Zn for ,) wk 82,.0 ± 15-6
Zn for 3 wk- S2-1 ± ·11-3
,; '
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TABLE 5.24
Trace Element Concentrations in Liver at 0 week
Trea tment ~roups
Trace e~~nu (pg/g) None cadmium cadmium + zinc
Cadmium l}06 :t l}048 5·64 ± i '54b 3·83 :t 0-63c
Zinc . 25·5 ± l}S8 27-9 :t ' 04) ZtB ± 1'2b
Iron 63'1 ± ""~'S8 41-4 '~ 3:0b 3900 ± 2'5b
Copper &41 ± l}478 6:35 ± O·32a 6·19 ± l}3oa
'Selenium 3'56 ± 'l}93 8 2·36 ± 1·17b 1'37 "± -l}6 J~
A1umin~m 2·22 ± cere HO ± lr69b 0·49 ± D-37b
Manganese , '1014 :t - (}oOSa 1·25 ± "l}OSb 1·23 ± l}06b
~ro~ium l}16 ":tQ.188 0-11 ± l}03a l}1O e l}"02a
r~
ValuC5 are.exqressed as means ± SO of,six ob servanon s.
..
. ;~~,.horizon tal rows values not shar ing a common superscnpu letter
slgnificantly 'diffe rent at P<().05 by Duncan's ~ultiple.range- te:st.
..
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zinc as compa red to DOn trea ted controls. Concentrations of iron, selenlum : .
and aluminum were )ow in mice treated with cadmium or cadmium with
zinc' as compared to untrCaled controls. The manga nese ~I was slightly
. , . .
b~1 significantly -elevated In mice receiving cadmium a~ne "or with ;qnc.
O ther trace elemen t levels. including copper , were ~ differe nt In the ' I
th.,re treetm en r groups.
\
. .~
.,
. . . .. _ •••>: • • • •
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CHAPTER 6
DI~S:USSION
In this 'IUdy the effect of a relatively low dose of oral cadmi~ . '
treatment on the itlfnune ' system and the interaction between ,cadmium and
zinc o~· .the)m~\Jne tells were ~4nined in mice. The ·d~e er cadmiu;'
- used was" appr~mlit.e1y comp8.!'8bie ~ possible human exposeee. The
"general ~ealth. ~f; ~nlmals, ',:,elgh., . gaIn l'ndfood , CO~~UniP'~ was notaffect~d ~ the cadmium' and ~nc tre{lt~L Also, .no abnormalities w~re
seen" on . gross exemtnation of 'any organ and no tanlmels di~(( du~fng the
, "
experiment. In other studies also where similar doses of cadmium were
used (Muller et 81.. 1919; Kollert - Roan and Kerkvliet, 1S!79;. Wesen~ and
Wesenber$. ' 1983; B1akley, 1985; Blakley and .Tomar, 1986; Borgman, Au and
Chandra, ' 1986)" no gcm\ri.lheilJth effects were reported. Malave and
DeRuffino (1984) reported a slight reduction i.n body weight of mice by
cadmium treatment at a d~ ' of 50 ppm; however the reduction was more
dis~mible 'beyond :3 ~cck.s of. trC8tme~t, the t;me · at which ca~mi~m
treatment was stopped in the present experiment. Zinc ,at the ' dose ~f 500
ppm also did .not affect the .gcrie"ra, heal~h of the . mi~ when given ~Io~e
or. 10gCth~r-.~th cachnium. 'J.'hus'.the arilma.~~ .ap~arCd to have t()l~ra1rf the .-
treatment well. _ • ~
. r:
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1. EFFECf OF CADMIUM ON IMMUNE RESPONSES
Cadmium at the oral dose of SO ppm for ~ weeks did not alter the
weight of the primary lymphoid organs ~ the spleen and thymus; nor ,the
lymphocyte counts in the blood, spleen and thymus. Also no effect after 3
and 6 weeks of cessation of cadmium treatment was observed. This finding
is in agreement with_those of Borgman, Au end Chandra (1986) and Malave
and DeRuffino (1984) _who also used similar dose of oral cadmium
treatment -. However, Yamada, Shimizu, l'awamura and Kubota .(1981)," and
Suzuki, Yamada ~d Shi~ (1~81) r~ported atrop~y of thcthymus •and .
enlargement of llie spleen following cadmium injeCl!On. Boaelka.: Burkholer
and Chang (1978) also reported increase in spleen size followi~g cadmium
injection." The difference, is probably due to the amount of _cadmi.um
deUve;ed to' the lmm~ne organs depending on....the m.ode of treatment . In
contrast to cadmium injection, following oral cadmium treatment a smaller '
amount4~cadmium would be absorbed and delivered to the - spleen and
thymus, The amount of cadmium was _probably less than that required to
cause gross s~clural and morphological alterations in the immune organs, '
. AJ a first step ' to characte.~ the effect of cadmium on the cellular
immune function, IgM and IgG -antibody producing cell response to sheep
f
red blood cells; a T cell dependent antigen, was estimated in a pl~que
assay; -and proliferative respon~s' 'Of spleen cells to ' the T cell mitogens
phyfohaeiJiagglutinin (PHA)· a~d concanavalin A (Con A) were studied In a
72 hour culture. Assay of ant~y production following stimulatlpn with
sheep red -blood ~t1s is a classical. test of immune function in an , l nt~cl
"animal: In , thill test, the functional int~grity of the antigen " pre.entlng
" "",'"
.-....
1lS
cells. B ceiIJ and the regulatorY helper and suppr essor T cells are assayed.
~e direct P~~ -~~ I~ ~roduction, wlule lhe indirect PFC assay ~ for
IgG production (Jerne et at.. 1974; MisheU and Shiigi, 1980). lymphocyte
transformation ""in virro to mitogens is a useful test to assess cell-mediated
- " -'
immunity. The mitogens PI-IA: and Con A are polyd onal activators of T
cells and, l1imulate the cells to unde rgo blast tra nsformation without
antlgeil. contact. Th~ assay0 is believed to mimic the in vivo immune
response (Maluisb and Stro~g. 1986).
In this study, ca,dmium at "a dose of 50 p pm in drinki~g water for" 3 \ Q:.
weeks caused a significant increase in IgM . and I ig<;i an tibody forming cell
-- . , . , ... \
number. ' Even 3 weeks afrer cessatiEm of cadmium treatment the. response 0
' tend ed to" be · hi~er. op~uierative ~~ " of spleen I cells to T cell .
mitogens als9 tended to be higher in cadmium treated oanimals. both
. - .
. immediately oafter 3 ~eks.... of cadmium trea tment - and 3 ~eekJ ,after
cessat~n of trea tmen t. 2!'ac observatiOns . are in agree me nt with those of
Malave and DeRuffino (1~) who also used 50 ppm ' cadmium in drin king
water and 'reported an increase in I~ an.tibody forming cell response a~
lymphocYte stimulation response to T· cell mitogens. Enhancemep,t of
mitogen 'responsiveness of T ceUs from animals treated ~th- SO ppm oral
cadmium hu also ' been' reported by others (Mu ller et al., 1979; BI~k1ey~ t... ,- .
• 1985).
In CC?ntrast ( 0 lew dose oral c8.dmium tre atment,' cadmium given by
Inje~tion . (Boz.elkilt· ih.lrkh~lder .and .~ng, 1978; FUjirilaki, . 1985), . l~hatation
(Orah~· et at,. ' l~8;·.~1>'?iak er al..· '1987), .or i~ ,a lar~Oral dose ' of
300. ppm for .10 v.:.eeb (KoUer , ~n and R08n.. ,191S) red uces ' the numbe r
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be antibody forming cells in the spleen and transformation response of
spleen cells to mi.t~gens. Cadmium given by injection causes an immediate
and proAellnced rise in tissue level, and absorption of cadmium .from the
lung is more complete than from the g~t. Also following . parente ral
administration. cadmium bypasses the portal drcut~tion and the liver-
where cadmium is supposedly incorJ>?rated kl melal1~lhioncin a~dercd
relatively non-toxic before release i.D the general circulation. Thus In thOse.
experiments 'where cadmium was admin istered .by parenteral routes, a larger
B~ount. of cadmi~m. and proba~ly'a more toxic for~. was 'delivered to thC(. ,
immune cells than in the present study, From these studies, it thus appears_
that a small 'dose. of ca'dmium increases the 'number ,of antlbo.dy forming
cells . and ' lymphocyte transformation response, ' whereas a 'farge .dose
suppresses' tbese responses. Demonstrati0I!, of augmentation of in- vitro IgM
antibody -response by 4 and 8 p.M cadmium and its suppression' at
concentrations ~f ·20 and 40 pM (Fujimaki, Murakami and Kubota, 1982)
further supports thls . concept. Failure to obtain any effect on antibody
fonning cell number (M~ler .et al., 1979) or demonstration of reduced
number (Blakley, 1985; Borgman, Au and Chandra, 1986) using low doses of
cadmium may be due to strain dependent d iffer~nces, as the expreSSi~of
heavy metal toxicity is known to vary in different species and strains of
laboratory animals (Malave, 1981; Balter, Nieder and Gray, ' 1982). In the
pr,esent study and also in the study of Malave and DeRuffino (1984),
. C57BlJ6 mice were used, which is differen"' to the strains used by Muller
et aI., (1979), Blakley (1985)' and Borgman, Au and ~andra (1986).
To further characterize the effects of cadmium on the immune system ....
and to find a possible explanation of the observed increase in ISM "and IgO
, ,
)
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anlibody.f\lrm ina: ce1lJ by cadmium, experiments were .perfo rmed ' to study .
the efta:! ' of cadmium 'on the B .cell, helpe r T cell and suppressor T cell '
numbers and suppressor cell actfvjty. Ant ibody produeti~n by Iymphocyte.s
ItimuiB.ted in vitro by the helper T ceO . dependent B eel! mitoge n-
pokeweed mitogen (PWM) .was also assayed . AJt_houg~ a ntibod y is produced
by the terminally differcntialed""'B cells : - thc plasma ·cens. the p~' is
. under the ' control of an intricate system of regulatory T cells. It is
possible that the effect 'of cadmium on these distinct cell types are dose
dependent.
.'
T cells classically subdivided . into ~ . fUD.ctional types • the
helperlinduce~ and suppressor/cyto,toxic T cells. ide~tified ,by ' the
expression 'of surface glycoprotein markers CD4 and CDS respectiv.cly. In
the -murine system CD4+ Jand COS+ ' T cells car r- be . identifie~ by the -'
monoclonal antibodies egelnst l.3T4 a.nd Lyt·2 antigens respectively {Adkin
et al., 1987; Lewis and ~halan, 1988). Expression of L3T4. and Lyt·2 '
an tigens by _t~~urine T cells is mutually exclusive both with respect to
functional T/ cellIclones ~~d with respect to sp~e~ie ' T . .cells (Dialynas,
Wilde:. ,Mayack. Pierr~ Wal).. Ha vran, Otten, ~ken, . Pierres, Kappler and -
Fitch, 1983). In Ihis . study, it was fou nd that SO ppm ~d~iU~ trea tmen t
for 3 wee ks select~ly· red uced the numbe r ' of COS+ T cells in the spleen.
. . ,
COST cells a re known to, include two distinct functional ce ll types, the
suppresso r · T cells which are involved in immunoregulation and the
cytotoxic T cells which are' the effector.' of T cell med iated ant!ge~.
specific -cytolYsis. R~uclion in CDS+ c:e'Us may be due '· to reduction. of
. , .
e ither or both cell~ howeve r, ·it is more. lik~ly that the suppr esso r T
cells . were affected by cadmium as in the cadmium treated animab : the
II
'••:' : '~ ' -' ''''' : ': '.. ,c·.·,,·····,..·.····;..,
,,$
.... ,' .
\
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suppressor cell ~ivity. tend ed to be lower. Malave and DeRu f!ino (1984)
also -reported reduction of suppressor. cell activit)' by Drat SO ppm cadmium
treatme~t in mice: ' The effe~ of cadmium on . suppress~ T cells was -
posSib~ a direct ' selectivp eg eci of cadmium on t.hi5- subset and "net an
indire'ct effect on the entire lyinpnoid system ' due to ··stress with increased
... secretion "of ~nic~leroi'ds, 0 The number of suppressor T celis was only
re~uced in cadmium treated mice and not i~ those recelving cadmium with
zinc.
P cell function may -also 'b;' lntluenceds-by cadmium. Fcjlmuki (1985)
re~~~~ dOirect ina~tfvation ot B cells resu.lting in . red uction of ISM
antibody r~sponse following ,' 8 . single large . dose .'cadmiuln) injection. At
, lower pa,r,enter.al' d06CS, cad~ium is ("eP.~et:1 10 cause slight splenomegaJy
and increase in B ' cell numbers in the ' spleen {Bozelka, Bur~holer' and
Chang,' 1978); while at oral doses- ranging Irorn SO 10 ·300 ppm in drinkiOng
~\aler cadmium increases ' lymphocyte' proliferation ' res ponse Co B cell '
mitogens (MtiIler et 'at , 1979; Koller, Roan and" Kerkvliet, 1979; Blakley,
1~8S), ' f~l}icu l~r h¥J'Crplasia . Of' I~P'h~i~ tissoue~ . :with marked B ce~l
·p~lifera~ion associated '.with , antibody exce:h (Powell, Jos~i, Dwjvede and
· Green " 1979) "and deposition of tgO in rena,1 glo~eruli" causing diffuse
membran~us nephro~aih; (Joshl et a l:~ 1981), ~ has been .postuta ted on the
basis of the latter findings that cad~iuin m~y act as a polyclonal B ' cell
, , . I , . . '.
• stimulant Or act synergistically wit~ other ' B cell. stimulants. fRlwcver, -ln
the present study, the number of B cells in· the spl.ec;.n was nor elteed by
cadmium treatmen t. ' Also ori stimulation with ' PWM, Iymphocytei from
0 , • , .~'
cadmium J reated mlce produced .arlllbodies in amounts' compar able t~ Ihole
observed in .the untreated mice. ;Thus ~t th~ d~e of ~o ppm for 3 weeks,
.v.'
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cadmium did not ~lter the ~ 'cel i nU~ber or functional 6ctiVity ?f the B
"cell itself.. So it ~~ ' be derived that the apparent increase in immune .
response Observed; foll<,'wing ,cadmium ' treatmen~ , was probably due to a
selective reduction of ,cell~. carrying CDS surface antig~n which identifies a
s~b5et of cells with suppressor ' activity, and not due to , sny direct effect
of cadmium on theB cells.
.On the basis of fi~dings of this st~dy and those or' others, a~d taking
into consideration that. cadmium 'i~ a cellular . toxic element, it can be
•.'proposed that cadmium ha~ important effects on Immuncregulatory T cell
, . ' , .
number and function; ' at a !e1atively low dose cadmium ~ffec ts the CDS+ T
cells With suppresser function a~dq there~y •augme~ts measurable immune .
,r':lnctions "'like antibody producti?'n against heterplogous antigens and
• . lymphocyte tra~fOnnl!:~iOn response , .to _mltcgens, wh; reas Jlt.• a high dose '
all cell types are affected, resulting in general i~pairment of imm~e
responses. This, model explains most of the 'experimental findings on
cadmium lmrminotoxicity and resolves : the ambiguity of the findings
reported by different investigators.
The effect of cadmium on natural-killer cell act ivity was also studied.
Natural-kil!er \ ~lIs are an important effector mechanism or non-specific
immunity: They ca~ recogmae surface ' changes1 in virus"infected ' or
~align.ant cells and 'lyse them. Natural-killer cells do n~1 require prior
5ensitizaiio~ I to become cytotoxic ' and their activity is " not restricted by
major hist~mpatibility 'complex (MHq antigens. No'rmally ~he immune
ceUs re':Ognize antigens onl)" when presented in conjunction with an MHC
'moie,cole; for exempte the Cl?4+ (helPe~/inducer) ' T cells' r~crignize foreign
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ant igens. when p~esented with self MHC class II molecule, . whilcCD8+
(supp ressor/cytotoxic) T cells recognize antigens presented in conjunclion
with class I molecules. In contrast, the natural-killer cells do not requ ire
either class I or II molecules for recognition of antigens. Th us UI vivo
they function as an effective surveillance mechanism agelnst infection,
part icularly viral, and emergence of tumour eel.ls. Natural-killer cell~ lyse
the target cells by a complex mechan!sm. They first attach 10 -the targ et
by a receptor, then lyse the cell in a ,Ca+ +.dependent mechanism- by
orienting 'the granules, G~lgi apparatu s and microtubular organizIng
complex toward ' the targ~t. and rele,as~g the lethal pore-forming j eotein
perfurin and other cytotoxic factors. Th e killer cells , themselves survive
, the e~counter with target ceil ~nd go on to kin again (Marx, i~86; Young
and Cohn, 1988).
In this study it was d~monslrated that" cadmium at Ihe ornl dose of SO
ppm . fo~ 3 w~eks ."reduces 'the natural-killer cell activity in mice, At. 12
hours, the reduction was statistically significant, but a similar trend was
observed also at 4 hours. It is possible that the low natural-killer cell
activity was due to a 'reduction in the ' total nu mber of natural-kilter cel!s
by cadmium. However, it seems that more than a simple numerica l
reduction of natural-killer cells occurred, as cadmium treated animals not
\
only h~ a low natural-killer activity but ~llso failed to show a n .lncrease
in activi\ with time. In contrast to. other treatment groups, the
percent age ~ target cell, lysis 'was _e~ntially .the same in cadmium treated
animals at 4 and 12 hours. It is known that one natural-killer cell can lyse
many targets by lysing them successively one after another. "Th us In In
vuro culture the" percentage of target cell l~js increases with time
.":'
.' '.'.
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(Kic uling, Klein and Wig:z.el1, 1975). Th e re sults of this study shgyoo th at
cadmium treatment prevented suc~ r~CTU itmcnt and as a whole reduced the
efficiency of the killing process..
6.1. POSSIBLE MECHANISMS OF CADMIUM IMMUNOTOXlCI1Y
In Ihis study it was demonstrated that a relatively low. dose of
cadm ium selec tively affects the supprcssor T cells and natural-killer ce lls
resulting in increased IgM "and 180 plaque-form ing cell number and reduced
natural-killer eeu act ivity. Th e cause or mechanism of the selective effects
of cadmium o n the se two cell types were ~ot investigated, but several
mechan isms ma y be post ulated to explain the obseiva tion.
~:It_· 15__ known that lymph ocytes cultured in vitro take J up a larger ,
amount of ....cadmiu m ' as ' compared to oth~r formed ~ents of blood
(Hilde brand a nd C ra m, 1979). But in leuk ocytes the inducible intrace llular .
metal binding protei n met allothi onein is prob ably not indu ced to the exte nt
as see n in other tissues like the kidn eys and liver (Ba.nne rjee , On osaka arid
Cherian, 1982) . Metall othloneJn is known to bind free intrac~lIular ca dmium
with high affinity and keeps it In a non-ionic form which is non-toxic. It
is po ssible that the s:~pressor T cells a nd the natural -killer ce lls eithe r _
take up . larger emcunrs "of •cadmium compared to other i types Of}.·
I'ymphocyt es or ' the metallothionein gene in these cells is not indu cd:l to .
the sa me exte nt as In othe'r cells. As- a resun, la rge am oun ts of the toxic
ionic form of cadmium may accumulate inside these cells resulting in their
loss of fl,lnctlonal competence . ". Alternatively, the subce:llular macllinery
,. " . : : ." ~ .\ ,
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unique to suppresso r _and natural-killer . cells may be more susceptible 10
ca dmium toxicity th an oth ers.
At ure subce llular level, cadmium may in te rfere with the function of
e nzymes and structural prot eins. Ca dmium may displa ce zinc from certa in
e nzymes essenti al for cellular funCti~n and render them inactive. DNA
polymera se , RNA polymerase and nucleoside phosphorylase are some of the .
zinc-dependent enzyme s tb~1 are crucial catalysiS involved in Ih.
re plicatio n and transcripti on of DNA duriC~ division, . and .thus are
importan t at various stages of immune res., {Liberman et et, 1963;
Ball ester and Pra sad, 1983). Du e to ~utual a ntagonism,' displacemen t of
zin c by ca dmium from th e ca talYtic part of these enzymes is po ssible.
Z inc is known to be esse ntial for the structural integrity of nu cleic
acids (Hambidge., Casey. and Krebs, 1986), some regul_atory protelrv' Involved
!n gene~ express ion (Klug and Rhodes, 1987), plasma m~mbran~s and
cytoskeleta 1 eleme nts - microtubule! and microfilam ents (Chvupil, 1976).
Nucleic, ac ids and the regulatory proteins .are of obvious importance in all
aspects of a.;lIular . functions incl.uding those of the immune cells.
Microtubul es and. . microfllament!J 'are essential for many cell membr ane
associated phen0-!'J,~na including a,~~igen processing . and mutupfteenon, They ·
a.re al~ .required for movement of, the , cells and their ' organ.elles. It is
poss ible' that due to _the physi~1 ,and chemical ' similarity between cudmlum
and zinc, .cadmium may displace zinc from these sites and affect ' their
struct ural Iptegrity and functions.
~
Large amounts of intracellular ' cadmium may also cause a ' relative zinc
. .
deficiency In the cells. Cadmium is known "to be a strong Inducer of
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rnetallothionein I)'IIthesis•.~ metallothionein is known to bind various
heavy metals particol arly cadmium, zinc and copper with high affinity
(Hamer, 1986; Dunn, Blalock and Cousins, 1987). Normally, the small
amount of metallothioneln' that is present inside the cells' is thought to
regulate the -z,navernen! of zinc and copper to active sites, like enzymes,
where they are required. "'tiature has devised such a mechanism' as zinc soli
copper ions arc toxic. It is possible tha~ following cadmium entry into the '
lymphocytes, the newly formed met allothionein binds zinc in addition to
cadmium and thus sequesters it from sites where it is required.
Cadmium may inhi~it the synthesis of intcrleukin s, which ere involved
h - . •
in immune responses. Reduction . of interleukin synthesis is possible as
-cedmfum is. ~own to adversely. affect enzyme fu~ctions .and ' protein
synthesis in various tissues (Kostial, 1986), and cadmium' induced reduction
in synthesis of one Iymphokine. - macrophage migration inhibitory factor
has been reported (Kiremidjian-Schumacher et at , 1 98~ ).
Cadmium may also interfere . with yalcium !"et~bolism in the af~ected
~ lymphocytes. Many cellular functions including those involved in immune
. .
res~se ~ are triggered by transmembrane movement of calcium. For the
natu~l.kilJer .cells, target cell lysis is, known to' be , ~ssocialed with a
massive increase in calcium iii tif killer eel.1 0'"0ung and Cohn, 1988~
Cadmium is known to inhibit~ uptake by epithelial cells (Verbost, .
Fln,; LOOk and Bonga, '1987). A similar effect .may - occur in the
. .
lymphocytes With reduction in the intracellular pool of available calcium.
, . . •• •, .. . . 'I. '"
I ' .
: :~
':' ," '-."
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6.3. EFFECI' OF ZINC ON CADMIUM-INDUCED IM~UNOPAmOLOGY
Cadmium and zinc have many physical and che-mica! similarities. Both
the metals are found together in nature ami also in biological tissues
, '
where they are t~ought to compete for common Ilgands. Manl. toxic effects
of cadmium have been related to altered zinc metabolism ' and zinc Is often
C?nsidered to be a metabolic 'antagonist 'of cadmium. In Ihis study, one"
major objective was to c~racterize the _effects of a relatively large . dose
of z:in~ on cadmium-induced immunopathology, Thus in some .animal gr~upS,
500 ppm zinc was given ln drinking water together with. or following
cadmium treatment.
The results demonstrate that zinc prevents t~e cadmium-induced
alterations in immune ' functions. It ~s shown that l enhancement of .lgM
and IgG antibody'~ forming cell -number indu~d by cadmium' ~as prevented
by- concurrent treatment of zinc" In animals given zinc afler cadmium
admlnistretion, the lymphocyte proliferation response to T-cell mitogens
"also tended to ~ lower than in other treatment groups. These findings are
in agreement with those of Malave and DeB-uffino (1984) who' also
demonstrated prevention of , cadmium-induced increase in Ig~ .antibody
response by zinc injection. However, . Shippee et 01., (1983) using large "
doses of cadmium and zinc by injecti(n in mice failed to sh'ow any . _:',
protective . effect .of ~nc on cadmi.um~ced 'alteration or ' linmune~
responses. It is likely that in acute toxicity studies ' in which large . . .
parenteral doses of cadmium are used, the a~~unt delivered l~thd~une -... :;
" . " ~ ' }
. cells is· very large which results in irreversible alteration. ' of immune celli.
»r small oral doses, the immune functions ~re altered for, a .h·~n time
•...
""'.":" -.'
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period and. r~er after c:essation of cadmium trea tment. ' Nevertheless, in
the seme ItUdy Shippee et at.. (1983) found that zinc completely ,prevented
the ' cadmium Induced ·'mortaJity'w hen given together with cadmium.
It was -also , ~emonstra tcd in the present study ttat the antagonism
between cadmium i nd zinc. occurred at the level of CDS+ T celts. wh ereas
animals receiving only t cadmium had a significant red uction of COS+ T cell
number, those receiving Cadmium and zinc together had CDS+ T cell counts .
comparable to the ~nimals receiving no treatmc~t. A1s~ . the a:~:/CDlt-+
ral~o, which de.notel the balance ,~lWee~ ' the immunoregulat~ry -~e IPCr. · and
sup~res~r T cells, -was not" altered in animals receiving cad~ium with zinc,
o while the ratio was increased by cadmium treat~ent ' a'lone~ This effect was '
.: probably' th~ result of a s~c , inteni~-n ' ~betW~en Cadm~um and' zinc, ~s ';1
rinc ~t~~n.t alone did not c8US~ 'any altf?rations of T celt 'su~t number•
- The· · B cell count a~ antibody production by . lymphocytes · on PWM
stimul8t~n was not altered by zinc treatment a jone or ~th cadmium. I
./
)
SuppressJon of natural-killer actMty by~~dmium was a~ prevented
: by concurrent administration.of zinc and reached statistical significance In
the .12 bour assay_ In the 4 hour assay, allhough the .suppresslon of
. n~t~ral-kil1er . r l\. activity ~ cadmium' was . not signi~C8nt, nevertheless
mic therapy dId create some entagonam . Also the increase m mean target
cell lysis bcJen 4 and 12 hour assay tended to be higher In animals
receiving cadml~m with zinc as compared to tho~ving only- cadmium.
The prevention\ : cadmium induced suppressIon. of' natural.kil!er cell
-, - \ _ . -" interaction between the twcielemenu
"'.'".,..,.;'.,.,., ,.,;, ' . " ., ,.., ';
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and not 8 non-specific stimulation of natura l-killer cell activity by zinc. as '
zinc tre8:tment alone did not increase the natural-killer cell ' activity.
6.4. POSSmLE MECHANISMS OF CADMIUM-ZINC INTERACflON
Various mechanisms may .be postulated to explain the inlernctio~
between cadmium and zinc on the immune cells. It is possible that the .
s~lective ~ffect of Cadmium on suppreswr T cells and .naturel-kilter cell~
was d~e to uptake o.r cadmium _by these cells i~ amounts larger than other
cell types o~ the immune . sYst~m. If that is the case, then large .amoJntl
of zinc may ,have antagoniied thu selective ca.dmi~~ accumulation, Such an ' .
~curr~~ce is likely' as •in vitro S(~dies' have shown that' the. upI8'ke' and ' .
t6xj~jty of cadmium to ,cult~red Cell lines a re re~uced by large "doses of.
~nc (MeshLtsuka, Ishlzawa and Nose,' 1987).
At the subcellular level ,aio cadmium and' zinc may a~lagonize eech
other at various sites , and steps. lyis possible thatcadmiu~ dlsplac~s :zinc
from certain enzymes or cel1~tar structural components cruclal . to imm.une
functions and a large dose of :zinc prevents or reverses the phenomenon. .
pretreat~ with zinc ~ known t? prevent cadmlum-lnduced altera tions In .
some enzyme activities (Watanabe et al., 1985;' Suzuki and ' Cherian, 1987).
and both cadmium and zinc have a. strong affinity. for the eytoskeletal
clements (Chvapil, 1976). It is possible that the cytotoxic. effect of
cadmium was due to 'a conditional rinc deficiency inside the cells and the
large dos.c of zinc abrogated this effect.
Zinc can also interfere with C8dmi~m metabolism. .Zinc treatment iJ
known til alter the shift of cadmium from one body compartment to .
~? ~" -,,.
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ano ther and also alow other ~&ru~m da tnb ution ' processes (Marcus, '1982;
Jone.. Jones, Holscher and Va~ghn., · 1~ Altera tion of cadmium
me tabolism by zine is probably mediat~ through metaUoth ione in' as bou;.
. the metals are known to have common _binding sites in the prc reln, It is
possible that zinc treatment induced synthesis of a type of metallothionein
that bound cadmium' with high affinitY and p~evenled cadmiu m toxicity to
essential structura l and fu.nClional co mponents or the cell.
~ Zinc-cadmium i nt~raction throu~ effec'ts on ca lcium meta bolism is also
cadmium. induced reduction of Calcium
6.5. EFFEcT OF CADMIUM AND ZINC ON KIDNEYS
. . .
. .Renal dysfunction characterized by low molecular weight prot einuria is
/'- long regarde d lU the characteristic feature of cadmium toxicity. Seve~1
. , studies have shown that 4,he p roximal tubular cells and , possibly the
glomeruli ere Involved in ebronie Cadmium toxicity, bo th ' in man and
labo ratory animals I (Fnberg, 1984; Piscator, 1986). Altho ugh the pre~
mec hanism cir cadmium. nephroioxiclty is no." known. ~he 'immune system
has ' often ~n implicated (Joshi c:t 8:1.. ~981; Bern ard et a l.. 1984). In the ,
prese nt atudy, : kidney sections ' were examined for deposition of IgG and
complement 0 . It was hypothes ized that cadmium containing complexes
deposited either in the glo.mcruli or in the renal tubules may result in an
.' autoimmune' response'. No evidence of any autoimmune reactlan involvlrig- , - .----7.
. ' . .. ~
IgG. end complement C3 deposi tion _w~ seen in the kidneys at B/lY
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observation time. It thus appe ars that nephropa thy induced by low doses of
cadmiumis not mediated by the immunologic mechanisms•
. On electron microscop ic examination. · the- mitochondria of the proximal
tubular cells from cadmium treated wee were found 10 be increased In
number,' S:OUen and the cisternae were -datorted, Inside several cl!ls, '
electron dense materials were observed.- Although the electron dense ,bodies
r were not further ~haracterizcd . they ' pf ollably rep~esent aggregated
eadmium-metallethicneln complexes. Similar findings were also reported . by
others (Fowler, 1983; Borgman, Au and Chandra, -,987): The Involveme~t 'Of
. the proximal tubuh\J cells can be explained from ' the known kinetics of
cadmium i"Q the .body. FoUcY.ing gastroin testina l absorptiori, cadmium is
incorp orated with met~nothiotein ~n the ' iiver and then (c1e~sed sl~ly
into t~e circulation (Kostial, 1986). Cadmi um-metallothionein complex in
the blood is probably filte red through the glomeruli an d reabsorbed from
. the proximal ' tubules (Piscato r, 1986). Microinjection stud ies in rat
nephrons show tha t cadmium compounds .are "preferentially taken up by the
proximal tubula r epi thelial cells. (Pelley-Bosco and Dlezi , 1987). Inside lh,e
tubule s, cadmium is rel~ased from , the metallothionein and incorporated
again into newly synthesized metetlothtoneln. During the •process of
degrad~iion of ' reabsorb ed cadmiu~~metaJlothionein complex and
incorporation into newly ~thesized metallothionein, a toxic ionic form of
cadmium , inay appea r transiently inside the tubular epithelial cells resulting
in their damage., Increased number of mitochondria seen Inside the cells
may' also reflect the -h.eightehed metabolic activity of these cells loaded
with additional cadm ium.
",:c ,,"-, ., . . '.'..• . , ., '.. ,'.'
I
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.6.6. TRACE ELEMENT LEVELS IN LIVER AND KID NEYS
The kidney and Uvc:r cadmium co ncentraliora were elevated in cadmium
treat ed animals. The kidney cadmium concentration was co m parab le to the
observation . re~rted by o thers where a similar •dose . and route of
treatment was used (Koller. Exon and Roan. 1976;- BlakleY. 1985; Borgman.
Au . and Chandra, 1986). ID.Jmediately after .cessation of cadm ium treatment.
cadmium concentration In the liver and kidneys were. almost equivalent,
whereas 6 weeks after cessation of cadmium treatment the concentr ation in
kidneys 'were ' almost double to that -in liver. Sim'i1a, change s in liver and
kidney cadm.ium di.stnb~.l lon following CeS58t~on. of j reatment have- also .
been reported-bY Borgman, Au and Chandra (1986). From these results, it
appe a rs that a fter ecuadOR of treatm ent, cadmium !s gra d ually lost from
the liver and taken up by the kidneys. This is in agreement with thePrevailin~ concept ?f cadmium kinetics in ttle bOdy (F riberg, 1984; )
Psce tc r, 1986). In the kidneys, cadmium is probab ly deposited in the
proximal tUbUla~ epith~lial ~ bound" to metallothione in. Cadmium being a .
/ .
strong inducer of mc talloth ion cin synthesis, wm increase its level ~urther
and . a llow ~re cadmi~m . to ~ de posited. The slight increase in kidney
'Weight seen arl~r cessation of cadmium tr~atnl~nl probably was caused by
increase d cadmium load and ,con comitant increase in meiallorhionein level,
Zinc giv;n together with cadmium resulted in lower liver and kidney
, cadmium concentration as cdmpared to cadmium alone. Even zinc treatment
. after cessation of ~dmlum treatme nt resulted in lowering o f tissue
cadmium .levett · S'l.lar observatl~n _In ruminants ~as been reported by
othen (La~~here, Do~ Reddy and Meyer, 1984; Reddy: Moh~mmad.
r:.; . • :~ ' .
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~anjam. Martino end Brown, 1987). It is possibl e that zinc altered the
di stnb ut ion of cadmium in th e body. This is likely as zinc , is kn own to
shift ca dmium from OI~e body compa rtment 10 the oth er (M arcus-, 1982) .
Alt erati on of cad mium absorp t io n and thus its total body bu rd en by zinc is
u nlikely as th e results . of ki netic ,studies on cadmium absorption argue
aga inst compe tition betwee n ca d mium and zinc at the level o f uptak e from
the intes tinal lume n (Foulkes. 1985 ).
Am ong changes . in ' eth er ~racc elements, the most striking was the
reduction " of liver iron concen tration in cadmium I r~Bted mice. Fri ~l.
~ . . ,
Borgm an and Chandra (1987) als o repo rted similar findings, however, unlike
th eir, finding, capper level was not seen to be de creased by cad mium,
Reduc tion of iron by cadmium trea tment is possible as cadmium may
int erfere with iron .abso rption o r increase loss of iron in -the urine (Weigel.
Elm adfa and Jager. 1984). M anganese level was slightly elevate d; ' and
se lenium level was decr eased folloWing cadmium treatment. Schroed er and
Nason (1974) also reporte d an Increase in liver !"1anganese following
cad mium treatm ent in rats. Zinc trea tment did not alter any of the trace
e le ment levels including copper .
6.7. REALTII IMPLICATION OF THE OBSERVATION S
. The implications_ of "the decrease In ".the number and function of
sup pressor T cells ' and natural-killer cell ac~ivity, in ~ mice by a relalivel~
low dose of oral cadmfum and its prevention by zinc are maiJj~oJd.
Suppressor T cells arc known to downregulate the immune re lponse
following an antigen challenge a nd ~h'us protect against the development of
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inappropriate excessive imm une response. Lou of suppressor T cen
funct ion in man is knOWll·to p redispose to conditions like atop ic diseases
and autoimmunity. In this study it was demonstra ted that a relatively low
dose of cadmium IClcetjvely ' affects suppressor T cells' and th w increases
the ratio of helper to lupp ressor T cells. Th is finding is more relevant to
(poss ible ' human cadmium exposure, as in man loW levels of exposure 'are
• . . 1 •
likely to occur. AltbQugh ;t is not, appropriate to in.fer from th~ animal
stuciY""that i~munologicaJ effects bf cadmium do occur in man at the
i
present levels - of exposure among t~c general pofu lation , it is interesting
to . note that " atopic d iseases ar~ more pre'yalent among smokers
(Zetterstrom, Osterman, Macha.do and , Johansson, 1981; Burrows, Halonen,.'
Lebowitz, Knudson' and Barbee , 1982) "r ho ~re known to be' exposed to
large amounts of cadmium, and a~mong people living in industrialized
coun tries (Krause. 1986) where cadmium exposure is morc likely to occur.
Hum an atop~c disorders arc ' predisposed by various genetic and
environm ental influences (Bjorkste n, 1987). Sup pressor T cells also play an
important role ~ ,this group of diseases and studies have shown that lOss
of supp~ T ~11 number and function pre~~ a~ predisposes to the
development of etoplc diseases (Chandra and Baker. ,1983; Tain io, 1985).
Susceptibility of supp~r T cells to cadmium " toxi1~ty •thus raises Ille
possibijj~ that ~metal may be an .importa nt cnviro ?mental influence 'on
the ~evelopment of human , atopic disorders. Cadlllliumi immunotoxicity may ·
also be involved In" other disess.cs, Iike ~ lnfe<:tlon a~d " !malignancy: Although
the health - effects of , cadmium arc no t ,greatly a.pppc~at~ at present, its
long haU:.life malCei it pcesibte " thai ch~onic cltpOSure to low, and "
presumably, non-toxic doses of the metal may. in fact; lead to
... .,'.':
J'
......: .."i
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aceumulati~n of levels, that can have adverse eff~cts on the i~mune s~tem
of man.
Loss of natural-killer cell function by cadmium may contribute to the
development of infection an~ ' malignancy. Observation of increa~ed
incidence of infections, including viral, in cadmium treated animals may be '
contributed to by I OS~ ~f ~atural-killer cell activity in addit'ion to other '\
. I
immune cell dysfunctions: Cadmium ereated ani~ls ere also known: to b~ve
increased malignancies. In rats and mice; cadmium given by injection,
. ' '. .inhalation or. in large oral doses produces malignancy at- various ' sites
(Had dow' et aI., 1964; Bomh~rd, Vogel and Loser, 1987). Prolonged'
inhalation of cadmium chloride ' fumes at exposure levels :.vithin tile current
occupational limits. has been demonstrated to cause a dose dependent
increase in lung cancer in rats (Takenakli ~ e t al., 1983). In humans the
carcinogenic ~ten~al of cadriliU~- is controversiaj, but a r~ent report in
which a large cohort was studied showed a definite increase i'i1 lung cancer
in industria" workers exposed to cadmium (Thun et al., 198.5), Although
these studies show that cadmium may cause can~r, the pathogenesis. or,
carcinogenicity has nor 'yet been clarified. It is possible that the loss of
. -'
natural-killer cell function, combined with 'impairment or other aspects or
immune responsiveness contributes , to the development and pe relstance of
cancer in experimental animals and probably in man exposed to cadmium
for a long period. The res~ts · of th is study thus pro~de a plausible
explanation of this important aspect of cadmiu~ toxicity.
The interaction between cadmium and zinc oJ! the immune cells .wa. ~ . -
the other significant . finding of this s.tudy. The toxic effect or cadmium I.
known to.be related in part to zinc d~nciencies and va~us "tudies ..~~ve
· previously demonstrated that large doses of zinc can prevent some acute
and chronic mani(at8tions of cadmium toxicity (parizek. 1957; Gunn, Gould
and Anderson, 196Jb; Perry, 'Erlanger and Perry, 1977; Ahokas, Dilts and
laHaye, 1980; Shippee el et, 1983; Warner er al., 1984; M:,-rlow and
Freeman, J987), Th is Sludy shows tha i even cellular effects of cadmium
can be prevented by a moderately large dose of 2:in~ Although animal
. .
studies C8.I be extrapolated directly 10 humans, a similar interaction
may also r in man, Thus it raises the , possibility that zinc may have
potential therapeutic 2enefit in situations of cadmiqm toxicity. Thus it can
· be proposed that zinc be 'considered_as a therapeutic agent for preventlcn
and treatment of clinical manifestations due to acute or 'c~ronic cadmium
. exposure,
On the other hand, deficiency . ·~ ~nc t~y ~lso ' i~cr~ ' 'thet''ty .
.of cadmium, ~though direct expcriment~1 ~den~ suppo~~.ng t?is : .~ ' .
is not available, the close relat~nship ~~cn cadmium and zinc rna es
· such a posIibility likely, Recent r,eports s~ that in large ~gmenu of :t~e
population, Mrtic:ularly among the independently-l.i'vint ~.lderly in .dC'icIoPed
. ,' .
countries, zinc nUtrl:ure . is less - th~n adequate (~ndstead, ~e~ksen.
Greger. 'Prasad and Good, 1982), This hitherto unrecognized 'zinc deficiency
~I ,been s~own to,.be associated with r~du~d . immunocompetence •~Bogden.
Oleske, Munves, Lavenhar, . ~ruening, Kemp, !i0lqing, Denny an~, Lauria.
1987) and _ ~. tho'ught to ~nribute to t,he deV.elop~ent of "". disea~es
like . cancer .and. autoimmuni which ~ rnX\ prevalent in old a~e .
p (Q1and.ra, 1985). It . is pouibl that j nadvertent cad"ihiwn-exposure throuBh. .\
\
... : .. ' .'
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food or cigarett e smoking in this segment of the populatton may aggrevete
the immuno logieal "effects of zinc de ficiency.
6.8. EFFECf OF ZINC THERAPY ON IMMUNllY AMONG SMOKERS
As an extension of the present worlt, the effect of zinc therapy on
immunity among cigare tte smokers was studied. Smokers were chosen as
the ~tu~ population, as cigarettes cont~ in a large amou nt of cadmium and
smokers a rc known to have alte rations of immune functions. One cigarette
generally contains about 2 J.l.8 of cad mium; of which 5 to 10 percent is
- inhaled (Peny , Thind and Perry, 1976). The cadmium present in cigarettes
is'dispersed int'? fine particles along with the smoke ~nd reaches the lower:
respiratory tract from where it is more completely absorbed. In contrast to
only 3 to 8 per ~nt cadmium absorption from the gut, absorption from ,the
lung j's us~ally abou t soper cent (Elinder et 11:\., 1976). Assuming · this SO
perce nt absorp tion, pne pack of 20 cigarett es will thus contribute 1 to 2
.ug cadmium. and one pack year (pack years ; number of packets smoked
daily_'x number of years smoked) of smoking. " will increase the body
cadmium burden by about 0.3 to. 0.7 mg. Considering 'the to tal body burden
of cadmium, which is 15 to 30 mg, this is a very large amount. Also
" cadmi~m . .absorbed from the , lung . reaches the. gener al circulation directly.
bypassing the liver where it is parti ally det oxified . by incorporation into
metallcthlcne tn. •
The ;mmun~' dysfunctlcns .d"eri~d 1bhea'; smokers Include ~rease
in leukocyte and lymphocyte counts (Hugh es. Haslam. Townsend, . Turner-
Warwick,~ 1985; .Petitti and Kipp., 1986); reduced - lmmunoglcbulln levels
!!-,-..-"
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(Gerrard. Heiner. Ko, Mink, Meyers and Dosman, 1980); reduced T cell and
helper T ceJI number, and increased suppressor t ~1I num~r (Ginns,
Gqldenheim, Miller, Burton, Gillick, Colvin, Goldstein, Kung. Hurwitz and
Kaz:emi, 1982); increased IymPh~e transforp1ation response to T cell
mitogens (Silvcnnan, Potvin, Alexander and Chre lin, 1975); and reduced
natural-kilier cell activity (Phillip,!. Maahall. Brown and Thompson, 1985).
.These immune dysfunctions. part icularly suppressed Jl8tural-killer cell
activity and aller~d ' Immunoreguletcry T cell profile could predispose
cigarette smokers to chronic lung inrections and malignancies (Ginns et
al., 1982; Phillips et 81.,' 1985).
While the effect of smoking on the immune system function and its
causal 8SSocia ~ioq with various disease processes are well established, -the
chemical c;ompound(!) In c1garelt~ w~ich causes ,these im~une alterations .is
not precisely ide~tiflcd. Among ' the numerous .lXlnstituents, cad~um _ is
likely to cause the immunosuppression, ~ cadmium is known to-have a
stcops affmlty for human lymphocytes (H ildebrand and Cram, 1979).
cigarette smoke contains' a large amount of cadmium, and in the present
mouse study it 1rtts been demonstrated that cadmium at low doses also
affects .the immune system. Since ~e C<l:,dmium induced immunopathology ",.
mice was sh~ to be' prevented by large doses of zinc, so . it was logical
to 'study the ~~ect of zinc' supplementatio~ on Immunity among cigarette
smokers.
".
Fourtee n healthy smokers and 10 non-smokers, aged between 23 and 35
yean, pnifcipated in the study. They were all free from any "overt
diseases and .taking .any dietary supplementation or medicatio~
.v:
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known to alter immune functions. The s~kers were consuming al Ieasl
one packet of cigarettes-a-day for a minimum of 6 yean. Due to their
young age. however, the pack-years of smoking were not large end varied
from 6 to 20. Young s~kers only were studied to exclude the naturl;Il age-
related decline of immunocompetence. The smoken and non-smokers were
matched for age, sex and body build (Table 6.1). The subjects were given
SO mg elemental zinc twice-a-day for 4 weeks, and blood was collected
immediately be fore and after zinc supp~ement8tion for study of immune
functions, lipid profile and trace element levels. The subjects were asked
. . .
nOI to make any noticeable changes in their smoking habit, diet or
physical activity ' during the study period. The study protocol was approved
by the Huma n Investigation Committee ot . the Faculty <tf: Medicine,
.Memorial Un~e~ity of New£oundland.
The laborat ory "methods followed essentially identical to the '
mouse study described in Chapter 4, with some modifICations as described
below. Blood leukocytes and Iymphocy1~ were counte d using standard
Neubauer counting chamber (Section 4.3.1). The lymphocytes were separa ted
by density grad ient centrif.ugation (Section 4.8.1), and the number of T
cells, helper/inducer T cells, suppressor/cytotoxic T ' cells, natunl·killer
cells and B ,cells were counted br direct immunofluorescence microscopy
(Section 4.7.1) using appropriate specific monoclonal or polyclonol
antibodies. The monoclonal antibodies used were phycoerythrin (PE)-
conjugated anti-Leu-a for T ' cells (CD3), fluorescein isothlocyanate (FI!q-
conjugated .anti-Leu.3a for helper/inducer"' T . cells (CO~), PEXonjugaled
~n1i-Leu-2a for suppressor/cytotoxic T cells (CDS) and PE-eonjugat~ antl-
Leu-He for natural-killer cells (CD I6) (all from Bect~n Dickinson
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TABLE 6.1
Ch ar actertstfcs of the Study Population
Number of subjects
Sex (ma le : female)
Age (yrsl, mean (range)
Height (em), mean ± sd
. Wei gh t (Kg), mean ± sd
Mid-ann ' circumference
(em), mean :!: sd
Triceps 'ki nCaid thickness
(mm), mean ± sd •
Cigare ttes smoked per day
mea n (range)
Pack-yean of smoking
mean (range)
•.. ,. '
Non-smokers Smokers
10
"4 :6 3 : 11
28·7 (23.35) 27'2 (23-34)
'165·6 :l: 10-4 16306 ± 12·6
60-3 ± 12·5 61-3 ::!: 1(}6
2&2 :!: 3·4 27-0 ± 4'2
17·0 ± 3·5 18·5 :t &4
23·2 (20-30)
13-6 (6-20)
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lmmunocytomet ry System, Mountain View, California) . For B cells, FITC·
conjugat ed goat anti-human immu noglobulins (l gG. 18M , IgA) F(ab')2 (Onho
D iagnos tic Sys tem, R aritan , New .-' Jersey) was used. Lymphocyte:
transfonn ation respon se of perip hera l blood lymphocyte s' 0 the T cell
mltcge ns PHA an d Con A ,were 8S53yc:d in a 72 hour cu lture (Section 4.5.2);
and natural-killer ce ll activity was assayed in a a-ho ur chromi um rele ase
may (Section 4.8) using the ' hum an leu kemi a cell noe K562 as targe ts.
Plasma samp les were . analyzed for elemen t levels . by
spectrophotometry (4.12) and seru m lip id levels were estima ted by sta ndard
...biochemical and electro phoretic methods. Da ta we re : ' a nalyzed on the
Memorial UniversitY VAX/VMS mainframe computer using the statistlcal
Packages MINrrAB (Rya~ Joiner :and Rya~ 19~D; Ryan, J~iner and. Rynn
1985b) and SAS (Cody' and Smith, 1985). The grouped t-test was used to .
compare ' the smokers and non-smokers values, while pa ired t-test was used
to . compare . the _pre- and
level used was 0.05.
post-zinc supplementation values. Significance
~
• ' Results of the study are shown in Tables 6.2, 6.3 and 6.4, and Figures
6.1, 6.2 and 6.3. In s~okers the leukocyte, Iym~hocyte, T cell,
helper/inducer T cell and natural killer count was unalter ed; while the
supp ressor/cytotoxic T ce ll count w~ high. The results are in ag~eemenl
with tho~ reported by others (H ughes er al., 1985; Peti iii and Kjpp, 1986;
Gin~s et 81., '1982). Zinc trea tment ' rc:du.ced the suppressor/eYtoto~ T cell
count of smekers to value. see n in non -smokers and . increased the ratio of
helpe r to' suppresse r T ce lls. Th ere is a discordance ~tween the: re.ult. ~f
CD8-+: suppressor/cytot~c T cell _ nu mber in the a~Imal and human
experiment. The reason for this difference is not clea r. Future work will
' , ,'"
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TABLE 6.2
Circulating Lymphocyte Profile
Non-smokers (0=10) Smokers (0= 14)
Before Zn After Zn • Before Zn After Zn
4iI
r;i'o~e 6-9 :t "H 7·5 ± 1·7 7'3 ± 1'3 7·8 ± 2·2
LiiQij)Locyte 2'4 ± 0·6 2'4 ± (}6 2·9' ± O·6§ 2·7 ± 0·8 .
T cell 65-0 ± 8·3 ~7'9 ± 50{) 65'1 ± 8-5 66-4 ± 4·8
%
\h'lper ~ 43·4 ± 7·4 41-2 .± 8·7 45·1 ± 10-3 46·9 ± 9-5
T~uppressor 24·7 :t 4·0 24·6 ± 2·9 29-4 ± &1- 25·2 ± 3·5
h~~f{~uPP 1·8 ± (}O3 "1·7 ± l}S 1-6 ± (}4 1·9 ± (}4t
s.een 32·3 ± 5·9 3(}l:t H 27'2 '± 5·7· 25'3 ± 3<5
%
NK-cell. 13·1 ± 2·9 13·7 ± 2·0 tH . ± 3·2 12·9 ± 3·9
. %
\
Results are expressed as mean ± sd.
·P<(H)5 'IS non-smo kers by grouped "t-test .
tp <(}OS 'IS pretreatment value by pai.red t-test.
§p- o-os vsnon-smokers by grouped t-test.
" L
.~
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TABLE 6.3
Serum U pid Profile
Non -smokers (n-=10)
Before Zn After Zn
Total-Chi 5·1 :t (}9 4·8 ::t: 0·9
(mmol/L) I ~
LDl-Ch1 3·0 ± (}OS 2·7 ± 0-7
(mmol/L)
HDl-Ch1 i-s ± os 1·5 :t {)o4
(mmol/L)
Tri&iY.Uride 1'3 ± 0-9 1-4 ± 100
Risk factb r 3·1 :t io H ." 0-6
Results are expressed as mea n e sd.
tP:<(H)5 vs pretreatm ent value by paired t-test,
-. Smokers (n.. 14)
Before Zn After Zn
S·3:t 1-1 5'; ).'1'0
3·4 :t 101- 3'1 :t: J·ot
1-3 :t {}o3 J'3 :t oa
H:t 0-4 }"·4.% (}S
4·3 ± 1·7 4-1:t 1-6
' .
v, ", '
. ..•..
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TABLE 6.4
"-Trace Element Levels in Plasma
Smokers (n"'14)
Before Zn After Zn
..
Before Zn After Zn
' .
~lVdl
Zinc 88.3 :t 13.8 130.9 :t 33.St 85.9 ± 10.5 i0 1.5 :t 11.8t
Copper 99.3 ± 23.3 . 92.7 .± 18.1t 116.8 .:!: 40.3 . 105.2 ± 326t _
Cadmium 0.81 ± 0.41 1.45 :!: Q.ss t 1.03 ± 0.39 1.51 :!: asst
ResullJ are expressed as mean ± sd.
t p<().()5 VI pre treatment value by paired t-t~t.
~_.
f
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LYMPHOCITE TRANSFORMATION RESPONSE TO
PHYTOHAEMAGGLUTININ
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FIG. 6.1
Lymphocyte transformation response to phytohaemagglutinin in non-smokers
and smokers lymphocytcs before and after zinc treatment. Results are
expressed as stimulation index which represents 'the ratio between the
mean counts per minute of triplicate cultures stimullJted with mitogen •
divided by the mean counts pelf minute of triplicate control cu l ture~. Bars
represent mean ± SD of 'ea~ group. Smokers had higher ('P <0.05)
stimulation index compared to non-smokers. Zinc treatment reduced
(tP<O.05)the response in smokers to non-smokers' level.
I
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LYMPHOCY11! TRANSFORMATION RESPONSE TO
CONCANAVAUN A
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FIG. 6.2
. Lymphocyte transrtlnnation response to concanavalin A in non-smokers and
smokers before and after zinc treatment. Results are exPressed as
stimulation index which represents the ratio between the counts per minute
.of triplicate cultures sti~ujated , With mitogen divided by the mean counts
per minule of triplicate CQf.trol cultures-.Ban represent mean ± SO of each
group. Smokers had higher (·P<O.OS) stimulation index comp~red to non-
smoken. Zinc treatment reduced (t P<o.OS) the response in smokers to non-
. smoken ' level .
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NATURAL-KILLER CELL ACTIVITY
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FIG. 6.3
Natural-killer cell activity (expressed as % lysis) in non-smoker, and
smokers before (0) and after (.) 'Zinc treatment. Each point represents one
value and the bars represent the mean value in each group. Smokera
tended (P>O.05) to have low baseline natural-killer '- cell activity as
compared to non-smokers. After zinc treatment the activity Increased
(P<O.05) in both non-smokers and smokers.
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.be required to deliniate the possible mechanism for such difference ·
between the mouse and human work. In varo Iymp~e trans formation
response 10 PHA and Con A was increased if1: smokers, Silvenn an er , 81..
{J97S) abo reported increased lymphocyte transformation response in )ding
smokers. Zinc red uced the response to conrfo( Values. The increased
reaetivil)' in these lubjeeu may reflect their . retauve fy you~g age and
relatively shorter duration of exposure .to cigarette smoke . Given a large
exposu re and older ~ubjects smoking is llSSOfiated with , ·reduction in such
lyinphocyte responses "(Silverman et el., 1915). Natural-killer ce ll activity,"
which is known to be suppressed in heavy smokers (Phillips et 01., 1985),
w.as seen t o be slightly reduced in this study, however. zinc treatment.
increased the response in both smokers and non-smokers. Serum tolw.
cholesterol and tDL-<:holesterol tended to be high while HDL-eholesterol
tendedyfJ'bs low in Imoken. Similar altera tions in serum lipid .. prpfile . in .
,heavy smokers have been re ported by et hers (Brischeuo, Connor, Connor .
and Matarazzo. 1983; Stamford. Matter, pen, Sady, Papane k and p esanta,
19&4). . Zinc trea tment had no marked effect on the serum lipid profile, '
LDL-cholesterol d~eased shghtly but sigmrJCantly m smokers followtng
ZInc trea~ment. , llowing . zinc sUPPrlementation, plasma ZI~c I~els
Increased In both ups while copper levels decr eased. De crease IR plasma
copper by ZInc has en" repo rted by others (Brewer, Hili, Prasad , chssak
and Rabbani, 1~). Plasma cadmium level was slightly increased in
smokers, and zinc treat~ent increased the level further in both ~.oups.
The" cause of Increased plasma cadmium by zinc is not known, it "pi'ight
represent an. increased mobiliZation of Cadmium from body. stores by zinc.
. ' . .... .:.. ~ '._-..
..,
~i
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Th e results show tha t a modera te dose of zinc can correct
.
smoki ng-induced alte rations of the cellular immune functions in ib is study
popula tion; It is tempting to specu late that the ~neficia l e ffect of zinc on
"-the immune alte ra tions in SfQO kCTS was the resu~ o f. cad mlu m-zlnc
interaction, ~ but furth er studies need to be doni before B definite .
conc lusio n can be reached. Studies sho uld be do ne to" confirm if cadmium,
indeed, _is the cause of immune . deran gementa" seen [n smokers" . Although
the e ffect of zinc on immunity a.mo ng smokers may be a ncn-e peelftc
effect, this is unlikely, as the effect was only observed in smoke rs en d
not in n0J.1-Smokers . ' That ~da;ljum and zinc Intera ction do. occuf i~"~
relation to ~igarette smoking . was d emo nst ra ted in studies by Kuhner t,
Kuhne rt, Debe nne and Williams (1987) and Kuhnert, Ku hne rt, Erhard,
Brashea r, Gro b-wergc and We bster ( 1987). ~ t was shown th at in preg nant
women who smoked, low bir th we ight o f babies was corr elate d with
increased'tadmiu~ level rn the place nta and decreased zinc level in fetal
circula tion. Based on the res ults it was . suggested that zinc '
supple me nta tion should be co nside red
for the pregna nt smo kers .
I!artial means of inte rvent ion
II has historically been d ifficult to prove causality betwee n smoking
and disease. Howeve r, with time, enough evidenc e has accumulated thllt a t
prese nt little doubt remains as ' to the adverse ' effects of smoking:
Similarly, it is difficult to p rove causal ity in the present st udy bet ween,
cad mium and zinc variables a nd immu ne dysfunction. . However, the results
do suggest . that an interactio n may exist, ' a.nd if it can be conclusively
shown, the n zinc tre atmen t ma y prov e to be a useful form ~or seco ndary
. . . \
. (> .
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,
prevention of .ec me llI·cffects of cigare tte smoking in those: who fail 10
give .up the ha~lt.
6.9. SUMMARY ·AND CONcetmlNG REMARKS
In this study it was"'demonstrs tcd that cadm ium at ern oral dose of .50
ppm affects the number and function o f suppressor T cells and natural-
killer cells in micc : Iu a result IgM and IgO antibody produc tion was
increased folltW.1ng cadmium treatment and the natura l·killer (em activity
was reduced. Altho'ugh cadmium is known to have a long hal f-life in
t issues , hs effects o n the immu ne system in thi s study wer e sho rt lived
and the im mune fu nclions of mice recovered within 3 weeks of cessation
of trealment. However, in the kidn eys, which were also affect ed - as
evidenced -by ultr ast ructural abn ormalities, the ~ffects o f ca d mium toxicity
persisted cvc~ 6.. weeks after cessairo n of treatme ,,:t. Th e other important
" , find ing ,of _ th is st udy was the ~emonstratlon that zinc at an oral dose of
SOOppm prevented the "ca d mium-induced imm unopathology.
. ( . .
The, mec hanismes) of - cadmi um-im munopathblogy and its prevention by
zinc ca n ~ mediated through ee mutua l anta~onism _'between the two
meta ls ' for , different struc~ural and regula to ry prqteins. It is ' known that
zinc -.is essential for the function of many meta~_I~nzymes so me of whi~h
are require d. for im'!1une -(unctions. and for the structural integrity of
biome mbra nes , .n ccle le acids and ge ne expression regulatory proteins. It is ,
possib le that cadmi um disp laces zinc" fro m these essential sites to exe rt its
toxic ~ffects and,a . large d oses o~ zinc prevents this phenomenon. Cadmium
. can also int erfer e with zi nc met abolism in tissues or cause Ii funct iona l·
-- ~ .:
(
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rine de ficiency in the immune eeus and tine: counteracts these effects.
Further studies should je done 10 test these hypo theses..
Cadmium-I nduced immunopathology panlally explains the oeserveuon of
increased infection and ma lignancy in laboratory animals treat ed with
cadmium. In humans. the possible immunotoxic pcte ntial of the metal is not
greatly appreciated, bUI demonstration of lmmunoicdch y b! a low dose of
cadmium In this study suggests th~ t cadmium may well be immunotoxlc In
man. Cadmium may thus be an lI'dditlonal risk (actor for the development
of certain diseases in man like atopic diseases, infection and malignancy,
all of which arc more- common in people exposed to unusual concentration.
of cadmium. O garett e smoken arc one such group who arc known to
. .
acquire . large amounts of cadmium from thi! source. Although the possible .
immu~otoxic compou nd (s) in ·cigareuc smokc is not kn~ cadmium Is a
likely candidat e.' Studies can be done to further eneraetenee the
immunological effeeu or cigarette smoking; role. oC cadmium, if any, In the
', . , ~' ..
phenomen on; and the ·Ciffcet -oC zinc on smokin'g induced immunopalhology•.
Results of ~e prelimiMl)' stu~ done as an extenslon ,of the mouse work,
suggest Ihal zinc may bencficial ly affect the immunc system alteratlcns
seen in cigare tte smokers, This.. fmdiag may thus lay 8 fertile ground for
future research',
Gyne~ol 1980; 136:216-221.
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